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Abstract 
Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing neurodevelopmental 
disorder, defined by maladaptive levels of inattentive and hyperactive/impulsive behaviours. In 
youth, more males than females receive a diagnosis and the literature is clear in identifying that 
females with ADHD may be underdiagnosed compared to males. The sex ratio balances out in 
adulthood, but the diagnosis in adulthood is less common in comparison to youth and is based on 
age-appropriate adaptations of behavioural symptom descriptions developed to reflect ADHD in 
childhood. Research has uncovered a wider range of traits that are characteristic of the disorder 
and could form part of the core symptomatology, which have the potential to aid diagnosis in 
adults, such as excessive spontaneous mind wandering.  
In this thesis, I capitalise on the strengths of epidemiological datasets to investigate sex 
differences in ADHD across the lifespan and aim to uncover factors that may influence differential 
referral and diagnostic rates. The first two empirical chapters examine sex differences in youth. 
Specifically, I examine whether different factors are associated with meeting diagnostic criteria in 
females versus males, whether sex-dependent biases in parental perceptions of ADHD symptoms 
exist, and whether the predictive associations of symptoms on being diagnosed and treated for 
ADHD differs in males and females. The last two empirical chapters investigate ADHD in adulthood 
and whether a new measure based on the internal subjective experience of ADHD symptoms - 
excessive mind wandering - could have clinical utility in ADHD diagnosis and add to our 
understanding of sex differences in the manifestation of ADHD.  
My findings suggest that females’ ADHD symptoms may need to be made more prominent by 
additional behavioural and emotional problems for them to receive clinical recognition for their 
ADHD, and that in the absence of prominent externalising problems females may be more easily 
missed in the ADHD diagnostic process. Furthermore, sex differences in parental perceptions of 
ADHD behaviours and impairment were demonstrated, indicating that parents may be less 
sensitive to ADHD symptoms and impairment in females which could lead to under-referral. My 
findings also suggest that excessive mind wandering is a common co-occurring feature of adult 
ADHD that has specific effects on impairment, and that a newly developed measure of mind 
wandering - The Mind Excessively Wandering Scale (MEWS) – could have clinical utility as an 
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additional screening tool in adult ADHD assessment and be used for treatment monitoring. 
Moreover, that the pattern of sex differences observed for the behavioural symptoms of ADHD in 
youth and adulthood are also reflected in the internalised and subjective experience of excessive 
mind wandering in adulthood.  
It is a public health concern if individuals with ADHD are being missed and not gaining access to 
services and treatment that they could benefit from, and thus are at greater risk for the adverse 
outcomes associated with ADHD. Overall, the results of this thesis highlight the need for a careful 
approach in the assessment of individuals with symptoms of ADHD, specifically females and 
adults. More research is needed to interrogate further the reasons why females with ADHD may 
be under-referred and under-diagnosed.  
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Chapter 1: Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by 
developmentally inappropriate and impairing levels of inattention and/or 
hyperactivity/impulsivity, that often persists into adulthood (Biederman, Petty, Evans, Small, & 
Faraone, 2010; Faraone, Biederman, Spencer, et al., 2006). ADHD has an estimated worldwide 
prevalence of 5.3% amongst children and adolescents (Polanczyk, de Lima, Horta, Biederman, & 
Rohde, 2007) and 2.5 – 4.4% in adults (Kessler et al., 2006; Simon, Czobor, Bálint, Mészáros, & 
Bitter, 2009). 
In children and adolescents, ADHD is more commonly diagnosed in males, with the sex ratio 
ranging from 2:1 to 10:1 (Arnold, 1996; Gaub & Carlson, 1997; Novik et al., 2006; Ramtekkar, 
Reiersen, Todorov, & Todd, 2010; Willcutt, 2012). However, the sex ratio in childhood and 
adolescence appears to be dependent on the type of sample, with higher male-to-female ratios 
found in clinical versus population-based samples. Further, the sex ratio in adulthood tends to be 
more equal (Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004; Solberg et al., 2018). This 
suggests that in youth, ADHD affects a greater proportion of females than reflected in clinical 
practice and that differences exist in the diagnostic process for males and females with ADHD 
symptoms (Biederman et al., 1999; Rucklidge, 2010). It also suggests that investigating sex 
differences in population-based samples could extend and enrich our understanding of the ADHD 
construct beyond that of clinical samples. Potentially, males and females may manifest their ADHD 
differently, which could contribute to sex differences in referral and diagnosis of the disorder. 
The conceptualisation of ADHD as a disorder of attention and hyperactive/impulsive behaviours is 
perhaps narrow, in the sense that there are a wider range of traits and impairments shown to be 
characteristic of the disorder. Further, despite the continuation of the disorder into adulthood 
being reflected in the latest edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5; American Psychiatric Association [APA], 2013), the defining symptom descriptions still 
very much reflect childhood ADHD. As ADHD does not have a single, simply identifiable form, 
diagnosing it requires an observer's interpretation of behaviour. In childhood, typically parents 
and teachers provide information on a child’s symptoms, whilst in adolescence and adulthood self-
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report is usually the main source of information for the diagnostic process. Although diagnosis is 
made based on the presence of the core symptoms of inattention and hyperactivity/impulsivity, 
studies have begun to identify other relevant (potentially core) features of ADHD that could aid 
the diagnostic process, such as excessive spontaneous mind wandering (Seli, Smallwood, Cheyne, 
& Smilek, 2015). Enhancing our understanding of the broader range of symptoms and problems 
associated with ADHD and the phenomenology that underlies ADHD symptomatology, has the 
potential to aid diagnosis and inform targets for interventions. It may also provide further insight 
into sex differences in the manifestation of ADHD.  
This thesis seeks to further our understanding of the sex differences in youth and adult ADHD 
which may influence referral and diagnostic rates, by examining whether: 1) different factors are 
associated with meeting diagnostic criteria in females versus males, 2) sex-dependent biases in 
parental perceptions of ADHD symptoms exist, and 3) symptoms differentially predict being 
diagnosed and treated for ADHD in males and females. Furthermore, this thesis investigates 
whether a new measure based on the internal subjective experience of ADHD symptoms - 
excessive mind wandering - could have clinical utility in ADHD diagnosis and add to our 
understanding of sex differences in the manifestation of ADHD. 
The following sections provide a more detailed overview of ADHD based on current understanding 
of the disorder, with specific focus on the aspects of relevance to this body of work. This 
introductory chapter concludes with an overview of the contents of this thesis. 
1.1 Diagnosis and symptoms of ADHD 
There are two classification systems used in the diagnosis of psychiatric conditions: the 
International Classification of Diseases (ICD-10), published by the World Health Organisation 
(World Health Organisation, 1992), and the Diagnostic and Statistical Manual of Mental Disorders 
(DSM), published by the American Psychiatric Association (APA) (American Psychiatric Association, 
2013). The research in this thesis is based on the DSM-IV or DSM-5 classification of ADHD (the 
specific edition is detailed in the relevant chapters). 
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The DSM-5 diagnostic criteria for ADHD sets out 18 symptoms: nine symptoms of inattention, six 
symptoms of hyperactivity, and three of impulsivity, grouped into the two symptom dimensions of 
inattention and hyperactivity/impulsivity (Table 1.1). To meet diagnostic criteria for ADHD, a child 
must present with six or more symptoms from at least one dimension (American Psychiatric 
Association, 2013). The criteria further specify that the onset of several of these symptoms must 
have been prior to age 12 years, have been present for at least 6 months to a degree that is 
inconsistent with the child’s developmental level, and that several symptoms must be present in 
more than one setting. There must also be clear evidence of symptoms interfering with 
functioning in the social, school, or work realm. If all criteria are met, and the symptoms are not 
better explained by another psychiatric disorder, then a diagnosis of ADHD can be made. For 
diagnosis in older adolescents and adults (aged 17 years and older), a slightly lower symptom 
threshold is implemented, with at least five symptoms required in either symptom domain.  
Based on the differential manifestation of the two core dimensions of symptoms, the DSM-5 also 
distinguishes three presentations of ADHD: the predominately inattentive presentation, met when 
six or more (five in adults) symptoms of inattention are present; the predominantly hyperactive-
impulsive presentation, met when six or more (five in adults) symptoms of 
hyperactivity/impulsivity are present; and the combined presentation, met when at least six 
symptoms (five in adults) of both dimensions are present. The DSM-5 also requires the level of 
severity to be specified (mild, moderate or severe). 
The ADHD diagnostic criteria in DSM-5 differs only slightly from the DSM-IV. The most prominent 
revisions include a change from the onset of symptoms and impairments before 7 years of age to 
onset of several symptoms before 12 years of age, age-appropriate changes to the wording of 
items (giving examples of how symptoms may manifest in adulthood), and allowing for the 
diagnosis of ADHD in conjunction with other frequently co-occurring disorders such as Autism 
Spectrum Disorder (ASD) (but the symptoms must not be better explained by this condition). 
Other subtle but important changes include an alteration from evidence of impairment in at least 
two settings, to evidence of symptoms in two or more settings, and that functional impairments 
should interfere with, or reduce the quality of functioning, compared to the previous requirement 






The ICD-10’s equivalent to ADHD as set out in the DSM-5, is ‘hyperkinetic disorder’ (World Health 
Organisation, 1992). Fundamentally, the two classification systems describe the same disorder, 
but with slight differences in item wording. However, the number of symptoms required in each 
domain differs, with the ICD-10 requiring endorsement of all three types of symptoms for 
diagnosis, perhaps more akin to the DSM-5 combined presentation of ADHD. In ICD-10, onset also 
remains at before 7 years of age. For these reasons, ICD-10’s hyperkinetic disorder is considered a 
stricter classification of the disorder, identifying a more severely affected group of individuals 
(Döpfner et al., 2008; Lee et al., 2008; Sørensen, Mors, & Thomsen, 2005). 
In clinical practice neither classification system is used in isolation, and additional guidelines on 
the diagnosis of ADHD are often provided; for example, in the UK the National Institute for Health 
and Care Excellence (NICE) provide guidelines for ADHD diagnosis and management (NICE, 2018). 
NICE recommend that, as well as comprising DSM or ICD assessment, the diagnostic process 
should also include assessment of the individual’s needs, circumstances (social, familial, and 












Table 1.1.DSM-5 symptom checklist for ADHD 
Inattention 
1. Often fails to give close attention to details or makes careless mistakes in schoolwork, at work, or during other
activities (e.g., overlooks or misses details, work is inaccurate)
2. Often has difficulty sustaining attention in tasks or play activities (e.g., has difficulty remaining focused during 
lectures, conversations, or lengthy reading)
3. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, even in the absence of any
obvious distraction)
4. Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace 
(e.g., starts tasks but quickly loses focus and is easily sidetracked)
5. Often has difficulty organizing tasks and activities (e.g., difficulty managing sequential tasks; difficulty keeping 
materials and belongings in order; messy, disorganized work; has poor time management; fails to meet deadlines)
6. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (e.g., schoolwork or
homework; for older adolescents and adults, preparing reports, completing forms, reviewing lengthy papers)
7. Often loses things necessary for tasks or activities (e.g., school materials, pencils, books, tools, wallets, keys,
paperwork, eyeglasses, mobile telephones)
8. Is often easily distracted by extraneous stimuli (for older adolescents and adults, may include unrelated thoughts)
9. Is often forgetful in daily activities (e.g., doing chores, running errands; for older adolescents and adults, returning
calls, paying bills, keeping appointments)
Hyperactivity and Impulsivity 
10. Often fidgets with or taps hands or feet or squirms in seat
11. Often leaves seat in situations when remaining seated is expected (e.g., leaves his or her place in the classroom, in 
the office or other workplace, or in other situations that require remaining in place)
12. Often runs about or climbs in situations where it is inappropriate (in adolescents or adults, may be limited to
feeling restless)
13. Often unable to play or engage in leisure activities quietly
14. Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or uncomfortable being still for extended 
time, as in restaurants, meetings; may be experienced by others as being restless or difficult to keep up with)
15. Often talks excessively
16. Often blurts out an answer before a question has been completed (e.g., completes people’s sentences; cannot
wait for turn in conversation)
17. Often has difficulty waiting his or her turn (e.g., while waiting in line)
18. Often interrupts or intrudes on others (e.g., butts into conversations, games, or activities; may start using other
people’s things without asking or receiving permission; for adolescents and adults, may intrude into or take over
what others are doing)
Note: Items replicated from DSM-5 (American Psychiatric Association, 2013) 
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1.2 Categorical versus dimensional approaches to ADHD 
Diagnostic manuals, including the DSM and ICD, implement categorical classifications of mental 
health disorders such as ADHD. Such diagnostic classification systems create a division between 
what is typical or ‘normal’ behaviour versus pathological and ‘abnormal’, leading to categorisation 
of an individual as meeting diagnostic criteria (affected) or not (unaffected). This clearly has utility 
for clinical practice, enabling the identification of individuals with ADHD that is severe and 
impairing and whom will likely benefit from access to treatment, equating to a binary treatment 
decision (Coghill & Sonuga-Barke, 2012). However, there is now much converging evidence that 
the behavioural symptoms of ADHD are quantitative traits distributed continuously throughout 
the population, lying on a spectrum of normal trait variation, with clinically significant ADHD 
representing the extreme of this continuum rather than being qualitatively different (Frazier, 
Youngstrom, & Naugle, 2007; Haslam et al., 2006; Larsson, Anckarsater, Råstam, Chang, & 
Lichtenstein, 2012; Levy, Hay, McStephen, Wood, & Waldman, 1997; Lubke et al., 2007; Salum et 
al., 2014). For example, the genetic and environmental aetiology are shown to be similar for 
categorical and dimensional definitions of ADHD behaviours (i.e., for both disorder and trait) 
(Chen et al., 2008; Larsson et al., 2012; Levy et al., 1997). Studies using a polygenic risk score 
derived from individuals diagnosed with ADHD predicted ADHD traits in the general population, 
which demonstrates high genetic overlap between the categorical diagnosis of ADHD and the 
continuous trait in the population (Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2014; 
Stergiakouli et al., 2015). The implications of such findings are that multiple genes and 
environmental influences of small effect contribute to the spectrum of symptoms and that no 
single factor is either necessary or sufficient for diagnosis. 
When viewing traits as dimensional, where to implement the cut-off for clinically significant 
symptoms that warrant diagnosis and treatment becomes a substantial issue. The absence of a 
distinct point of rarity means that it becomes unclear where to delineate the boundary between 
normal and pathological. This is further complicated by the considerable heterogeneity of ADHD; 
for example, two people can be diagnosed with ADHD but have very different manifestations (i.e., 
present with different combinations of symptoms from the diagnostic criteria). Careful 
consideration of the diagnostic threshold for ADHD is of great importance. In clinical practice, in 
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moderate to severe cases the continuous nature of the disorder should not create difficulties with 
regard to diagnosis, as at the extremes of range it is likely to be apparent who warrants 
intervention. However, in mild cases or more subtle manifestations of the disorder, it is less clear 
cut (Asherson, Buitelaar, Faraone, & Rohde, 2016). If the cut-off is too strict, children who would 
benefit from support may be excluded from this option. Questions also arise around what should 
happen to individuals presenting at subthreshold to the diagnostic criteria but who may still 
experience significant functional impairment and whom would benefit from treatment (Coghill & 
Sonuga-Barke, 2012; Polanczyk, Salum, Sugaya, Caye, & Rohde, 2015). Furthermore, some critics 
of the categorical approach have raised the issue that the same criteria are applied to males and 
females, and since the empirical basis for these criteria is derived from research conducted largely 
among males only, this could be inappropriate and a potential reason why more males than 
females are diagnosed (Lubke et al., 2007) (this is discussed further in section 1.3.4.2). This 
highlights the importance of managing diagnostic thresholds effectively, since failure to meet full 
diagnosis limits access to a range of services, despite the association of subthreshold ADHD with 
real world impairment (Angold, Costello, Farmer, Burns, & Erkanli, 1999; Balazs & Kereszteny, 
2014; Bussing, Mason, Bell, Porter, & Garvan, 2010; Faraone, Biederman, Spencer, et al., 2006; 
Hong et al., 2014; Noren Selinus et al., 2016). Conversely, if the cut-off is too low then typically 
developing children could be labelled with ADHD and given unnecessary stimulant medication. 
The National Collaborating Centre for Mental Health (NCCMH, 2009) emphasise the importance of 
linking symptoms to impairment, which may be a better measure of identifying those who would 
benefit from treatment rather than arbitrary symptom counts. Conceptually, impairment is not 
the same as severity. In ADHD, severity relates to the frequency, pervasiveness, and intensity of 
the symptoms, whereas impairment is what results from the symptoms. Consequently, one could 
have high severity of symptoms but not experience impairment, perhaps due to environmental 
circumstances being suited to symptoms (for example, an artist who experiences the spontaneous 
and uncontrolled thoughts as the root of their creativity, or those with high levels of support from 
significant others). Another individual could have symptoms of less severity but experience high 
functional impairment, again speaking to the heterogeneity of ADHD. 
Both categorical and dimensional approaches to ADHD have value in the investigation of the 
disorder and its underlying psychopathology. A benefit of the categorical approach is that it offers 
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a common language between clinicians, healthcare professionals and researchers, and reduces the 
potential of risky and unethical treatment where not indicated (Coghill & Sonuga-Barke, 2012). 
However, a dimensional approach to ADHD enables investigation of ADHD in population-based 
samples unselected for clinical extremes for epidemiological research, reducing the risk of 
ascertainment bias that is associated with clinical samples. Further, these types of samples include 
children for whom formal diagnosis is absent or unknown and also enables the study of the clinical 
need of those who do not meet full diagnosis. The research in this thesis uses both symptom 
counts - viewing behaviours along a continuum of severity - and clinical cut-off. The approach used 
is specified in each chapter, with some employing both approaches. The importance of 
impairment in ADHD is also emphasised. 
1.3 Epidemiology of ADHD 
1.3.1 Prevalence 
Meta-analytic evidence estimates the worldwide prevalence of ADHD in children and adolescents 
at 3.4 – 7.2% (Polanczyk et al., 2007, 2015; Thomas, Sanders, Doust, Beller, & Glasziou, 2015; 
Willcutt, 2012), leading it to be considered one of the most common neurodevelopmental 
disorders in childhood. The evidence suggests that the prevalence has remained constant over the 
past three decades (Collishaw, 2015; Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; Rydell, 
Lundström, Gillberg, Lichtenstein, & Larsson, 2018; Safer, 2018; Thomas et al., 2015) in both boys 
and girls (Rydell et al., 2018), and that cross-cultural variability is limited (Polanczyk et al., 2015; 
Willcutt, 2012), speaking against the view that ADHD is merely a cultural construct. However, as 
with most mental health disorders, the diagnosis of ADHD is dependent on subjective ratings of 
symptom clusters as opposed to objective measures of etiological processes or biomarkers. This 
can lead to wide variability in prevalence estimates, and research shows that heterogeneity in 
estimates across studies can be attributed to varying study methods, including the diagnostic 
criteria employed, the diagnostic measures used, inclusion of impairment criterion, source of 
informant, and sampling methods (Polanczyk et al., 2007, 2014, 2015; Willcutt, 2012). This 
suggests that methodological differences influence overall prevalence and highlights the 
importance of establishing pervasiveness of symptoms and impairment. However, evidence does 
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document that diagnosis and medication rates have increased over time (McCarthy et al., 2012; 
Rydell et al., 2018; Safer, 2018). This could be attributed to a variety of factors, such as increased 
awareness of ADHD, changes in clinical practice and ADHD management, parental and public 
attitudes to diagnosis and treatment, adjustment to the DSM criteria, and/or changes in the 
impact of symptoms and degree of impairment (which could be influenced by societal and cultural 
norms and interpretation of ADHD symptoms) (Safer, 2018). 
In adulthood, the prevalence of ADHD is estimated at 2.1 – 5.8% (Faraone & Biederman, 2005; 
Fayyad et al., 2007; Kessler et al., 2006; Matte et al., 2015; Simon et al., 2009; Vitola et al., 2017; 
Willcutt, 2012). It is not clear if the lower prevalence rates in adulthood compared to those 
observed in youth reflect true estimates due to remittance of ADHD from childhood (which will be 
discussed more in section 1.3.2), or lower recognition of ADHD in adults leading to under-diagnosis 
(Asherson et al., 2016; Deberdt et al., 2015; Faraone & Biederman, 2005; Ginsberg, Quintero, 
Anand, Casillas, & Upadhyaya, 2014). There are still relatively few diagnostic services for adult 
ADHD in many regions of the world, and those with ADHD in childhood can also be lost during the 
transition from child to adult mental health services (Asherson et al., 2016; Ginsberg et al., 2014). 
Further, adult ADHD symptoms such as emotional lability and restlessness are often mistaken for 
comorbid disorders and attributed to another disorder altogether (Ginsberg et al., 2014). Under-
diagnosis could also result from the employment of different informants in the diagnostic process 
in adulthood, where ADHD diagnoses relies heavily (often exclusively) on self-report as compared 
to parent and teacher reports in childhood. In addition, up until the release of the DSM-5 
(American Psychiatric Association, 2013), adult ADHD diagnosis was based on behavioural 
descriptions of ADHD symptoms developed for children, with no adaptation for adult 
presentations (American Psychiatric Association, 1994, 2000), which is likely to have affected 
prevalence estimates (Matte et al., 2015; Vitola et al., 2017). 
A clear understanding of the prevalence of ADHD is imperative for efficient service planning and 
resource allocation, which has implications for both the affected individual and society. This may 
be especially important for clinicians working with adults, as compared to in childhood, screening 
for ADHD in adults is not commonplace (Faraone & Biederman, 2005). Further, identifying the 
most effective screening methods and informant, and the most appropriate cut-off thresholds for 
diagnosis is of great importance (Polanczyk et al., 2015). In adulthood, assessing ADHD symptoms 
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based on observed behaviours may be less appropriate and subjective reports of mental state 
changes could be more informative, but limited attempts have been made with regard to a 
phenomenological approach in ADHD (i.e., an approach based on subjective experience) (Asherson 
et al., 2016). One objective of this thesis is to examine the value in taking a phenomenological 
approach to ADHD by evaluating a newly developed measure based on patient reports of their 
internal experience of ADHD (further information is given in section 1.5.2.2). 
1.3.2 Developmental Trajectory 
Initially, ADHD was believed to be a disorder confined to childhood, but it is now recognised to 
frequently persist into adolescence and adulthood (Asherson et al., 2016; Biederman et al., 2010; 
Faraone, Biederman, & Mick, 2006), with estimates of persistence rates ranging from 15 – 87% 
(Biederman, Monuteaux, et al., 2006; Cheung et al., 2016; Faraone, Biederman, & Mick, 2006; van 
Lieshout et al., 2016). A meta-analysis of follow-up studies found that ~15% of children with ADHD 
retained full diagnostic status (syndromatic persistence) by the age of 25 years, but when including 
those meeting criteria for partial remission (symptomatic persistence, involving maintenance of 
partial diagnostic status with impairment) the persistence rate was in the region of 40 - 60% 
(Faraone, Biederman, & Mick, 2006). More recent follow-up studies have found much higher 
persistence rates, ranging from 50 – 86.5% for full diagnosis (Cheung et al., 2016; Lara et al., 2009; 
van Lieshout et al., 2016) and 8.4% maintaining subthreshold symptoms (van Lieshout et al., 
2016). The persistence of inattentive symptoms tends to be greater than symptoms of 
hyperactivity-impulsivity, which have been shown to decline with age (Biederman, Mick, & 
Faraone, 2000; Larsson, Dilshad, Lichtenstein, & Barker, 2011; Pingault et al., 2015; Sollie, Larsson, 
& Mørch, 2012; van Lieshout et al., 2016; Willcutt, 2012). 
Varying persistence rates could result from differences across studies in the classification of 
persistence or remittance, the inclusion of impairment criteria, the subtype and severity of the 
study sample, and the presence of comorbidity (van Lieshout et al., 2016). Limitations also exist in 
the relatively small sample sizes of existing persistence studies and that follow-up was only into 
young adulthood. Studies in larger cohorts are needed, as well as those that study later adulthood 
(i.e., >25 years). Thus, it is hard to deduce clear developmental trajectories of ADHD. 
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Although findings suggest that ADHD attenuates over time, symptom reduction across the 
developmental trajectory could reflect developmental insensitivity of earlier versions of the DSM 
(Faraone, Biederman, & Mick, 2006). The detailed studies were before the introduction of DSM-5, 
where changes were implemented in the diagnostic criteria to facilitate diagnosis in adults, and so 
‘true’ persistence rates may potentially be higher than the existing estimates. The DSM-5 also 
allows for the possibility that adults with ADHD may not have met full diagnostic status in 
childhood, enabling children who had subthreshold levels of symptoms and no impairment to 
meet diagnostic criteria for ADHD in adolescence and adulthood. Thus, the DSM-5 acknowledges 
the possibility that full diagnosis of ADHD may emerge at difference stages in the developmental 
trajectory (Asherson et al., 2016). 
Recently, evidence has emerged that raises the possibility of a late-onset form of ADHD in the 
absence of a history of substantial symptoms in childhood (Agnew-Blais et al., 2016; Caye et al., 
2016; Moffitt et al., 2015). Three large-scale longitudinal population-based studies found that 
around 67.5 – 90% of adults who met diagnostic criteria for ADHD did not meet criteria in 
childhood. Agnew-Blais et al. (2016) also found that those with late-onset ADHD were more likely 
to be female and have higher IQ. Such studies propose that ADHD may not always be a 
continuation of the childhood disorder, but instead emerge in late adolescence or adulthood. They 
raise the possibility that late-adolescent or adult-onset ADHD could represent a distinct diagnostic 
entity that differs in onset, developmental trajectory, and aetiology from childhood ADHD (Agnew-
Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015). The studies also speak to the view that the 
age of onset criteria are based on clinical wisdom and are not yet strongly supported by empirical 
data (Asherson et al., 2016).  
This is currently a topic of considerable debate and it has been suggested that the studies showing 
late-onset ADHD may have overestimated its prevalence (Asherson et al., 2016; Faraone & 
Biederman, 2016). These studies had methodological limitations, such as not assessing 
subthreshold symptoms or using the 18 DSM items in childhood (Caye et al., 2016), and the use of 
self-report in adulthood instead of informant report (as in childhood diagnosis) (Agnew-Blais et al., 
2016; Caye et al., 2016). Another potential explanation for these findings is that in the presence of 
positive scaffolding or protective factors (e.g., high IQ, well developed executive functioning skills, 
supportive and structured home and school environment), instead of presenting with the full 
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diagnostic syndrome some children may manifest subthreshold ADHD symptoms (Asherson et al., 
2016; Faraone & Biederman, 2016). Due to this scaffolding they are able to compensate for their 
symptoms, but once such scaffolding is removed (e.g., when leaving the home or school 
environment) and new challenges of adult life present, the full syndrome may emerge (Asherson 
et al., 2016; Faraone & Biederman, 2016). Thus, individuals with childhood-onset and adult-onset 
may have the same underlying liability for ADHD, but when such protective factors are present in 
childhood the symptoms may not become impairing and exceed diagnostic thresholds until a later 
developmental stage when this scaffolding is removed (Agnew-Blais et al., 2016; Kosaka, Fujioka, 
& Jung, 2018). This highlights the importance of monitoring subthreshold symptoms in childhood 
(Faraone & Biederman, 2016).  
It is also possible for this explanation to work in the converse way, in that children who meet full 
diagnostic criteria for ADHD in childhood may no longer meet threshold in adulthood due to the 
selection of environments that are more suited to their symptoms. Thus, symptoms are no longer 
experienced as impairing (Agnew-Blais et al., 2016; Kosaka et al., 2018). 
A recent study has proposed that the symptoms and impairments of those with late-onset ADHD 
may be better explained by substance use or another mental health disorder (Sibley et al., 2018), 
and studies in adult ADHD clinics suggest adult-onset to be less frequent (Lopez, Micoulaud-
Franchi, Galera, & Dauvilliers, 2017; Solanto, 2018). Thus, these recent findings require replication 
and further investigation and should be interpreted with caution at this early stage. However, the 
absence of a childhood diagnosis of ADHD should not preclude adults with ADHD from accessing 
services if their level of impairment warrants it (Agnew-Blais et al., 2016). 
1.3.3 Co-occurring disorders 
Studies in both epidemiological and clinical samples show that most individuals with ADHD have 
multiple co-occurring disorders (Bauermeister et al., 2007; Biederman, Newcorn, & Sprich, 1991; 
Elia, Ambrosini, & Berrettini, 2008; Ford, Goodman, & Meltzer, 2003; Ghanizadeh, 2009; Jensen & 
Steinhausen, 2015; Kadesjö & Gillberg, 2001; Kraut et al., 2013; Larson, Russ, Kahn, & Halfon, 
2011). A recent study found 52% of children and adolescents diagnosed with ADHD had at least 
one co-existing psychiatric disorder and 26% had two or more (Jensen & Steinhausen, 2015), 
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whilst others have found as many as 87% have one or more co-existing diagnoses and 67% have 
two or more (Kadesjö & Gillberg, 2001). Individuals with subthreshold ADHD symptoms can also 
experience high rates of comorbidity (Kadesjö & Gillberg, 2001). 
Externalising problems such as conduct disorder and oppositional defiant disorder are among the 
most frequent co-occurring behavioural disorders, found in between 10-67% of youth with ADHD 
(Bauermeister et al., 2007; Bendiksen et al., 2017; Elia et al., 2008; Ford et al., 2003; Ghanizadeh, 
2009; Jensen & Steinhausen, 2015; Kadesjö & Gillberg, 2001; Kraut et al., 2013; Larson et al., 2011; 
Reale et al., 2017; Steinhausen et al., 2006; Wichstrøm et al., 2012). Internalising problems, such 
as mood and anxiety problems are also commonly found to co-occur with ADHD. Studies indicate 
that between 6-44% of youth with ADHD also have a co-occurring anxiety disorder (Bauermeister 
et al., 2007; Elia et al., 2008; Larson et al., 2011; Reale et al., 2017; Steinhausen et al., 2006; 
Wichstrøm et al., 2012), and between 3-32% have co-occurring depression (Bauermeister et al., 
2007; Elia et al., 2008; Ghanizadeh, 2009; Larson et al., 2011; Steinhausen et al., 2006; Wichstrøm 
et al., 2012). 
ADHD also shows high rates of comorbidity with other neurodevelopmental disorders and specific 
learning difficulties (Jensen & Steinhausen, 2015; Kadesjö & Gillberg, 2001; Thapar & Cooper, 
2016). One of the most commonly co-occurring neurodevelopmental disorders is autism spectrum 
disorder (ASD), which has been shown in 6-50% of children with ADHD (Jensen & Steinhausen, 
2015; Larson et al., 2011; Rommelse, Franke, Geurts, Hartman, & Buitelaar, 2010). Co-existing 
learning difficulties (such as dyslexia, dyscalculia and writing disorders) have been found in 
between 3-56% (Carroll, Maughan, Goodman, & Meltzer, 2005; DuPaul, Gormley, & Laracy, 2013; 
Larson et al., 2011; Reale et al., 2017; Sexton, Gelhorn, Bell, & Classi, 2012).  
Co-occurring disorders are also frequent in adulthood, with around 75-90% of those with ADHD 
believed to have at least one co-existing condition (Ginsberg et al., 2014; Kooij et al., 2010). In this 
age group, co-occurring conditions also include conduct and oppositional problems, depression, 
anxiety, ASD, and learning difficulties (Bolea-Alamañac et al., 2014; Friedrichs, Igl, Larsson, & 
Larsson, 2012; Ginsberg et al., 2014; Hesson & Fowler, 2018; Kessler et al., 2006; Schmidt & 
Petermann, 2009). Furthermore, bipolar disorder, personality disorders and substance use 
disorders are also common (Bolea-Alamañac et al., 2014; Gudjonsson, Sigurdsson, Sigfusdottir, & 
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Young, 2012; Hesson & Fowler, 2018; Jacob et al., 2007; Kessler et al., 2006; Sobanski, 2006; 
Solberg et al., 2018). For example, studies have estimated that among adults with ADHD, between 
5-32% may also have bipolar disorder (Asherson et al., 2014; Halmøy et al., 2010; Solberg et al.,
2018), 30% have a co-occurring personality disorder (Huntley & Young, 2014), and between 9-58% 
have a substance use disorder (Magon & Müller, 2012; Sizoo et al., 2010; Sobanski, 2006; Solberg 
et al., 2018). Sleep problems are also frequently reported in adults with ADHD (Asherson et al., 
2016; Bjorvatn et al., 2017; Díaz-Román, Mitchell, & Cortese, 2018; Van Veen, Kooij, Boonstra, 
Gordijn, & Van Someren, 2010). 
In many cases of those with ADHD and co-existing symptoms of other disorders, diagnostic 
overshadowing may occur and alternative diagnoses may be given (Asherson et al., 2014; Ginsberg 
et al., 2014; Kooij et al., 2010; Reale et al., 2017). Co-occurring symptoms and disorders may be 
associated with greater impairment (Bauermeister et al., 2007; Steinhausen et al., 2006), and as it 
is so often the case that ADHD is comorbid with other disorders it can be challenging to 
disentangle which symptoms are leading to the adverse outcomes (Nigg, 2013). 
1.3.4 Sex Differences 
A striking observation in childhood ADHD, and a well-established feature of the disorder, is the 
large sex difference in referral and diagnostic rates, in the direction of male dominance. The ratio 
of males to females with ADHD in youth falls in the realm of 2:1 to 10:1 (Arnett, Pennington, 
Willcutt, Defries, & Olson, 2015; Biederman et al., 2002; Novik et al., 2006; Ramtekkar et al., 2010; 
Willcutt, 2012), with the more pronounced male: female ratios found in clinical samples compared 
to population-based samples. Further, by adulthood the sex ratio of ADHD tends to be closer to 
equal (Biederman et al., 2004; Solberg et al., 2018). This suggests that in youth, females may be 
underdiagnosed in the community (Ramtekkar et al., 2010), indicating potential sex differences in 
the process of referral and diagnosis for those with ADHD symptoms (Arcia & Conners, 1998). 
More research in non-referred samples is needed to greater understand these issues, facilitate 
further understanding of the disorder, and ensure that females with ADHD are not being ‘missed’ 
in childhood leading to greater risk of negative long-term outcomes. This was a primary objective 
of this thesis and so a more detailed overview of current understanding of sex differences in ADHD 
is now provided. 
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One explanation for the observed sex differences in referral and diagnosis in youth is that females 
with ADHD are more likely to present with predominantly inattentive symptoms, and often greater 
levels of internalising symptoms such as anxiety and depression, rather than the hyperactive and 
impulsive symptoms (Arnold, 1996; Quinn, 2008). In contrast, males with ADHD are often 
characterised as presenting with externalising disruptive behaviours, with more hyperactivity, 
impulsivity, and co-occurring behavioural problems such as oppositional defiant and conduct 
disorder (Arnold, 1996; Quinn, 2008). If females present with less overt disruptive behaviour they 
may be less likely to be referred due to their behaviour having less of a negative impact on parents 
and teachers. Additionally, their internalising symptoms may lead to alternative diagnoses, such as 
an anxiety disorder or depression. However, the literature provides inconsistent findings regarding 
sex differences in the phenotypic presentation of ADHD. Findings also appear to be affected by a 
range of factors, including the diagnostic measures used, the informants, and the sample type  - 
namely if it is a clinically ascertained or population-based sample (Gaub & Carlson, 1997; Gershon, 
2002; Ramtekkar et al., 2010).  
Studies in clinical samples of males and females have found the combined presentation is the most 
prevalent, followed by the inattentive and hyperactive/impulsive presentations (Biederman et al., 
1999, 2005, 2002; Ghanizadeh, 2009; Novik et al., 2006). Some studies have found that females 
are more likely than males to be diagnosed with the inattentive presentation (Biederman et al., 
2002; Rucklidge, 2010), whilst others have shown no difference (Ghanizadeh, 2009). Population-
based studies tend to show that males are more likely than females to meet criteria for all of the 
subtypes of ADHD (Ford et al., 2003; Graetz, Sawyer, & Baghurst, 2005; Levy, Hay, Bennett, & 
Mcstephen, 2005; Ramtekkar et al., 2010; Willcutt, 2012), and that the inattentive presentation is 
most common in both sexes (Ramtekkar et al., 2010; Willcutt, 2012). However, a meta-analytic 
review found that among children meeting criteria for ADHD from the population, a significantly 
larger proportion of females had the inattentive presentation compared to males, with the 
opposite pattern for the combined presentation (Willcutt, 2012). A study employing interview 
assessment (rather than rating-scales) found that although a greater percentage of females had 
the inattentive versus hyperactive/impulsive presentation, there was still a higher percentage of 
males with the inattentive presentation compared to females (Ford et al., 2003). The use of 
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structured diagnostic interviews for subject identification when exploring sex differences in ADHD 
has been highlighted as a necessity (Gaub & Carlson, 1997). 
These findings suggest that females with ADHD are more prone to having difficulties with 
attention, although findings are not consistent or definitive. Primarily inattentive symptoms tend 
to be rated as less impairing than the externalising hyperactive and impulsive symptoms (Coles, 
Slavec, Bernstein, & Baroni, 2012; Willcutt, 2012), and research indicates that individuals with the 
combined presentation are more likely to be referred (Willcutt, 2012). This means an individual 
with primarily inattentive symptoms of ADHD may be less frequently referred for services 
(Nussbaum, 2012), which has implications for females if it is the case that they have a more 
inattentive presentation. 
Regarding co-existing symptoms, when comparing females and males in clinical samples, some 
studies show that females with ADHD demonstrate less risk for depression (Biederman et al., 
2002), whilst others find that females score greater for depression and males for anxiety 
(Mitchison & Njardvik, 2015), and others find that females and males are equally as likely to be 
impaired by anxiety and/or depression, but females have greater parent-rated emotional 
symptoms (Novik et al., 2006). Further, some studies have shown males to have greater conduct 
disorder compared to females (Jensen & Steinhausen, 2015), whilst others find an absence of 
differences in externalising symptoms (Mitchison & Njardvik, 2015). A number of other studies 
also detail a lack of sex differences for co-occurring problems (Arcia & Conners, 1998; Novik et al., 
2006; Sharp et al., 1999). Population-based samples show the percentage of males and females 
with ADHD meeting symptom criteria for depressive disorders to be similar (Graetz et al., 2005), as 
well as the absence of sex differences for externalising disorders (Graetz et al., 2005; Levy et al., 
2005).  
Research has also demonstrated that females with ADHD are less likely to have learning difficulties 
or manifest problems at school compared to males (Biederman et al., 2002; Graetz et al., 2005), 
which could lead to lower identification of ADHD in females (Biederman et al., 2002; Graetz et al., 
2005). In addition to greater prosocial behaviour in females compared to males with ADHD (Novik 
et al., 2006), this could mask impairment to key informants. 
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In relation to symptom severity, studies tend to show that males and females in clinical samples 
have similar severity, but in population-based sample males tend to have higher ratings compared 
to females. In one of the first meta-analyses of sex differences in ADHD, Gaub and Carlson (1997) 
found lower rates of inattention, internalising behaviour, peer aggression and peer disliking 
among females versus males with ADHD identified from non-referred populations. However, in 
clinic-referred samples these differences between males and females with ADHD were not 
observed. Findings also demonstrated within-sex differences; clinic-referred and non-referred 
males with ADHD presented with similar levels of internalising behaviour relative to non-ADHD 
males. In contrast, clinic-referred females with ADHD had higher levels of internalising behaviours 
than females without ADHD, but this was not shown in non-referred females with ADHD versus 
females without ADHD. This highlighted that clinic-referred females may not be representative of 
non-referred females in the same way that males are. In the most recent meta-analytic review, 
Gershon (2002) found that in non-referred populations, females with ADHD had lower ratings for 
hyperactivity and inattention than males, but in clinic samples parent ratings of inattentiveness 
were greater for ADHD females than ADHD males. Of note, conclusions from both meta-analyses 
were based on extremely small female samples.  
Findings from more recent studies investigating sex differences in ADHD symptom severity in 
diagnosed cases are inconsistent: some studies have demonstrated that ADHD symptom severity 
is greater in females (Fedele, Lefler, Hartung, & Canu, 2012), lower in females (Arnett et al., 2015), 
or a there is a lack of differences between male and female symptom severity (Elkins, Malone, 
Keyes, Iacono, & McGue, 2011). In contrast, most population-based screens for ADHD tend to find 
higher mean ADHD symptom scores in males relative to females (Larsson et al., 2012; Levy et al., 
2005; Martin et al., 2014), although there are exceptions (Graetz et al., 2005).  
Sex differences in adult ADHD have received much less attention in the literature in comparison to 
childhood (Corbisiero, Hartmann-schorro, Riecher-Rössler, & Stieglitz, 2017; Fedele et al., 2012) 
and have often been neglected as a potential moderator of the nature of adult ADHD (Solberg et 
al., 2018; Williamson & Johnston, 2015). The few studies that do exist also demonstrate mixed 
results regarding whether males and females are affected differently by ADHD in adulthood. Some 
studies find that females with ADHD have higher symptom levels and impairment than males with 
ADHD (Fedele et al., 2012; Fredriksen et al., 2014; Nussbaum, 2012), some show only higher 
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current inattention symptoms (Biederman et al., 2004), and others show a similar phenotypic 
presentation (Rasmussen & Levander, 2009; Wilens et al., 2009). A lack of differences could be due 
to the fluidity of the subtypes and the reduction of hyperactive/impulsive symptoms with age 
(Larsson et al., 2011). Regarding sex differences in co-morbidity, studies are lacking and again the 
existing findings are mixed. A recent study using Norwegian national registry data found that the 
association between ADHD and psychiatric comorbidities differed significantly amongst males and 
females (Solberg et al., 2018). Specifically, prevalence differences between ADHD and non-ADHD 
adults were significantly larger amongst females than males for anxiety disorders, bipolar disorder, 
major depressive disorder, and personality disorder. The opposite pattern was observed for 
schizophrenia and substance use disorder, with greater prevalence differences amongst males. 
The reason for the substantial sex difference in ADHD diagnosis observed in youth is unclear 
(Martin, Taylor, et al., 2018; Martin, Walters, et al., 2018) and is likely to be complex due to the 
extreme heterogeneity of ADHD. One hypothesis is that the observed sex differences may reflect 
true etiological differences due to a ‘female protective effect’. This theory proposes that females 
require greater genetic and environmental ‘load’ or exposure to risk factors associated with ADHD 
to manifest the same degree of impairment as males with ADHD and warrant diagnosis (Eriksson, 
Lundström, Lichtenstein, Bejerot, & Eriksson, 2016; Rhee & Waldman, 2004; Taylor et al., 2016). 
Partial support for this hypothesis has been demonstrated: for example, siblings of females with 
ADHD have been found to display greater risk of ADHD compared to siblings of males with ADHD 
(Martin, Walters, et al., 2018; Rhee & Waldman, 2004; Taylor et al., 2016). This suggests that when 
ADHD exists in females it reflects a greater exposure to genetic and environmental factors 
associated with ADHD compared to ADHD in males. An alternative explanation is that parents may 
have a higher threshold for recognising ADHD symptoms in daughters, or clinicians may have a 
higher threshold for diagnosing ADHD in females (Martin, Walters, et al., 2018). Furthermore, 
clinicians may be more likely to diagnose ADHD in females if their ADHD symptoms are 
accompanied by additional behavioural problems which make their ADHD symptoms more 
prominent (Martin, Walters, et al., 2018). 
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Another set of hypotheses put forward are the Mean Difference and the Variance Difference 
Models. The Mean Difference Model proposes that, relative to males, the female liability 
distribution for ADHD symptoms is shifted in the less-affected direction. Given the absolute cut-off 
for diagnostic status, fewer females will fall into this category and so more males will be diagnosed 
(Arnett et al., 2015). When controlling variances across sexes, it has been shown that more males 
are present in the top affected percentile and more females are present in the least affected 
percentile (Arnett et al., 2015). The Variance Difference Model proposes that greater variance in 
males symptom scores leads to more males falling into the extreme tails of the distribution (this 
also has the expectation that more males fall into the non-symptomatic extreme) (Arnett et al., 
2015). Arnett et al. (2015) found this was the case, but the sample was over-selected for ADHD 
symptoms which, as detailed next, may mean that more males were selected. Thus, the findings 
require replication. 
Speaking to the view that observed sex differences do not reflect ‘true’ differences, it may also be 
that the lower prevalence of ADHD in females in clinical samples is due to systematic referral or 
identification biases, or that diagnostic criteria are biased or poorly defined for females compared 
to males (Williamson & Johnston, 2015). Despite it now being widely recognized that a large 
number of females suffer from ADHD (Nussbaum, 2012; Rucklidge, 2010), diagnostic criteria may 
be geared towards the identification of ADHD in males (Martin, Taylor, et al., 2018; Nussbaum, 
2012). Indeed, the DSM-IV criteria for ADHD were based primarily on observations of behaviour in 
male children (Lahey et al., 1994) and the DSM-5 field studies included a greater percentage of 
males (Clarke et al., 2013). It has also been shown that parents perceived the DSM-IV ADHD 
criteria as being descriptive of males (Ohan & Johnston, 2005). If diagnostic criteria are based on 
male presentation of the disorder, then females may be less likely to meet full diagnostic criteria 
and instead classify as subthreshold (Hong et al., 2014), particularly if ADHD in females is 
expressed as greater internalising symptoms, rather than externalising symptoms that are not as 
directly observable. 
As there is currently no existing biomarker for diagnosis, behavioural diagnoses such as ADHD can 
bring issues of interpretation and perception. The tendency to view ADHD as a predominantly 
male disorder can affect how behaviour in males and females is perceived by individuals key to the 
diagnostic process (such as parents and teachers). If a male stereotype of ADHD is the norm, then 
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it is possible that parents and teachers may not as readily recognise manifestations of ADHD in 
females compared to males. Thus, potentially only the most severe females or those whose 
symptoms manifest as disruptive behaviours will be identified. A recent study found that parent 
ratings of females with ADHD were not consistent with levels of directly observed behaviours 
(Meyer, Stevenson, & Sonuga-Barke, 2017). In males and females with directly comparable levels 
of ADHD symptoms in the classroom (based on blind assessment from researchers using a 
validated ADHD observation measure), parents and teachers rated the ADHD behaviours lower in 
females. This led the authors to conclude that parents and teachers may be less sensitive to 
ADHD-type behaviours in females (Meyer et al., 2017).  
Another factor which may suggest a clinical referral bias in childhood is that the sex disparity 
appears to balance out in adulthood (Ginsberg et al., 2014; Solberg et al., 2018). However, the 
reasons for this remain unclear. It could indicate that in youth females with ADHD tend to be 
misdiagnosed or underdiagnosed, but this changes in the adult years due to greater awareness of 
ADHD and/or greater ability of adult women to self-report on ADHD symptoms. Further, females 
are more likely to present to adult mental health services compared to males, initiating referral 
themselves as opposed to parents and teachers in childhood (Arcia & Conners, 1998; Kessler et al., 
2006). Alternative explanations are that the age of onset tends to occur later in females (Agnew-
Blais et al., 2016), or it may reflect a buffering effect of earlier developmental maturity and 
increased sociability which masks impairment in females. 
Thus, the high sex ratio in diagnostic rates of ADHD could partly reflect sex-specific stereotypes 
operating in the referral process and/or bias in the current diagnostic criteria, or the way they are 
applied to males and females in clinical settings. Clearly, referral and diagnostic biases are 
potentially important contributing factors to the observed sex differences in the prevalence of 
ADHD and it is imperative to clarify these possible sources of bias as potentially females with 
ADHD are being missed and not gaining access to services they would benefit from. However, they 
are unlikely to be the sole explanation. As discussed, in the population mean scores are generally 
higher for males suggesting the contribution of other factors (Martin, Taylor, et al., 2018). 
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Given that historically ADHD was thought of as primarily a male disorder, our current 
understanding of ADHD is mainly based on findings from studies of how the disorder manifests in 
young males. Knowledge regarding the impact and expression of ADHD in females in childhood 
and especially adulthood remains relatively sparse (Holthe & Langvik, 2017).  
Further, much of the knowledge we have about sex effects in ADHD comes from clinical samples. 
Given the male preponderance observed in clinical samples of children with ADHD, such studies 
may not provide the full picture regarding sex differences in ADHD or generalise to the overall 
ADHD population. This potential problem is suggested by the difference in ratio of males to 
females with ADHD in population-based samples compared to in clinical samples (with greater sex 
ratios found in clinical samples). Previous meta-analyses have also highlighted that clinic-referred 
females may not be representative of non-referred females in the same way that males are (Gaub 
& Carlson, 1997; Gershon, 2002). Clearly information is needed about those individuals whose 
ADHD is not diagnosed, especially females. The two meta-analyses of sex differences in ADHD 
called for more research to better understand sex differences in ADHD and highlighted a particular 
need for population-based studies to avoid potential biases inherent to clinical samples (Gaub & 
Carlson, 1997; Gershon, 2002). It is therefore of interest to consider in more detail the differences 
between females and males in non-referred or population-based samples to identify sex 
differences in the presentation of ADHD which might contribute to the systematic sex bias in 
diagnostic practice. 
However, despite many studies highlighting the issue of sex differences in ADHD and the lack of 
clear understanding regarding them, there is still a lack of research in this area. Many studies fail 
to acknowledge sex differences as a core moderator in their analysis and very few actually test for 
sex effects. In those studies that do, most look at sex differences post hoc rather than a priori 
(Davies, 2014). Additionally, many studies often do not include an equal balance of males and 
females in their studies to allow for powered analysis of sex differences in relation to their chosen 
outcome, with many studies of ADHD still recruiting predominantly male samples. Regarding 
adulthood, in their review of sex differences in adults with ADHD, Williamson and Johnston 
commented that “gender has been neglected as a potential moderator of the nature of ADHD in 
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adulthood”, and findings on sex differences in adults with ADHD seem to be lacking (Corbisiero et 
al., 2017; Fedele et al., 2012). 
If we are to significantly progress in our understanding of ADHD then it is imperative that a clearer 
understanding of the impact of sex in the disorder is achieved, including how the disorder 
manifests in females. Sex effects can influence all aspects of ADHD, from referral and diagnosis, to 
intervention and outcomes. When ADHD remains unrecognised, leading to late or missed 
diagnosis, this means that adequate treatment options are lost, and long-term outcomes may be 
more adverse (Holthe & Langvik, 2017; Quinn, 2005). For this reason, it is of great importance that 
both sexes are equally included in research studies of ADHD, at least until differences and 
similarities in males and females with ADHD have been firmly established. Studying sex differences 
in ADHD can also increase our understanding of the underlying aetiology, and will benefit the 
academic community, clinicians, teachers, females with ADHD and their families, as well as society. 
Understanding sex differences in ADHD also has the potential to inform diagnostic practices. For 
example, if it is the case that females with ADHD have a more internalising manifestation of the 
disorder then it could be of value to develop measures that are better able to assess these aspects 
of ADHD. Current measures are validated in male samples and are very much based on male 
manifestations of ADHD, reflecting predominantly externalising behavioural symptoms. As it is 
possible that the manifestation of ADHD in females differs from males, it is important to examine 
if alternative assessments may aid diagnosis. 
1.3.5 Summary 
ADHD is one of the most common psychiatric disorders of youth that frequently persists into 
adulthood, although research in this age group is relatively limited in comparison to childhood 
ADHD. A high incidence of co-occurring traits and disorders are found in those with ADHD and the 
evidence suggests that ‘pure’ ADHD without comorbidity is a rarity. In youth, more males than 
females are diagnosed with ADHD, whilst in adulthood females constitute a more equal proportion 
of the ADHD population. Reasons for the shift in the ratio of diagnosed males-to-females between 
35
childhood and adulthood remain to be clarified. Further, the ratio of males-to-females with ADHD 
in childhood differs in clinical versus population-based samples, potentially meaning that females 
are being ‘missed’ or misdiagnosed. This has led to questions regarding the manifestation of ADHD 
in females. It also highlights – along with the current view of ADHD as a dimensional trait - the 
value of studying the ADHD phenotype in population-based samples. 
1.4 Aetiology of ADHD 
Consistent with its heterogeneity, ADHD is a multifactorial disorder that presents a complex 
aetiological architecture arising from the interplay between genetic and environmental factors 
(Thapar & Cooper, 2016).  A key focus in the investigation of ADHD has been on understanding 
how the combined effect of genetic and environmental influences contribute to risk for ADHD and 
its associated impairments. 
1.4.1 Genetics 
Family, twin, and adoption studies consistently indicate that ADHD is highly heritable (Faraone et 
al., 2005). For example, twin studies of liability for ADHD among children and adolescents have 
found strong genetic influences, with heritability estimates around 60-90% (Burt, 2009; Faraone et 
al., 2005; Larsson, Chang, D’Onofrio, & Lichtenstein, 2014; Nikolas & Burt, 2010). Similar 
heritability estimates for the two symptom dimensions of ADHD have been shown, with 
substantial genetic overlap found between inattention and hyperactivity/impulsivity as well as 
independent genetic effects (Greven, Rijsdijk, & Plomin, 2011; Larsson, Lichtenstein, & Larsson, 
2006; McLoughlin, Ronald, Kuntsi, Asherson, & Plomin, 2007; Nikolas & Burt, 2010). Studies also 
suggest persistent ADHD is more familial than non-persistent ADHD (Biederman et al., 1995; 
Faraone, 2004). Regarding sex differences, twin studies have not demonstrated quantitative or 
qualitative sex differences (Larsson et al., 2012, 2014; McLoughlin et al., 2007; Polderman et al., 
2015). Thus, the influence of genetic and environmental risk factors in the development ADHD 
appears to be of similar magnitude in males and females. 
Lower heritability estimates in the order of 30% have been reported in late adolescence and 





reflect the use of self-ratings in adult population samples giving rise to measurement error, rather 
than a lower genetic contribution to ADHD in adults. This was indicated by a review of studies that 
found the heritability of adult ADHD could be as high as 70-80% when employing cross-informant-
rated ADHD (Brikell, Kuja-Halkola, & Larsson, 2015), including a study of clinically diagnosed adults 
which estimated the heritability at 88% (Larsson et al., 2014). 
Most twin studies of ADHD have examined continuous symptoms in population-based samples, 
due to the assumption that risk for ADHD is normally distributed along a continuum throughout 
the population. Similar estimates of the genetic and environmental contributions have been found 
in studies using a categorical definition (Larsson et al., 2012, 2014). 
A more recent approach to examining the genetic architecture of ADHD involves genome-wide 
scans of a large number of unrelated individuals with ADHD compared to controls. Genome-Wide 
Association Studies (GWAS) have identified multiple common genetic variants associated with 
ADHD, each of very small effect. The most recent ADHD GWAS used a substantially larger dataset 
than previous studies and identified 12 genome-wide significant loci associated with ADHD 
(Demontis et al., 2017). Investigating sex differences in ADHD at the genetic level using the recent 
ADHD GWAS, no differences in polygenic burden between male and female ADHD cases were 
found, suggesting that in both sexes it is largely similar common genetic risk variants that 
contribute to ADHD (Martin, Taylor, et al., 2018; Martin, Walters, et al., 2018).  
1.4.2 Environmental risk factors 
Despite evidence for a large genetic component, the aetiology of ADHD is unlikely to be explained 
by genetic factors alone (Lifford, Harold, & Thapar, 2009; Thapar, Cooper, Eyre, & Langley, 2013; 
Thapar, Cooper, Jefferies, & Stergiakouli, 2012). Several environmental measures have been 
associated with risk for ADHD, such as premature birth, low birth weight, dietary factors, 
environmental toxins, psychosocial factors (e.g., adverse social and family environments), and in-
utero exposure to maternal stress, smoking, alcohol, prescribed drugs, and illicit substances 
(Thapar & Cooper, 2016; Thapar et al., 2012). However, associations between these environmental 
factors with ADHD cannot be seen to infer causation as exposure to environmental risks is not 





families with ADHD (i.e., parents provide both genetic and environmental influences) (Langley, 
Heron, Smith, & Thapar, 2012; Thapar & Cooper, 2016; Thapar et al., 2012). In addition, some 
environmental risk factors associated with ADHD may not be involved in the causal pathway, but 
influence the course and outcome (Thapar et al., 2012). For example, psychosocial risks associated 
with ADHD, such as low income and family adversity, may shape the developmental trajectory, 
severity and outcomes of ADHD rather than causing ADHD (Thapar et al., 2013). 
1.4.3 Gene-environment interplay 
Genetic and environmental factors do not act in isolation, and there is likely to be interplay 
between the two. Certain genotypes may increase the likelihood of exposure to certain 
environmental influences (gene-environment correlation) and so environmental risks can be 
brought about as a consequence of genetic propensities (Plomin, 2014). The most important 
environmental risk factors for ADHD and its secondary impairments are likely to be affected by 
genetically influenced parent and child dispositions that demonstrate gene-environment 
correlation (Thapar et al., 2013). The interplay can also take the form of gene-environment 
interaction, whereby certain genotypes can make an individual more susceptible to environmental 
risk or protective factors (Nigg, Nikolas, & Burt, 2011; Purcell, 2002). That is, the effect of 
environmental factors may depend on genetic liability, with the environment likely to play a role in 
modifying genetic factors. With each risk gene likely to have low penetrance, environmental risks 
are more likely to play an important role in the likelihood of individuals developing ADHD (Gizer, 
Ficks, & Waldman, 2009). Understanding environmental risk and protective factors along with 
their interaction with genetic risk can enable an extension of the findings from genetic studies, 
exploring the pathways to varying outcomes in individuals with ADHD (Deault, 2010). Even with a 
model that assumes a strong heritable component to ADHD, the environment remains an 
important factor to be considered in relation to the disorder’s development, manifestation, and 
outcome (Johnston & Mash, 2001). 
1.4.4 Summary 
Findings from quantitative and molecular genetics studies suggest that ADHD is highly heritable 
and of complex polygenic inheritance. Multiple environmental risk measures have also been 
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identified but their role in the aetiology of ADHD remains uncertain. The current view is that it is 
multiple common genetic variants of small to moderate effects in combination with certain 
environmental factors that contribute to risk for ADHD, but in isolation none are necessary or 
sufficient (Faraone et al., 2015). Due to the complex nature and heterogeneity of ADHD, as well as 
its shared genetics with other disorders, uncovering its genetic basis and the interplay of genes 
and environmental factors remains challenging.  
1.5 Clinical Assessment of ADHD 
1.5.1 Diagnostic considerations 
Psychiatric diagnoses are based on operational criteria and rely on descriptive accounts of 
symptoms. Currently, there are no biomarkers to determine ADHD and the diagnosis is made 
when a set of defined behavioural symptoms and criteria for onset, course and impact have been 
met. Thus, diagnosis of ADHD is dependent on subjective ratings of symptom clusters as opposed 
to more objective measures of aetiological processes or biomarkers.  
Methods to evaluate ADHD vary across the lifespan, although the principle approach remains the 
same. In childhood and adolescence, the primary informants in the diagnostic process are usually 
parents and teachers who rate symptoms based on observed behaviours. It is partly for this reason 
that the diagnostic criteria reflect observed behaviours as opposed to reports of internal mental 
states (Asherson et al., 2016).  However, there is only low-to-moderate cross-informant 
agreement for reports of ADHD symptoms; an observation that is one of the most robust findings 
in clinical child research (De Los Reyes & Kazdin, 2005). Correlations between parent and teacher 
ratings for ADHD symptoms range from 0.09 - 0.66, with a tendency towards higher rated 
symptoms from parents than teachers (Achenbach & Rescorla, 2001; Antrop, Roeyers, Oosterlaan, 
& Oost, 2002; Goodman, 2001; Murray et al., 2007; Narad et al., 2015; Papageorgiou, Kalyva, 
Dafoulis, & Vostanis, 2008; Sibley, Pelham Jr, Molina, et al., 2012; Sollie et al., 2012; Wolraich et 
al., 2004) and greater agreement for hyperactivity/impulsivity than symptoms of inattention 
(Murray et al., 2007; Narad et al., 2015). 
39
Explanations for these discrepancies include parents being better placed to assess their child’s 
overall functioning compared to teachers, as they observe and interact with them across a wider 
range of settings and situations, as well as receiving feedback from teachers regarding their child’s 
school behaviour (Shemmassian & Lee, 2012). However, teachers are likely to be more familiar 
with age-appropriate behaviour compared to parents and may be more tolerant of problem 
behaviour (Antrop et al., 2002). That said, ADHD symptoms are to some extent situation specific, 
and so this may not necessarily reflect differences in the way symptoms are interpreted by 
different informants (Valo & Tannock, 2010). 
Additionally, self-report is sometimes used among youth, which can be helpful with regard to 
general adjustment and comorbidity (especially in children aged 6 and above), but less so for 
reporting the presence or absence of ADHD symptoms (Taylor et al., 2004). Low agreement is also 
found between youths and parents (correlations range from 0.41 – 0.48) and youths and teachers 
(0.29 – 0.32) (Achenbach & Rescorla, 2001; Goodman, 2001).  
In late adolescence and adulthood, symptom presence is more often established with self-report 
(Asherson, 2005) and it is not always possible to obtain information from parents or employers. As 
with youth, agreement between adult self-report and friends, spouses, and parents are modest 
(Kooij et al., 2008; Magnússon et al., 2006; Van Voorhees, Hardy, & Kollins, 2011). Diagnosis of 
ADHD can be further complicated by difficulties establishing the presence of symptoms in 
childhood, and individuals may underestimate their difficulties (Du Rietz et al., 2016; Faraone & 
Biederman, 2016; Knouse, Bagwell, Barkley, & Murphy, 2005). However, there are also some 
studies showing that adults are able to provide accurate accounts of their current behaviour 
(Murphy & Schachar, 2000) and may provide more accurate information than informants (Kooij et 
al., 2008). 
Since the ADHD diagnosis requires the presence of symptoms in multiple settings, multiple-
informant reports are valuable and, where possible, should be incorporated into the diagnostic 
assessment in both clinical and research settings (Taylor et al., 2004). In youth, guidelines 
recommend that the views of children are taken into account when determining the clinical 
significance of impairment as a result of diagnostic symptoms (NICE, 2018). Further, self-report is 





moods and feelings. In adulthood, it is possible that greater emphasis should be placed on internal 
mental states as opposed to observable behaviours, which might enable more accurate self-report 
of ADHD symptoms such as inattention and restlessness (see section 1.5.2.2). 
Rating scales are often used in the assessment of ADHD due to their efficient nature, good 
psychometric properties, and because they can be used with multiple informants (Shemmassian & 
Lee, 2012). One disadvantage when used with informants is uncertainty about how the questions 
are interpreted, ratings applied, and halo and adaptation effects (Taylor et al., 2004). Thus, rating 
scale questionnaires are useful as an initial screening tool and for an indication of symptom 
severity, but potential biases in perceptions should be taken into consideration. For example, sex-
specific stereotypes may influence interpretations of behaviours by informants (Meyer et al., 
2017). Thus, as outlined in the NICE guidelines, a diagnosis of ADHD should not be made solely on 
the basis of rating scale or observational data, despite their value as an adjunct (NICE, 2018). 
Structured diagnostic interviews that address all relevant diagnostic criteria (e.g., age of onset, 
persistence, impairment) are considered the gold standard based on their superior psychometric 
properties (Shemmassian & Lee, 2012). The advantage of such interviews is that examples of 
specific symptoms and impairment can be elicited, and decisions based on the views of a trained 
clinical or research investigator. 
1.5.2 Additional symptoms 
Currently, ADHD is defined almost entirely at the behavioural level by reports of inattentive, 
hyperactive and impulsive behaviours. However, people with ADHD also present with other 
symptoms, including some that may form part of the core symptomatology. These include more 
subjective and internal experiences of their mental state such as emotional lability and excessive 
mind wandering (Asherson et al., 2016). Enhanced understanding of the broader range of 
symptoms or problems associated with ADHD and the phenomenology that underlies ADHD 






Research has demonstrated that emotional lability (EL) or emotional instability/dysregulation - 
characterised by volatile and fluctuating emotions and irritable mood - is a common co-occurring 
feature in ADHD (Reimherr et al., 2010; Skirrow et al., 2014). As many as 47 - 76% of children and 
adolescents and 72 - 90% of adults with ADHD report symptoms of EL (Anastopoulos et al., 2012; 
Mick, Spencer, Wozniak, & Biederman, 2005; Sobanski et al., 2010). Research also shows EL to be 
associated with persistence of ADHD into adulthood (Barkley & Fischer, 2010) and to contribute to 
impairments in major life domains, frequently showing independent effects beyond core ADHD 
symptomatology on schooling, family life, and social problems (Anastopoulos et al., 2012; Barkley 
& Fischer, 2010; Barkley & Murphy, 2010; Skirrow & Asherson, 2013). EL symptoms may also be 
more prominent in females (or viewed as less acceptable in females) (Reimherr et al., 2010; 
Sobanski et al., 2010), and linked specifically with hyperactivity/impulsivity (Skirrow & Asherson, 
2013; Skirrow, McLoughlin, Kuntsi, & Asherson, 2009; Sobanski et al., 2010). These findings have 
implications for clinical practice, suggesting that clinicians should also screen for ADHD in 
individuals who present with severe emotional instability (Skirrow et al., 2014, 2009). 
In both the DSM-IV and DSM-5, symptoms of emotional lability (i.e., mood volatility, irritability) 
are outlined as associated features of ADHD that may be used to support the diagnosis (American 
Psychiatric Association, 2000, 2013). It has also been suggested that EL may be best 
conceptualised as one of the core components of the disorder (Barkley, 2010; Reimherr et al., 
2010). Evidence demonstrates that ADHD pharmacological treatments have a similar effect on 
reducing EL as on the core symptoms of inattention and hyperactivity/impulsivity (Moukhtarian, 
Cooper, Vassos, Moran, & Asherson, 2017; Reimherr et al., 2010; Rösler et al., 2010; Skirrow et al., 
2009). In addition, EL is present at an increased rate in family members of individuals with ADHD 
(Epstein et al., 2000; Surman et al., 2011), and shares genetic influences with ADHD (Merwood et 
al., 2014). However, EL lacks specificity to ADHD since it is also seen to occur across a wide range 
of psychiatric disorders, such as borderline personality disorder and bipolar disorder (American 
Psychiatric Association, 2013; Skirrow et al., 2009). 
42
Adults with ADHD also report frequently experiencing excessive and uncontrolled mind wandering 
(Asherson, 2005). Descriptions include having a ‘mind like a hamster wheel’, ‘mind like a 
whirlwind’, and ‘thoughts jumping or flitting between different ideas’. In contrast to the core 
ADHD symptomatology (inattention and hyperactivity/impulsivity), mind wandering is very much a 
descriptive term of internal processes as opposed to a directly observable behaviour. 
Mind wandering is a universal human experience, conceptualised as periods in time when 
attention and the contents of thoughts shift away from external sources and/or ongoing tasks, to 
unrelated internal thoughts or feelings (Smallwood & Schooler, 2015) (known as stimulus-
independent or task-unrelated thought [Smallwood, 2013]). This is a ubiquitous and universal 
human experience, with individuals spending between 24 – 50% of their waking hours focusing on 
self-generated mental content (Kane et al., 2007; Killingsworth & Gilbert, 2010; Smallwood & 
Schooler, 2015; Song & Wang, 2012). The contents of a wandering mind are believed to be 
associated with affective processes (Jonkman, Markus, Franklin, & Van Dalfsen, 2017), regulated 
by executive control, and are most often of a personal nature (Smallwood & Schooler, 2015).  
Most mind wandering experiences occur without explicit awareness and individuals often fail to 
realise their mind has wandered (i.e., the individual lacks meta-awareness of their mind wandering 
state) (Christoff, Gordon, Smallwood, Smith, & Schooler, 2009; Schooler, 2002). The occurrence of 
mind wandering without meta-awareness has been referred to as ‘zoning out’, in contrast to 
‘tuning out’ which occurs when one is aware their mind has wandered (Smallwood & Schooler, 
2015). Zoning out episodes have shown association with heightened behavioural cost, such as 
failure to inhibit responses (Smallwood, McSpadden, & Schooler, 2007). The type of mind 
wandering the individual is engaging in is also of relevance and may indicate differing neural 
processes. Self-generated thoughts can occur both intentionally/deliberately (e.g., when planning 
the menu for a dinner party whilst driving to work) or unintentionally/spontaneously (e.g., when 
our mind drifts off during a lecture). Spontaneous mind wandering could reflect executive control 
failure, as opposed to deliberate mind wandering that could be engaging executive processes for 
internal information processing (Seli et al., 2015). Although mind wandering is often thought to 
represent a cognitive failure with negative implications, in some cases it may confer functional 
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value, such as for creativity or future planning, and so a complex balance of benefits and costs is 
involved.  
Despite the ubiquitous nature of mind wandering, not all minds wander to the same degree. 
Excessive mind wandering has been linked to impairment and implicated in disorders such as 
ADHD (Biederman et al., 2017; Franklin et al., 2014; Jonkman et al., 2017; Seli et al., 2015; Shaw & 
Giambra, 1993). Furthermore, both mind wandering and ADHD are related to inattention and 
distraction from external sources due to internal thoughts; and mental restlessness, a descriptive 
term encompassing mind wandering, has been reported to be common in ADHD (Downey, Stelson, 
Pomerleau, & Giordani, 1997; Weyandt et al., 2003). Given that individuals with ADHD report the 
experience of their mental state in descriptive terms that are closely related to mind wandering, 
there is strong premise to link the phenomenon of mind wandering to ADHD. Specifically, it may 
be closely linked to the inattention and characterise the subjective experience of this symptom 
(Biederman et al., 2017). However, relatively few studies exist in this area, with research on mind 
wandering and ADHD being largely independent.  
In an early study of mind wandering and ADHD, Shaw and Giambra (1993) looked at the number of 
task-unrelated thoughts in college students with a childhood history of ADHD, relative to those 
with no prior diagnosis of ADHD but who scored highly on self-report measures of ADHD 
symptoms (sub-clinical group), and to those who had low symptom scores (control group). 
Participants were asked to engage in a simple vigilance task where they were intermittently asked 
to indicate if they were experiencing thoughts unrelated to the task. If so, they were asked to 
specify if these task-unrelated thoughts were deliberate or spontaneous. Those with a childhood 
history of ADHD experienced significantly more spontaneous, but not deliberate, task-unrelated 
thoughts compared to the sub-clinical and control groups. The sub-clinical group also 
demonstrated more task-unrelated thoughts compared to controls. These preliminary findings 
suggested that a core difficulty for adults with ADHD is controlling thoughts unrelated to the 
current task or the external environment. 
Mind wandering was also associated with ADHD symptomatology in an adult community sample in 
both the laboratory and everyday life (Franklin et al., 2014). Franklin et al. (2014) found a 





lack of awareness of engaging in mind wandering. Furthermore, those with high ADHD symptom 
scores were more likely to experience mind wandering episodes that were detrimental to 
performance of the task at hand and that interfered with daily life. This is perhaps because they 
were more likely to lack meta-awareness of their mind wandering, since meta-awareness was 
found to mediate the relationship between ADHD symptomatology and detrimental mind 
wandering. Namely, the association between ADHD symptoms and detrimental mind wandering 
was reduced when accounting for awareness of mind wandering. Those with low ADHD scores 
tended to have detrimental mind wandering episodes that were also useful. In other words, they 
were willing to incur the cost to the current task if they believed the mind wandering episode 
conferred some benefit. 
More recently, Seli et al. (2015) showed that spontaneous rather than deliberate mind wandering 
is associated with ADHD symptoms, which is consistent with Shaw and Giambra’s (1993) earlier 
findings. The authors examined this in both clinical and non-clinical samples, and these findings 
were similar across groups. Regression analysis also revealed spontaneous mind wandering to 
show a strong independent association with ADHD symptoms, whereas deliberate mind 
wandering was only weakly associated. 
Some authors suggest that mind wandering in ADHD may be closely linked to the inattentive 
symptoms (Biederman et al., 2017; Jonkman et al., 2017). However, questions remain regarding 
whether excessive spontaneous mind wandering in ADHD is an epiphenomenon of the processes 
that lead to ADHD symptoms or has a more direct causal role in generating the symptoms and 
impairments of ADHD. For example, both mind wandering and ADHD have been linked to 
dysregulated deactivation of the Default Mode Network (DMN), a specific network of interacting 
brain regions that demonstrates a task-related dichotomy, with activation at rest and task-induced 
deactivation (Andrews-Hanna, Smallwood, & Spreng, 2014; Bozhilova, Michelini, Kuntsi, & 
Asherson, 2018; Castellanos et al., 2008; Christoff et al., 2009; Fassbender et al., 2009; Liddle et 
al., 2011; Mason et al., 2007; Peterson et al., 2009; Tian et al., 2008, 2006; Uddin et al., 2008; Zang 
et al., 2007). 
Collectively, these findings suggest that adults with ADHD frequently experience excessive and 
uncontrolled mind wandering, which could be a major source of the difficulties they experience 
45
day-to-day. The DSM-5 diagnostic criteria reflects this, with mention of being distracted by 
unrelated thoughts or the mind seeming elsewhere even in the absence of any obvious 
distraction. As with emotional lability, mind wandering may represent a core deficit in ADHD, but 
it is also seen in other conditions such as anxiety and depression (worrying or ruminations) or 
obsessive compulsive disorder (Seli, Risko, Purdon, & Smilek, 2017). Further research is needed to 
clarify the nature of the relationship between mind wandering and ADHD, and Chapters 4 and 5 of 
this thesis explore this. 
1.5.3 Treatment and intervention 
Given the high prevalence rates and the impairing nature of ADHD, there is a continued need for 
efficient and effective management of ADHD across the lifespan to improve prognosis for 
individuals affected by the disorder. The proportion of the population receiving treatment for 
ADHD in the UK and other Western countries is much lower than the estimated prevalence (Bolea-
Alamañac et al., 2014). The NICE guidelines recommend that when planning the management of 
ADHD, individuals have a comprehensive, holistic treatment plan that addresses psychological, 
behavioural, and educational/occupational needs (NICE, 2018). Treatment and intervention for 
ADHD will depend on symptom severity, impairments, and individual preference, but generally 
involves pharmacological treatment and/or behavioural interventions. 
The NICE guidelines recommend that in children under 5 years first-line treatment should be an 
ADHD-focused group parent-training programme. If ADHD symptoms remain pervasive and 
impairing, then further specialist opinion should be sought before the offer of medication. In 
children over 5 years, NICE recommend environmental modifications as first-line treatment (e.g., 
parental-education and classroom strategies), and medication should only be offered if symptoms 
are still causing significant impairment. In the most severe cases (i.e., individuals who are still 
experiencing significant impairment whilst on medication), it is advised that cognitive behavioural 
therapy (CBT) is offered as an adjunct to medication. In line with the persistence of ADHD into 
adolescence and adulthood, NICE recommends that healthcare providers ensure the continuity of 
care for people with ADHD (NICE, 2018).  
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In adults with ADHD, if symptoms are still causing impairment after environmental modification, 
then medication should be offered. Non-pharmacological treatment for adults with ADHD should 
be offered to those who do not wish to take medication, have difficulty adhering to medication, or 
who have found medication to be ineffective or intolerable. At a minimum, NICE recommend that 
non-pharmacological treatment should include the option of a structured and supporting 
psychological intervention focused on ADHD, regular follow-up, and may include a full course of 
CBT. However, it is important to note that across countries there is variation in the recommended 
first-line treatment for ADHD, for example in the USA the first-line treatment for adolescents 
tends to be medication, preferably in combination with behavioural therapy (Subcommittee on 
Attention-Deficit/Hyperactivity Disorder, 2011). 
When pharmacological treatment is offered, the first-line medication often involves stimulants 
such as methylphenidate and lisdexamfetamine (NICE, 2018), which affect the dopaminergic and 
noradrenergic systems (Engert & Pruessner, 2008). In those who have not responded to, or are 
unable to tolerate stimulant medications, non-stimulant alternatives can be offered, such as 
atomoxetine, a noradrenaline reuptake inhibitor (NICE, 2018). There is a large body of research 
demonstrating moderate to large effects of these medications on ADHD symptoms and outcomes 
in children and adolescents (Abikoff et al., 2004; Brown et al., 2005; Chan, Fogler, & Hammerness, 
2016; Cheng, Chen, Ko, & Ng, 2007; Findling et al., 2011; Garnock-Jones & Keating, 2009; Gayleard 
& Mychailyszyn, 2017; Prasad et al., 2013; Ruiz-Goikoetxea et al., 2018; Tanaka, Rohde, Jin, 
Feldman, & Upadhyaya, 2013; Van der Oord, Prins, Oosterlaan, & Emmelkamp, 2008) and adults 
(Castells et al., 2011; Faraone & Glatt, 2010; Koesters, Becker, Kilian, Fegert, & Weinmann, 2009; 
Mészáros et al., 2009; Moriyama, Polanczyk, Terzi, Faria, & Rohde, 2013; Sobanski et al., 2012; 
Surman, Hammerness, Pion, & Faraone, 2013), although the literature base is much smaller in this 
group and is limited beyond the fifth decade of life (Solanto, Surman, & Alvir, 2018). A recent 
systematic review and network meta-analysis comparing the efficacy and tolerability of ADHD 
medications across the life-span supports methylphenidate in children and adolescents and 
amphetamines in adults, as the preferential first-choice medications for the short-term treatment 
of ADHD (Cortese et al., 2018). However, pharmacological treatments have limitations, such as 
side effects (most commonly including reduced appetite and insomnia) (Cheng et al., 2007; 
Schachter, Pham, King, Langford, & Moher, 2001) and non-response, and complete normalisation 
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of symptoms is rare (Banaschewski et al., 2006). Additionally, the long-term effectiveness and 
safety of pharmacological treatments is not fully known (Cortese et al., 2018; van de Loo-Neus, 
Rommelse, & Buitelaar, 2011).  
Regarding non-pharmacological interventions, behavioural interventions including 
psychoeducation, CBT, support groups, skills training, and coaching are thought to provide 
benefits in the management of ADHD (Asherson et al., 2016). A recent meta-analysis, with blinded 
ratings of outcomes, found that behavioural interventions to treat children and adolescents with 
ADHD (including behavioural training, social skills training, CBT, and organisational skills training) 
had beneficial effects on important aspects of child and parent functioning, such as reducing 
conduct problems and increasing positive parenting, but non-significant effects on core ADHD 
symptoms (Daley et al., 2017, 2014). A variety of other non-pharmacological interventions for 
ADHD are also receiving increasing empirical interest, such as mindfulness (Hoxhaj et al., 2018; 
Mitchell et al., 2017; Mitchell, Zylowska, & Kollins, 2015), neurofeedback (Cortese et al., 2016), 
and cognitive training (Cortese et al., 2015). 
Overall, evidence for the efficacy of behavioural interventions in reducing core ADHD symptoms is 
not established and limited by the fact that many of those assessing the behavioural outcomes are 
not blinded to the intervention allocation (Cortese et al., 2015, 2016, Daley et al., 2017, 2014; 
Sonuga-Barke et al., 2013). Taken together, these findings highlight the need for increasing the 
number of studies assessing the efficacy of behavioural interventions for ADHD and enhancing 
their methodology, for example through blinded randomised-controlled designs and the inclusion 
of a range of outcome measures (Daley et al., 2017; Sonuga-Barke et al., 2013). 
Dietary interventions, such as omega-3 fatty acid supplementation (Bloch & Qawasmi, 2011; 
Cooper, Tye, Kuntsi, Vassos, & Asherson, 2015), restriction diets and food colour/additive 
exclusion (Nigg, Lewis, Edinger, & Falk, 2012) have also received much empirical interest, with 
some evidence to support their beneficial effects (Sonuga-Barke et al., 2013). However, the 
evidence is too weak to recommend such dietary interventions as standalone treatments for 
ADHD, but they could be useful in managing ADHD in certain cases (Nigg et al., 2012; Pelsser, 





Multimodal treatment plans including both medication and psychological interventions which are 
based on the specific needs of the presenting individual should be considered for managing ADHD 
(NICE, 2018). The large Multimodal Treatment Study of Children with ADHD (MTA) suggests 
superiority in combination treatment for composite outcomes and domains of functional 
impairment (such as academic achievement, social skills, and parenting behaviour) in the short 
term; however, evidence for the long-term effectiveness is not substantiated (Hinshaw & Arnold, 
2015). Furthermore, other studies tend not to support a significant advantage of medication 
combined with non-pharmacological intervention (Abikoff et al., 2004; Daley et al., 2017; Van der 
Oord et al., 2008).  
Interest in developing additional interventions is growing and will increase the choice for those 
with ADHD and the likelihood of finding a suitable management plan that works for them. 
Recently, studies have looked at cannabinoids and exercise as interventions which could hold 
promise in reducing the impact of ADHD (Cooper et al., 2017; Den Heijer et al., 2017; Rommel et 
al., 2015).  
 
Generally, the ADHD treatment literature has not focused on sex differences, and there is no clear 
answer regarding sex-by-treatment effects or the moderating role of sex (Rucklidge, 2010). Some 
studies have shown that males are more likely to receive ADHD medication than females (Angold, 
Erkanli, Egger, & Costello, 2000; Derks, Hudziak, & Boomsma, 2007), which could be due to 
different manifestation of the disorder. The possibility that females with ADHD are undertreated is 
an important public health concern (Rucklidge, 2010). The current thesis includes investigation of 
whether the predictive association of ADHD symptoms on receiving pharmacological treatment 
differs in males and females.  
1.6 Prognosis: Functional Impairment and Long-term Outcomes of ADHD 
In both childhood and adulthood, ADHD is often a severe and impairing disorder, with functional 
impairment necessary for diagnosis and tending to be the primary reason for referral. ADHD is 
associated with functional impairments that span multiple settings and affect a realm of major life 
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domains, such as home/family life (Chutko, Anisimova, Surushkina, & Aĭtbekov, 2011; Deault, 
2010; Eakin et al., 2004; Harold et al., 2013; Johnston & Mash, 2001; Lange et al., 2005), at 
school/work (Biederman, Faraone, et al., 2006; Biederman et al., 2008; Frazier, Youngstrom, 
Glutting, & Watkins, 2007; Gjervan, Torgersen, Nordahl, & Rasmussen, 2012; Kuriyan et al., 2013; 
Loe & Feldman, 2007; Mannuzza, Klein, Bessler, Malloy, & LaPadula, 1993; Murphy & Barkley, 
1996), and social contexts (DuPaul, McGoey, Eckert, & VanBrakle, 2001; Gardner & Gerdes, 2015; 
Harpin, Mazzone, Raynaud, Kahle, & Hodgkins, 2016; Henry, Jones, Henry, & Jones, 2011; Hoza, 
2007; Hoza et al., 2005; Kok, Groen, Fuermaier, & Tucha, 2016; Michielsen et al., 2015; Mrug et al., 
2012). ADHD is also associated with a greater likelihood of antisocial behaviour in adolescence and 
adulthood (Asherson, 2005; Langley et al., 2010; Thapar, van den Bree, Fowler, Langley, & 
Whittinger, 2006), criminality (Asherson et al., 2012; Cahill et al., 2012; Fletcher & Wolfe, 2009; 
Ginsberg, Hirvikoski, & Lindefors, 2010; Langley et al., 2010; Young, Moss, Sedgwick, Fridman, & 
Hodgkins, 2015), driving-risk and traffic accidents (Barkley & Cox, 2007; Jerome, Segal, & Habinski, 
2006), problematic substance use (Charach, Yeung, Climans, & Lillie, 2011; Harstad, Levy, & 
Committee on Substance Abuse, 2014; Huntley & Young, 2014; Langley et al., 2010; Lee, 
Humphreys, Flory, Liu, & Glass, 2011), and risky sexual behaviour (Flory et al., 2006; Hosain, 
Berenson, Tennen, Bauer, & Wu, 2012). While the symptoms of ADHD may attenuate in severity as 
individuals move across the developmental trajectory into adulthood, their impact on various 
aspects of daily functioning is still significant. Further, poorer outcomes tend to be seen when 
ADHD is untreated (Shaw et al., 2012). However, not everyone will experience the same 
impairments, again demonstrating the heterogeneity of the disorder. Some individuals may 
actually take advantage of their ADHD symptoms and so their impairing nature is reduced (Becker, 
Chorpita, & Daleiden, 2011).  
The impact of impairments linked with ADHD goes beyond the individual, affecting society as a 
whole, with large economic costs to the public (Bernfort, Nordfeldt, & Persson, 2008; Birnbaum et 
al., 2005; Doshi et al., 2012; Parsonage, 2014; Pelham, Foster, & Robb, 2007; Snell et al., 2013). 
Beyond the direct expenditures from assessment and treatment, there are long-term indirect 
costs linked to special education provisions, the criminal justice system, and problematic 
substance use treatment (Bernfort et al., 2008; Ford, Fowler, Langley, Whittinger, & Thapar, 2008; 
Hinshaw, 2018). From a societal perspective, education costs have been shown to account for the 
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largest proportion of total costs for ADHD (Parsonage, 2014; Snell et al., 2013; Telford et al., 2013). 
If individuals with certain presentations of ADHD, and specifically females, are being missed this 
will have important public health implications. The NICE guidelines (2018) specifically raise the 
issue of under-recognition of ADHD in females and encourages awareness of this amongst 
practitioners. 
1.6.1 The relationship between symptoms and impairment: undiagnosed and 
subthreshold ADHD 
The literature also demonstrates associations between subthreshold levels of ADHD and negative 
outcomes (Balazs & Kereszteny, 2014; Bussing et al., 2010; Faraone, Kunwar, Adamson, & 
Biederman, 2009; Hong et al., 2014; Malmberg, Edbom, Wargelius, & Larsson, 2011; Noren Selinus 
et al., 2016; Shankman et al., 2009). Access to a range of support services is limited in those with 
subthreshold ADHD, such as educational provisions, despite the association of subthreshold ADHD 
with real world impairment (Angold et al., 1999; Balazs & Kereszteny, 2014; Bussing et al., 2010; 
Faraone, Biederman, Spencer, et al., 2006; Hong et al., 2014; Noren Selinus et al., 2016). Also, 
many individuals with subthreshold symptoms go on to meet criteria for the full syndrome in 
adolescence and adulthood (Bussing et al., 2010; Lecendreux, Konofal, Cortese, & Faraone, 2015; 
Noren Selinus et al., 2016). This has public health implications given the associated negative long-
term outcomes.  
Further, ADHD symptoms and impairment are not isomorphic (Becker et al., 2011; Gathje, 
Lewandowski, & Gordon, 2008; Gordon et al., 2006). Thus, some individuals may be subthreshold 
and experience significant impairment, whilst others can meet threshold symptomatically but not 
experience significant impairment (Gathje et al., 2008; Gordon et al., 2006). Additionally, beyond 
adaptive functioning on the continuum is positive functioning, and it is not a foregone conclusion 
that symptom severity and functional impairment are always positively associated. For example, 
those with relatively severe symptoms may function well as a result of personal resilience, 
compensatory behaviours, and/or environmental supports  (Becker et al., 2011), including more 





1.7 Thesis aims and outline 
This overarching aim of this thesis is to provide further understanding of sex differences in ADHD. 
The first part of this thesis (Chapters 2 and 3) investigates sex differences in ADHD in youth and 
the second part investigates ADHD in adulthood (Chapters 4 and 5). Analyses are based on data 
from five different projects: 
1) The Pathways to Hyperactivity and Attention Deficit Study (PHAD), a spin-off study of children 
from the Twins Early Development Study (TEDS) (Trouton, Spinath, & Plomin, 2002) which is a 
large population-based study of over 15,000 twins born in the United Kingdom between 1994 and 
1996;  
2) The Child and Adolescent Twin Study in Sweden (CATSS) (Anckarsater et al., 2011), an ongoing 
prospective longitudinal cohort study that targets all twins born in Sweden since 1992, which can 
be linked to Swedish National Population-based Registers containing information on psychiatric 
care and drug prescriptions;  
3) The Mood Instability Research in ADHD study (MIRIAD) (Skirrow & Asherson, 2013), a case-
control study of adult men with and without ADHD;  
4) The Oils and Cognitive Effects in Adult ADHD Neurodevelopment study (OCEAN), a case-control 
study of adults with and without ADHD;  
5) The Creativity, Occupation, Mind Wandering and Education Study (COME-ON! – What does a 
wandering mind lead to?), a large online survey study of adults from the population with and 
without ADHD. 
Two of the results chapters are published articles and have been presented in published format, 
and two of the results chapters are currently under peer-review. References from the published 
results chapters are shown in the articles only and are not repeated in the main reference list at 
the end of the thesis. Supplementary materials for each study are presented in the appendices. An 
outline of the subsequent chapters is provided below. 
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The first empirical study (Chapter 2) uses a population-based sample to investigate sex differences 
in traits relevant to the pathology of ADHD in relation to diagnosis. Specifically, it examines 
whether, amongst males and females with comparably elevated levels of ADHD symptoms, 
different characteristics impact whether males and females meet diagnostic criteria based on a 
comprehensive diagnostic interview. Thus, the diagnosed group are not clinically ascertained. 
Measures of core ADHD symptom dimensions, co-occurring behavioural and emotional problems, 
and impairment are examined. This study also investigates sex-dependent biases in parental 
perceptions of ADHD symptoms through examining whether, despite children meeting diagnostic 
criteria through detailed interview, parents under or over-rate their children’s behaviour relative 
to the objective interview measure, and if a different pattern is observed in males and females. 
The second empirical study (Chapter 3) uses a population-based sample linked to data from 
national registries to investigate whether the predictors of ADHD clinical diagnosis and 
pharmacological treatment differ in males and females. Specifically, it examines sex differences in 
the severity and presentation of ADHD symptoms, conduct problems, and learning problems in 
males and females with and without clinically diagnosed ADHD, and then examines if there are sex 
differences in the predictive associations of these symptom domains on being diagnosed and 
treated for ADHD. This study has been published in European Child & Adolescent Psychiatry 
(Mowlem et al., 2018). 
My investigation of sex differences in ADHD led me to ask more about the expression of ADHD and 
the basic phenomenon of the disorder, and if females do present differently to males with ADHD, 
this could suggest that a new perspective and way of looking at the psychopathology of ADHD may 
be needed. It became clear that further research was needed to identify the best screening 
methods for ADHD, which may differ for males and females and be more sensitive to the 
differential manifestation of the disorder across sex. Thus, the second part of the thesis takes a 
phenomenological approach to ADHD and investigates a new measure of the subjective 
experience of excessive mind wandering, and if there are sex differences in mind wandering in 
adults with ADHD. 
The third empirical study (Chapter 4) investigates the ‘symptom’ of mind wandering in ADHD 
through evaluation of the psychometric properties of a newly developed measure of this internal, 
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subjective experience of ADHD in adults: The Mind Excessively Wandering Scale (MEWS). 
Specifically, it examines the validity and reliability of the MEWS as an instrument to assess adult 
ADHD, including how it relates to core symptom dimensions currently used for clinical diagnosis. In 
addition, it examines if the MEWS is sensitive to treatment effects and if it accounts for unique 
variance in function impairment in adults with ADHD. This study has been published in the Journal 
of Attention Disorders, and is the first paper to be published on this scale (Mowlem et al., 2016). 
The fourth empirical study (Chapter 5) further validates the MEWS in a large population sample 
and examines sex differences in the manifestation of adult ADHD. Specifically, it evaluates the 
factor structure of the MEWS, assesses measurement invariance across sex, age, and ADHD 
diagnostic status, examines reliability and validity, and investigates sex differences in mind 
wandering, inattention, hyperactivity/impulsivity, emotional lability, impairment and wellbeing. 
The thesis concludes (Chapter 6) with a summary of the main findings from each of the results 
chapters before drawing them together to discuss the wider implications of this body of work. The 







Chapter 2. Do different factors influence whether girls versus boys meet 
ADHD diagnostic criteria? Sex differences among children with high ADHD 
symptoms 
 
This chapter is adapted from a manuscript currently under review. 
Mowlem, F.D., Agnew-Blais, J., Taylor, E., & Asherson, P. (under review). Do different factors 
influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among 
children with high ADHD symptoms. 
 










We investigate if different factors influence whether girls versus boys meet diagnostic criteria for 
attention-deficit/hyperactivity disorder (ADHD) among children with high ADHD symptoms. 
Participants were 283 children aged 7-12 from a population-based study. Girls and boys meeting 
diagnostic criteria for ADHD, based on an objective investigator-based interview, were compared 
to children who did not meet criteria despite high symptoms on a rating-scale measure of ADHD. 
We assessed factors that could differentially relate to diagnosis across girls and boys including 
ADHD symptoms, co-occurring behavioural/emotional problems and impairment, and sex-effects 
in rater perceptions of ADHD symptoms. While overall similar factors distinguished girls and boys 
who met diagnostic criteria from high-symptom peers, effect sizes were larger in girls. Emotional 
problems were particularly salient to distinguishing diagnosed versus high-symptom girls but not 
boys. Parents rated boys meeting diagnostic criteria as more impaired than high-symptom boys 
but did not do so for girls, and under-rated diagnosed girls’ hyperactive/impulsive symptoms 
compared to more objective interview assessment, with the opposite observed in boys. Results 
suggest girls’ ADHD may need to be made more prominent by additional behavioural/emotional 
problems for them to meet full diagnostic criteria and that sex differences in parental perceptions 
of ADHD behaviours and impairment exist. 
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2.2 Introduction 
A well-established feature of attention-deficit/hyperactivity disorder (ADHD) is the large sex 
difference in referral and diagnostic rates. The ratio of boys to girls diagnosed with ADHD in 
childhood falls in the range of 2:1 to 10:1 (Arnett et al., 2015; Biederman et al., 2002; Novik et al., 
2006; Ramtekkar et al., 2010; Willcutt, 2012), with higher ratios seen in clinical compared to 
population samples. This difference highlights the possibility that ADHD may be underdiagnosed in 
girls in clinical practice (Ramtekkar et al., 2010). Further, it suggests that investigating sex 
differences in population-based samples could extend and enrich our understanding of the ADHD 
construct beyond that of clinical samples.  
A common explanation for the observed sex differences in referral and diagnosis is that girls with 
ADHD are more likely to present with predominantly inattentive symptoms, rather than the more 
potentially disruptive hyperactive/impulsive symptoms, as well as greater levels of internalising 
symptoms such as anxiety and depression which might lead to alternative diagnoses (Arnold, 
1996; Quinn, 2008). In contrast, boys with ADHD are often characterised as presenting with more 
hyperactivity/impulsivity, and co-occurring behavioural problems such as oppositional defiant and 
conduct disorder (Arnold, 1996; Quinn, 2008). It has also been shown that proportionally more 
boys than girls with ADHD annoy or upset their teachers, and that parents see the ‘feminine’ 
ADHD diagnostic items as less problematic than the ‘masculine’ ones (Graetz et al., 2005; Ohan & 
Johnston, 2005). It is highly likely that these explanations, along with the greater rate of diagnosis 
in boys, has led to an ADHD stereotype of a ‘disruptive boy’, which may influence how behaviour 
in boys and girls is perceived by individuals key to the referral and diagnostic process (e.g., parents 
and teachers). Consistent with this view, it has been shown that parents perceived the DSM-IV 
ADHD criteria as being descriptive of boys (Ohan & Johnston, 2005).  
If sex-specific stereotypes of ADHD exist, then it is possible that parents and teachers may not as 
readily recognise manifestations of ADHD in girls compared to boys. Furthermore, sex differences 
in recognition of ADHD may in part reflect bias in the diagnostic criteria, or the way they are 
applied. For example, if diagnostic criteria are based on a male presentation of the disorder then 
females may be less likely to meet full diagnostic criteria (Hong et al., 2014). 
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The male preponderance could also be due to underlying aetiology of ADHD in relation to a 
‘female protective effect’. This model proposes that females require greater genetic and 
environmental ‘load’ or exposure to factors associated with ADHD to manifest the same degree of 
impairment and warrant diagnosis as males with ADHD (Eriksson et al., 2016; Rhee & Waldman, 
2004; Taylor et al., 2016). Partial support for this hypothesis has been demonstrated, for example 
siblings of females with ADHD have been shown to display greater familial risk of ADHD compared 
to siblings of males with ADHD (Martin, Walters, et al., 2018; Rhee & Waldman, 2004; Taylor et al., 
2016). Of note, such findings could result from parents having a higher threshold for recognising 
ADHD symptoms in daughters or clinicians having a higher threshold for diagnosing ADHD in 
females, and/or greater likelihood of diagnosing ADHD in females if their ADHD symptoms are 
accompanied by additional behavioural problems which make their ADHD symptoms more 
prominent (Martin, Walters, et al., 2018). 
Several methodological limitations exist in the study of sex differences in ADHD. First, many 
studies of ADHD are comprised of predominantly (or exclusively) male participants, limiting our 
understanding of ADHD in females; although efforts to investigate ADHD in females are increasing 
(e.g., Biederman et al., 1999; Hinshaw, Owens, Sami, & Fargeon, 2006). Further, the DSM-IV 
criteria for ADHD are based primarily on observations of males (Lahey et al., 1994), and DSM-5 
field studies included a greater percentage of males (Clarke et al., 2013). Second, much of our 
knowledge about sex effects in ADHD comes from clinical samples, yet referral bias related to sex 
suggests that studies in clinical samples may not provide the full picture regarding sex differences 
in ADHD, or generalise to the overall ADHD population. In addition, individuals whose ADHD is not 
diagnosed are absent from clinical samples and so findings may not be wholly applicable to 
females if they are more often ‘missed’. Moreover, previous meta-analyses highlight that clinic-
referred girls may not be representative of non-referred girls in the same way that boys are (Gaub 
& Carlson, 1997; Gershon, 2002). Third, an additional obstacle in assessing sex differences in ADHD 
is that to date, nearly all studies of population or non-referred samples have relied on parent or 
teacher rating scales. If a male stereotype of ADHD is the norm, potentially only the most severe 
girls or those whose symptoms manifest as disruptive behaviours will be identified. 
It is important, especially for clinical practice, to understand more about phenotypic differences in 
boys and girls with ADHD (Taylor et al., 2016), including sex differences beyond that of ADHD 
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symptoms. One way to do this is to examine girls and boys from the general population with 
comparable numbers of ADHD symptoms and investigate which children meet diagnostic criteria, 
to help understand whether different factors impact if boys and girls meet diagnostic threshold. 
One hypothesis is that if current diagnostic criteria and perceptions of ADHD characterise a male 
stereotype, and/or if there is a female protective effect, then girls may be less likely to meet 
diagnostic criteria or receive an ADHD diagnoses unless their symptoms are made more prominent 
by additional problems, for example greater emotional problems or school impairment. 
To address the methodological issues detailed above, the current study examined data from a 
population-based twin sample, overcoming issues of referral and clinic bias. Separate trait and 
diagnostic measures of ADHD were available which extends methodology typically used in 
population-based samples. We examined what characteristics distinguish girls meeting diagnostic 
criteria (based on the Parental Account of Childhood Symptoms [PACS]) from girls who do not 
despite high ADHD symptom levels on a rating-scale measure of ADHD, and if the same 
distinguishing characteristics operate in boys. We examined core ADHD symptom dimensions, co-
occurring behavioural and emotional problems, and impairment. We also assessed sex-dependent 
biases in parental perceptions of ADHD symptoms by examining whether, despite their offspring 
meeting diagnostic criteria, parents systematically under- or over-rate relative to the PACS, and if 
this differs for boys and girls. 
2.3 Method 
2.3.1 Sample 
Participants were 283 children: 153 (121 boys, 32 girls) who met DSM-5 research diagnostic 
criteria for ADHD based on the Parental Account of Childhood Symptoms (PACS) investigator-rated 
parental interview (M=9.33 years, SD=0.77), and 130 (81 boys, 49 girls) who showed a high level of 
ADHD symptoms based on parental report using DSM-5 symptom criteria but did not meet full 
diagnostic criteria (M=9.52 years, SD=0.88). We refer to the groups as the ‘diagnosed ADHD’ group 
and the ‘high-symptom’ group. Further details of the PACS is given in the measures section and 
details on how the diagnosis is made can be found in the supplementary material (Appendix A). 
We defined a high level of ADHD symptoms as the presence of 5 or more symptoms (out of 18), 
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based on definitions used in previous studies (Biederman et al., 1996; Faraone, Kunwar, Adamson, 
& Biederman, 2009; Faraone et al., 2006; Shankman et al., 2009). Of note, three children were 
missing their ADHD symptom score (2 boys, 1 girl) but met PACS diagnostic criteria, and 16 (14 
boys, 2 girls) met PACS diagnostic criteria but had less than 5 symptoms present on the DSM-5 
ADHD rating-scale; these children were included in the diagnosed group (see Fig. 2.1 for a flow 
chart of how the groups were derived).  
Participants were part of the Developmental Pathways to Hyperactivity and Attention Deficit Study 
(PHAD), a sub-study of children at risk for ADHD identified from the Twins Early Development 
Study (TEDS), which is a population-based study of over 15,000 twin pairs born in the United 
Kingdom between 1994 and 1996, followed up prospectively from the age of 18 months. Details of 
TEDS is described elsewhere (Trouton et al., 2002), and details of the PHAD sample ascertainment 
can be found in the supplementary material (Appendix A). Briefly, children were screened for 
ADHD symptoms at age 7 years. Twins at risk were identified by at least one twin in each twin-pair 
scoring in the top 15% of the TEDS population for ADHD symptoms. 196 families with children 
identified as being at risk for ADHD (comprising 276 boys and 116 girls) completed the PACS ADHD 
diagnostic interview at the family home when the children were aged between 7–12 years 
(M=9.42 years, SD=0.84 years) (data was collected for both children in the twin pair regardless of 
whether one or both had been identified as being at risk for ADHD). Exclusion criteria were: autism 
spectrum disorder, learning disability, and neurological disability.  
2.3.2 Measures 
Parents completed a checklist assessing the 18 DSM-IV items for inattention (9 items) and 
hyperactivity/impulsivity (9 items) (American Psychiatric Association, 1994). Each item is rated on 
a four-point likert scale from 0 (not at all true) to 3 (very much true), with the highest possible 
score being 54. Of note, DSM-IV items for ADHD are the same in the most recent edition (DSM-5), 
and so we refer to DSM-5 for clarity. 
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The Parental Account of Childhood Symptoms (PACS) was used to identify children who met 
diagnostic criteria for ADHD. The PACS is an investigator-rated semi-structured interview 
developed as a standardised measure for use in assessing and recording accurately the behaviours 
of children. Parents are asked to describe the behaviour of their child across a range of situations 
in relation to its frequency and severity, which is then scored according to a standardised 
operational scale (Chen & Taylor, 2006). As such, PACS can be considered a gold-standard tool for 
the research assessment of children with ADHD (Chen et al., 2008; Müller et al., 2011), and shows 
high inter-rater reliability (Chen et al., 2008). Details on the PACS diagnosis have been described 
elsewhere (Chen et al., 2008; Müller et al., 2011) and are included in the supplementary material 
(Appendix A). 
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Figure 2.1. Flow diagram of how the ‘diagnosed ADHD’ and ‘high-symptom ADHD’ groups were 
derived for the current study 
The Strengths and Difficulties Questionnaire (SDQ) was used to assess behavioural and emotional 
problems using mothers ratings (Goodman, 1997). The SDQ comprises 5 subscales: emotional 
problems, conduct problems, hyperactivity, peer problems, and prosocial behaviour. The SDQ 
subscales can also be used to generate a ‘total problem’ score. The hyperactivity items were not 
used in this study as this behaviour is already measured. 
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The SDQ impact supplement comprises items related to overall distress and impairment which can 
be used to generate an impact score ranging from 0-10 (see supplementary material, Appendix A, 
for further information). The PACS includes questions on both impairment and school behaviour, 
as related to the child’s inattention and/or hyperactivity/impulsivity problems. The impairment 
items include: ‘problem is cause for concern’, ‘serious problem perceived/much concern’, ‘no 
control over behaviour’, ‘serious impairment/social impact of problem’, and ‘interviewer rates 
problem as markedly or severely abnormal’. Items are scored on likert scales which were used to 
create dichotomous variables for ‘yes’ or ‘no’ categories; we then calculated a total impairment 
score for each participant ranging from 0-5. School behaviour items were scored as ‘yes’ or ‘no’ 
and included: ‘child shows distress’, ‘problems getting on with others’, ‘difficulty concentrating’, 
‘change of school due to problems’, ‘suspended or excluded’, ‘special educational provision’, 
‘complaints about hyperactivity’, and ‘complaints about aggression’. We did not to include the 
‘difficulty concentrating’ item in analysis due to it being so closely linked with the definition of 
ADHD. ‘Change of school due to problems’ and ‘suspended or excluded’ were also omitted from 
analysis due to so few participants endorsing these items. A total school impairment score was 
derived for each participant ranging from 0-5. 
2.3.3 Statistical analysis 
We compared girls and boys meeting PACS DSM-5 diagnostic criteria to girls and boys with a high 
level of ADHD symptoms who did not meet diagnostic criteria on a-priori selected variables: 
parent-rated levels of inattention and hyperactivity/impulsivity, co-occurring behavioural and 
emotional problems, and impairment. We used linear regression models for continuous outcomes 
and logistic regression for binary outcomes. Age was controlled for in all analyses and we adjusted 
for familial clustering using the cluster(variable) function in Stata 14  (StataCorp, 2015). Effect sizes 
were established using Cohen’s d for continuous variables (where: d≥0.20 is a small effect, d≥0.50 
a medium effect, and d≥0.80 a large effect) and odds ratios for categorical variables. 
To describe sex differences in the diagnosed and high-symptom groups, we compared girls versus 
boys meeting diagnostic criteria on the PACS, and high-symptom girls to high-symptom boys. To 
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investigate which characteristics distinguish girls above and below the diagnostic threshold, and if 
the same distinguishing features operate in boys, we compared PACS diagnosed girls to high-
symptom girls and PACS diagnosed boys to high-symptom boys by testing for an interaction 
between diagnostic group (diagnosed versus high-symptom) and sex (male versus female). A 
significant sex-by-diagnostic group interaction would indicate that certain characteristics are 
greater in diagnosed versus high-symptom individuals and in one sex compared to the other. 
To elucidate potential sex biases in parent report of ADHD symptoms we examined whether, 
despite both sexes meeting diagnostic criteria, parents systematically under- or over-rate ADHD 
symptoms compared to the PACS interview assessment, and if this differs by sex. We tested for an 
interaction between sex and measure (parent-rating scale versus PACS) separately for total scores 
on the inattention and hyperactivity/impulsivity scale in the diagnosed group of children using 
linear regression. A significant interaction would suggest ADHD symptom score differs as a 
function of the type of measure and that this difference is greater in one sex compared to the 
other, or that the direction of the difference differs in girls and boys. 
2.4 Results 
Of the 153 children meeting PACS diagnostic criteria for ADHD, 121 were boys (79%) and 32 were 
girls (21%), giving a male-to-female ratio of 3.8:1. Of the 130 children in the high-symptom group, 
81 were boys (62%) and 49 were girls (38%), a male-to-female ratio of 1.7:1. The ratio of 
diagnosed to high-symptom girls was 0.65:1 compared to 1.5:1 for boys. The diagnosed and high-
symptom groups did not differ significantly in the total number of symptoms present based on the 
DSM-5 parent-rated scale (p=.10, d=0.20), fulfilling a critical assumption on which the study design 
lies (i.e., that the diagnosed and high-symptom groups had comparable numbers of ADHD 
symptoms, therefore we can identify other factors that distinguish these groups). 
Among the children meeting PACS diagnostic criteria, girls had higher rated emotional problems 
(p=.04, d=0.47) and were more prosocial (this difference showed a trend towards significance: 
p=.06, d=0.42), compared with equivalent boys (Table 2.1). Girls meeting diagnostic criteria also 
had lower parent-rated impact scores (p=.03, d=-0.47), relating to overall distress and impairment, 
compared to boys meeting diagnostic criteria. Few characteristics distinguished girls and boys in 
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the high-symptom group, except that girls were significantly more prosocial (p<.001, d=0.78), had 
lower levels of conduct problems (p=.03, d=-0.45), and were less likely to have complaints about 
hyperactivity at school (p=.02, OR: 0.36 [95% CI: 0.15, 0.86]) compared to boys (Table 2.1). 
Table 2.1. Characteristics of PACS diagnosed and high-symptom girls and boys. Mean (SD) unless 
otherwise stated 
PACS diagnosed High-symptom 
Characteristica Girls (n=32) Boys (n=121) p Cohen’s d Girls (n=49) Boys (n=81) p Cohen’s d 
ADHD (parent-rated) 
Inattention 17.62 (5.37) 16.47 (5.87) .32 0.20 15.78 (4.58) 14.75 (4.94) .25 0.22 
Hyperactivity/ 
Impulsivity 
15.39 (5.66) 15.37 (6.44) .89 0.003 13.96 (5.63) 14.49 (4.85) .65 -0.10 
Co-occurring difficulties 
Emotional  4.55 (2.75) 3.39 (2.37) .04 0.47  2.95 (2.10) 3.19 (2.47) .63 -0.10 
Conduct  3.24 (2.23) 3.72 (2.06) .35 -0.23 2.00 (1.69) 2.87 (2.13) .03 -0.45 
Peer 3.34 (2.29) 3.58 (2.56) .61 0.37 1.73 (1.87) 2.15 (2.18) .33 -0.21 
Prosocial 7.28 (2.39) 6.33 (2.22) .06 0.42 8.48 (1.97) 6.77 (2.40) <.001 0.78 
Total Problem 
Score 
11.14 (5.56) 10.69 (5.23) .71 0.09 6.68 (3.61) 8.22 (5.08) .11 -0.35 
Impairment 
Total Impact Score 
(SDQ) 
1.79 (2.28) 2.93 (2.44) .03 -0.47 1.15 (1.46) 1.51 (2.18) .31 -0.19 
PACS total 
impairment 
2.16 (1.69) 2.07 (1.84) .83 0.05 0.73 (0.93) 0.89 (1.16) .41 -0.15 
School Impairment (PACS) 
Child shows distress 
(%) 
43.8 49.6 .55 
OR: 0.80 
(0.38, 1.66) 
42.9 29.6 .14 
OR:1.78 
(0.84, 3.78)  
Problems getting 
on with others (%)
40.6 47.1 .52 
OR: 0.78 
(0.37, 1.66) 





40.6 42.2 .91 
OR: 0.95 
(0.40, 2.29) 





59.4 58.7 .96 
OR: 1.02 
(0.47, 2.24) 





21.9 33.9 .72 
OR: 0.54 
(0.18, 1.62) 





2.06 (1.37) 2.31 (1.46) .37 -0.17 1.08 (1.17) 1.25 (1.33) .44 -0.14 
Bold data signify statistical significance of the tests 
PACS = The Parental Account of Childhood Symptoms; ADHD = Attention-deficit/hyperactivity disorder; OR = 
Odds ratio (with 95% Confidence Intervals)  
a Data were missing on some variables; all available data were used in analysis 
All models were adjusted for familial clustering and age 
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2.4.1 Distinguishing characteristics of PACS diagnosed versus high-symptom girls, 
compared to boys 
Compared to high-symptom girls, girls meeting PACS diagnostic criteria had significantly higher 
reported levels of emotional (p=.02, d=0.65), conduct (p=.04, d=0.63), and peer problems (p=.002, 
d=1.20), as well as higher total problem scores (p=.001, d=0.95) (Table 2.2). The PACS diagnosed 
girls were also more impaired based on the PACS impairment measure (p<.001, d=1.05) than the 
high-symptom girls, but the SDQ parent-rated impairment measure did not distinguish the two 
groups. At school, diagnosed girls received more complaints about hyperactive behaviour (p<.001, 
OR: 3.07 [95%CI: 2.42, 16.73]) and had higher overall school impairment scores (p=.001, d=0.77). 
Girls meeting diagnostic criteria were also 3.89 times (95%CI: 1.19, 12.76) more likely to receive 
special educational provision (p=.03) than those with high ADHD symptom scores. 
Compared to the high-symptom boys, boys meeting PACS diagnostic criteria had greater parent-
rated inattention (p=.03, d=0.32) (Table 2.2), higher reported levels of conduct (p=.01, d=0.41) and 
peer problems (p<.001, d=0.60), and higher total problem scores (p=.004, d=0.48). Greater 
impairment was demonstrated in boys meeting diagnostic criteria compared to high-symptom 
boys on all the impairment measures (see Table 2.2). 
Overall there were no significant sex by diagnosis interactions, suggesting that many of the same 
factors distinguished high-symptom children from those who met diagnostic criteria in both boys 
and girls (Table 2.2). There were, however, some interactions nearing statistical significance in 
which certain characteristics played a larger role in distinguishing high-symptom girls from girls 
meeting diagnostic criteria, as compared to the equivalent groups of boys (Table 2.2, 
Supplementary Fig S1, Appendix A). Regarding co-occurring problems, girls who met PACS 
diagnostic criteria had more emotional problems compared with high-symptom girls (d=0.65, 
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p=.02), while this characteristic did not distinguish diagnosed and high-symptom boys (d=0.08, 
p=.57; OR for interaction: 1.40 [95%CI: -0.05, 2.86], p=.058). Both girls and boys meeting PACS 
diagnostic criteria were distinguished from their high-symptom peers by greater total problem 
scores on the SDQ, and specifically conduct and peer problems, but the magnitude of the effect 
was greater in girls (total problems score: d=0.95 vs 0.48; conduct problems: d=0.63 vs 0.41; peer 
problems: d=1.20 vs 0.60). In addition, a factor that showed a trend towards significance in 
distinguishing diagnosed girls versus high-symptom girls but not boys, was prosocial behaviour 
(girls: d=-0.55, p=.08 vs boys: d=-0.19, p=.34). 
The SDQ total impact score (parent-rated measure of impairment) only distinguished between the 
PACS diagnosed and high-symptom boys, with almost double the effect size (boys: d=0.61 vs girls: 
d=0.33). Whereas the more objective PACS measure of impairment distinguished children meeting 
full diagnostic criteria from the children with high-symptoms who did not meet full diagnostic 
criteria in both girls and boys; however, the magnitude of this difference was greater in girls 
(d=1.05 vs 0.78). 
The total school impairment score distinguished PACS diagnosed from high-symptom children in 
both girls and boys, with similar effect sizes. PACS diagnosed boys were 2.38 times (95%CI: 1.31, 
4.30) more likely to show distress at school than high-symptom boys, but PACS diagnosed and 
high-symptom girls were equally as likely to (OR: 1.09, 95%CI: 0.46, 2.56). In both girls and boys, 
the likelihood of children meeting diagnostic criteria having complaints about their hyperactivity at 
school was greater than in high-symptom children, but the odds were greater for girls (OR: 3.07 
[95%CI: 2.42, 16.73] vs 2.27 [1.24, 4.17]; OR for interaction: 2.82 [0.91, 8.72], p = .07). Problems 
getting on with others and complaints about aggression similarly distinguished diagnosed boys and 
girls from their high-symptom peers, but the difference was only significant for diagnosed versus 
high-symptom boys.  
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Table 2.2. Results of statistical analyses for within sex differences between diagnosed vs high 
symptom children, and sex-by-diagnostic status interaction analyses 
Bold data signify statistical significance of the tests 
PACS = The Parental Account of Childhood Symptoms; ADHD = Attention-deficit/hyperactivity disorder; OR = 
Odds ratio (with 95% Confidence Intervals)  
a Data were missing on some variables; all available data were used in analysis 
All models were adjusted for familial clustering and age  
b Results for interaction analyses are presented as odds ratios (for School impairment measures, except total 
school impairment score) or unstandardised regression coefficients (for ADHD, co-occurring difficulties, and 
impairment) with 95% CIs. 
c p = .054 
PACS diagnosed vs high-
symptom girls 




Characteristica p Cohen’s d p Cohen’s d b/OR (95% CI) p 
ADHD (parent-rated) 
Inattention .16 0.37 .03 0.32 0.10 (-2.77, 2.97) .95 
Hyperactivity/ Impulsivity .45 0.25 .39 0.15 0.42 (-2.71, 3.54) .79 
Co-occurring difficulties 
Emotional  .02 0.65 .57 0.08 1.40 (-0.05, 2.86) .06 
Conduct  .04 0.63 .01 0.41 0.39 (-0.82, 1.61) .53 
Peer .002 1.20 <.001 0.60 0.20 (-1.02, 1.41) .75 
Prosocial .08 -0.55 .34 -0.19 -0.73 (-2.03, 0.56) .27 
Total Problem Score .001 0.95 .004 0.48 1.99 (-0.96, 4.95) .19 
Impairment 
Total Impact Score (SDQ) .20 0.33 <.001 0.61 -0.78 (-2.04, 0.47) .22 
PACS total impairment <.001 1.05 <.001 0.78 0.24 (-0.59, 1.06) .57 
School Impairment 
(PACS) 
Child shows distress .84 OR: 1.09 (0.46, 2.56) .004 OR: 2.38 (1.31, 4.30) 0.45 (0.16, 1.25) .12 
Problems getting on with 
others 
.05c OR: 2.65 (0.98, 7.15) .003 OR: 2.72 (1.42, 5.21) 1.04 (0.31, 3.44) .95 
Special educational 
provision 
.03 OR: 3.89 (1.19, 12.76) <.001 OR: 5.23 (2.38, 11.50) 0.69 (0.17, 2.74) .60 
Complaints about 
hyperactivity 
<.001 OR: 3.07 (2.42, 16.73) .008 OR: 2.27 (1.24, 4.17) 2.82 (0.91, 8.72) .07 
Complaints about 
aggression 
.14 OR: 3.07 (0.70, 13.54) .02 OR: 2.58 (1.20, 5.55) 1.31 (0.24, 6.99) .76 
Total school impairment .001 0.77 <.001 0.76 -0.07 (-0.77, 0.63) .85 
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To further ensure that the findings were not a function of differences in the number of ADHD 
symptoms between the groups being compared, analyses were re-run adjusted for this. This 
revealed the same pattern of results in terms of significance.  
2.4.2 DSM-5 parent-rated ADHD symptoms compared to the PACS-reported symptoms 
in the diagnostic group 
A comparison of the frequency of parent rated DSM-5 ADHD symptoms compared to the same 
items on the PACS is illustrated in Fig. 2.2. In both boys and girls meeting diagnostic criteria, 
frequencies of inattentive symptoms were greater in the parent-rated scale compared to the PACS 
interview, apart from ‘attention to details’ (12.5% lower in the parent-rated scale in girls and 7.5% 
in boys), ‘organizing tasks’ (28.1% lower in girls and 22.3% in boys), ‘loses things’ in girls only (3.1% 
lower), and ‘listening’ and ‘forgetful’ in boys only (0.8% and 2.5% lower respectively). 
Sex differences in the two measures were more noticeable for hyperactive/impulsive symptoms. 
In girls meeting diagnostic criteria, hyperactive/impulsive symptom frequencies were higher in the 
PACS compared to the parent-rated scale, except for ‘difficulty playing quietly in leisure activities’ 
(34.4% lower in the PACS) and ‘exhibits a consistent pattern of restlessness’ (50.1% lower). In 
diagnosed boys hyperactive/impulsive symptom frequencies were higher in the parent-rated scale 
than the PACS, except for leaves seat (1.7% lower on the parent-rated measure), runs about 
(20.6% lower), and interrupts or intrudes (26.5% lower). This pattern was reflected in the total 
score, and analyses found a significant sex-by-scale interaction for hyperactivity/impulsivity (p<.02, 
95%CI: -2.48 - -0.32) indicating that parents tend to under-rate girls and over-rate boys for the 
presence of hyperactive/impulsive symptoms compared to the PACS (Fig. 2.2). 
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Total score 











Girls 5.78 (2.85) 5.19 (1.86) 0.59 4.96 (2.83) 5.56 (1.88) -0.60
Boys 5.42 (2.87) 4.82 (2.11) 0.60 4.96 (2.89) 4.38 (2.34) 0.58 
Figure 2.2. Frequencies of ADHD symptoms on the PACS interview compared to the parent-rating 
scale in children meeting full diagnostic criteria  
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2.5 Discussion 
In this study, we compared girls and boys who met full ADHD diagnostic criteria using an objective 
interview assessment to those who did not despite elevated levels of ADHD symptoms. When 
examining the factors that distinguished girls and boys who met full diagnostic criteria from their 
high-symptom peers, we found diagnosed girls had more additional problems than high-symptom 
girls, while this effect was less strong for boys. This could suggest girls with ADHD require a higher 
burden of other behavioural/emotional problems before they meet criteria for the disorder. We 
also found sex-dependent parental perceptions of ADHD behaviours and impairment. 
We found that girls meeting diagnostic criteria had higher rated emotional, conduct, and peer 
problems, total problem scores, and complaints about hyperactivity at school compared to the 
girls with high symptoms that did not pass the diagnostic threshold. Although similar differences 
were observed in boys (except for emotional problems) effect sizes were greater in girls, and were 
not due to the diagnosed and high-symptoms girls having a greater difference in ADHD symptoms 
compared to the equivalents groups of boys. The prominence of emotional symptoms to girls 
meeting diagnostic criteria suggests that this characteristic may be more important to the female 
phenotype and that girls may express their difficulties differently to boys. Higher rated emotional 
problems in girls than boys with ADHD has been shown previously (Novik et al., 2006). It is 
possible that emotional problems are not perceived to be as problematic compared to disruptive 
behaviours by individuals key in the diagnostic process, such as parents and teachers, reducing the 
likelihood of referral compared to children displaying disruptive behaviours. Further, perhaps 
emotional problems experienced by girls with ADHD are how they express or manifest their 
impairment, which could overshadow their ADHD symptoms in clinical assessment and lead to 
receiving alternative diagnoses more closely associated with the internal manifestation of 
symptoms (e.g., anxiety or depression), or delay time to diagnosis. Indeed, there is evidence to 
suggest that girls are diagnosed later (Agnew-Blais et al., 2016). This is problematic given the long-
term outcomes associated with ADHD and may be a particular issue if these symptoms result from 
the strain of compensating for their symptoms. It is important that the presence of emotional 
problems does not rule out an ADHD diagnoses (Quinn, 2008). 
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Parent-rated impairment using the SDQ did not distinguish between diagnosed versus high-
symptom girls; yet it did in the equivalent groups of boys. This is an important finding with regard 
to sex differences in ADHD as referral based on parent concern requires recognition of 
impairment, yet parents appear to be less able to spot impairment among girls. One interpretation 
of these findings is that parents may not be as good at judging impairment in girls, highlighting 
that objective measures of impairment are especially important in the assessment of girls’ ADHD 
symptoms (Gaub & Carlson, 1997). Some diagnostic tools, such as rating-scale measures of ADHD 
or standardised parent interview assessments, may lead to underestimating girls’ impairment and 
contribute to their under-diagnosis, and parents may be less likely to take girls for assessment if 
they perceive them to be less impaired by symptoms compared to boys. Furthermore, this has 
implications for whether girls with ADHD receive appropriate treatments. 
One characteristic that may influence the perception of impairment is prosocial behaviour. Not 
only is it clear that social functioning is likely to be linked with perceptions of impairment and 
coping, socially adaptive behaviour may mask symptoms and impairment to informants (Livingston 
& Happé, 2017). It appears that prosocial behaviour may have an influence on diagnostic status in 
girls but not boys. One interpretation of these findings it that in the presence of positive social 
behaviour, girls’ symptoms may be ‘masked’ making them appear less impaired, which could 
reduce the likelihood of girls with ADHD symptoms being referred and subsequently fewer girls 
compared to boys being diagnosed with ADHD. This hypothesis requires more research, along with 
the question of whether prosocial behaviour acts as a form of compensatory mechanism in girls 
with ADHD. 
Finally, we also found sex-dependent biases among parental perceptions of ADHD symptoms in 
children meeting diagnostic criteria. Parents under-rated diagnosed girls hyperactive/impulsive 
symptoms compared to the more objective accounts from the PACS, with the opposite pattern 
observed in boys. These findings suggest that sex-specific biases in perceptions of child behaviour 
may exist. As with the parental under-report of impairment in girls discussed previously, this also 
has clinical implications for the referral and subsequent diagnosis of girls with ADHD symptoms. 
Parents may be less likely to take girls for assessment if they perceive them to display less 
stereotypical ADHD behaviours (as well as being less impaired). It may also contribute to a 
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systematic bias in diagnostic practice, as it may influence the identification and interpretation of 
symptoms by clinicians if they are relying on parental reports. 
The present study has several strengths. We extended the methodology typically used in 
population-based studies by incorporating a comprehensive diagnostic interview and were 
therefore able to investigate sex differences in the factors that may affect whether children with 
high ADHD symptoms meet diagnostic criteria in a population-based sample. In addition, the use 
of an objective, investigator-rated interview enabled investigation of potential sex-specific biases 
in parental report of ADHD symptoms. We have begun to tackle some of the possible contributing 
factors to the sex differences that could impact the referral and diagnostic process, but replication 
is needed. 
However, some limitations should be noted. While sizeable for a study of its kind, there was a 
mismatch in the number of girls to boys, which is a common issue for studies of sex differences in 
ADHD. This reduces the power in interaction analyses to detect group differences and if these 
interactions were small they may have been missed; analyses should be repeated in a larger 
sample. We also acknowledge that the exclusion of children with autistic spectrum disorder and 
learning problems (applied during the original selection process for deriving the PHAD sample) 
may somewhat limit the generalisability of our study, particularly if females with ADHD are more 
likely to have such co-occurring conditions. However, the literature currently does not provide 
evidence that this is necessarily the case (Biederman et al., 2002; Green et al., 2015; Mulligan et 
al., 2009; Novik et al., 2006), and such exclusions are not unusual in studies of childhood ADHD 
(Cheung et al., 2015; Cooper, Martin, Langley, Hamshere, & Thapar, 2014), Finally, in the current 
study we were not looking at who gets diagnosed in clinical settings, but rather investigating sex 
differences associated with meeting diagnostic criteria in a unique sample with less selection than 
studies of children who present to clinics. Unfortunately, as with many population-based studies, 
we do not have information on which individuals were actually referred, and so it is not possible to 
infer directly what the implications of the findings are on the referral and diagnostic process in 
clinical practice. 
It is clear that research is needed to identify the best screening methods, most accurate 
informants, and most appropriate thresholds for the diagnosis of ADHD, which may differ for boys 
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and girls (Rucklidge, 2010). It is likely that the same instruments should be used for boys and girls, 
but possibly with the addition of items that are more sensitive to the manifestation of ADHD in 
girls (Arnold, 1996). For example, items that relate better to social functioning and emotionality, 
and that are better placed to assess more internalising symptoms (Skogli, Teicher, Andersen, 
Hovik, & Øie, 2013). Perhaps this is timely given the ADHD diagnostic criteria are primarily based 
on studies in males (Clarke et al., 2013; Lahey et al., 1994). 
In summary, these data suggest that factors which distinguish girls who meet full ADHD diagnostic 
criteria from high-symptom peers who do not may be somewhat sex specific, with additional 
behavioural and emotional problems playing a larger role in distinguishing diagnosed from high-
symptom girls than the equivalent male comparison. Additionally, we found different parental 
perceptions of ADHD behaviours as shown by our comparison of parent report to a more objective 
measure of ADHD symptoms. Such differences may explain why girls are less likely to be referred 
for their ADHD behaviours. This may also contribute to the relatively low recognition rate of ADHD 
in girls in clinical practice if girls with ADHD are perceived to display less stereotypical disruptive 
ADHD behaviours and perceived as less impaired by symptoms than boys, especially in the 
presence of socially adaptive behaviour and more internalising emotional symptoms. From a 
clinical perspective, our findings highlight the importance of detailed interview assessments in the 
diagnostic process, especially for girls who may not be identified with rating-scale measures which 
are more subject to sex biased perceptions of behaviour, and that emotional problems should not 
be used to rule out an ADHD diagnoses.  
74
Chapter 3. Sex differences in predicting ADHD clinical diagnosis and 
pharmacological treatment 
This chapter is presented as a published paper. It is an exact copy of this publication: 
Mowlem, F.D., Rosenqvist, M., Martin, J., Lichtenstein, Asherson, P., & Larsson, H. (2018). Sex 
differences in predicting ADHD clinical diagnosis and pharmacological treatment. European Child & 
Adolescent Psychiatry 
Supplementary materials for this chapter, as detailed in the text, are attached in Appendix B. 
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Abstract
In youth, ADHD is more commonly diagnosed in males than females, but higher male-to-female ratios are found in clini-
cal versus population-based samples, suggesting a sex bias in the process of receiving a clinical diagnosis of ADHD. This 
study investigated sex differences in the severity and presentation of ADHD symptoms, conduct problems, and learning 
problems in males and females with and without clinically diagnosed ADHD. We then investigated whether the predictive 
associations of these symptom domains on being diagnosed and treated for ADHD differed in males and females. Parents 
of 19,804 twins (50.64% male) from the Swedish population completed dimensional assessments of ADHD symptoms and 
co-occurring traits (conduct and learning problems) when children were aged 9 years. Children from this population sample 
were linked to Patient Register data on clinical ADHD diagnosis and medication prescriptions. At the population level, 
males had higher scores for all symptom domains (inattention, hyperactivity/impulsivity, conduct, and learning problems) 
compared to females, but similar severity was seen in clinically diagnosed males and females. Symptom severity for all 
domains increased the likelihood of receiving an ADHD diagnosis in both males and females. Prediction analyses revealed 
significant sex-by-symptom interactions on diagnostic and treatment status for hyperactivity/impulsivity and conduct prob-
lems. In females, these behaviours were stronger predictors of clinical diagnosis (hyperactivity/impulsivity: OR 1.08, 95% CI 
1.01, 1.15; conduct: OR 1.43, 95% CI 1.09, 1.87), and prescription of pharmacological treatment (hyperactivity/impulsivity: 
OR 1.24, 95% CI 1.02, 1.50; conduct: OR 2.20, 95% CI 1.05, 4.63). Females with ADHD may be more easily missed in the 
ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems.
Keywords Attention-deficit/hyperactivity disorder/ADHD · Sex differences · Clinical diagnosis · Population-based study
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a neu-
rodevelopmental disorder characterised by age-inappropriate 
and maladaptive levels of inattention and/or hyperactivity/
impulsivity. In children and adolescents, ADHD is more 
commonly diagnosed in males, with the sex ratio ranging 
from 2:1 to 10:1 [1–5]. However, sex ratios appear to be 
dependent on the type of sample, with higher male-to-female 
ratios found in clinical versus population-based samples. 
Furthermore, the male-to-female ratio is smaller in adult 
clinic samples than in childhood and adolescent samples 
[6]. This suggests that, in youth, ADHD affects a greater 
proportion of females than reflected in clinical practice and 
that differences exist in the diagnostic process for males and 
females with ADHD symptoms [7, 8].
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The findings relating to sex differences in ADHD are 
variable and sometimes contradictory, partly due to differ-
ences in sample characteristics. Meta-analyses tend to show 
less severe symptoms in females versus males with ADHD 
identified from non-referred, community populations, but 
similar levels in clinically ascertained samples—with the 
exception of inattention for which females had higher rat-
ings in the more recent meta-analysis [5, 9]. Several other 
studies have also not found support for sex differences for 
ADHD symptoms and co-occurring problems in clinical 
and referred samples [1, 10]. While important information 
has been gained from both population-based and clinical 
samples of children with ADHD, the approach of investigat-
ing sex differences in either a population-based or clinical 
sample means that it is not clear what factors are specifically 
leading to the clinical diagnosis of children with ADHD 
from the population, and if these differ as a function of sex.
Sex differences in the phenotypic expression of ADHD 
are often proposed as an explanation for the greater rates of 
ADHD diagnosis in males. A common hypothesis is that 
females with ADHD are more likely to present with predom-
inantly inattentive symptoms, and less hyperactive/impulsive 
or conduct problems than boys, and are thus perceived as 
less problematic [4, 7, 11]. Therefore, females with ADHD 
problems that manifest as predominantly inattentive symp-
toms and lower levels of disruptive behaviours may be less 
likely to receive a diagnosis of ADHD [5].
Studies also show sex differences in the pattern of ADHD 
treatment, with males being more likely to receive ADHD 
medication than females [12, 13]. However, the underlying 
reasons for the observed sex differences in treatment remain 
to be investigated. Different pharmacological treatment 
rates in males and females could also be due to a different 
manifestation of the disorder. It is important to understand 
whether certain symptom manifestations have greater influ-
ence on being prescribed pharmacological treatment, and 
the possibility that females with ADHD are undertreated is 
an important public health concern [8].
Another consideration in the diagnostic and treatment 
process of individuals with ADHD is the presence of co-
occurring learning problems, since learning problems rep-
resent another leading reason for identification of children 
with ADHD. Research has demonstrated that females with 
ADHD are less likely to have learning difficulties or mani-
fest problems at school compared to males [14, 15], which 
could also lead to lower identification of ADHD in females. 
Sex differences in learning problems related to ADHD, and 
their impact on the diagnostic and treatment process, are not 
well investigated.
This study investigated sex differences in ADHD using 
a large population-based sample [The Child and Adoles-
cent Twin Study in Sweden (CATSS)] linked to Swedish 
National Patient Register data on clinical ADHD diagnoses 
and prescribed ADHD medications. Thus, enabling investi-
gation of a population-based and clinical sample for which 
there is not an ascertainment bias and overcoming important 
limitations of studies reliant on one type of sample alone. 
We first described the severity of ADHD symptoms, con-
duct, and learning problems in males and females with and 
without clinically diagnosed ADHD, followed by examina-
tion of the ADHD symptom presentation. We then inves-
tigated whether the predictive associations of inattention, 
hyperactivity/impulsivity, conduct problems, and learning 
problems on being diagnosed and treated for ADHD dif-
fered in males and females. It was hypothesised that (1) at 
the population level, males would show greater symptom 
severity than females, but at the clinical level similar sever-
ity would be observed, with the exception of inattention for 
which levels may be higher in females as suggested by meta-
analysis, (2) hyperactivity/impulsivity and conduct problems 
would be a stronger predictor of diagnosis in females than in 
males and inattention a weaker predictor, and (3) in children 
with a clinical diagnosis of ADHD, hyperactivity/impulsiv-
ity and conduct problems would be a stronger predictor of 
medication status in females than males.
It is important to increase our understanding of sex effects 
in ADHD and whether certain symptoms are more predic-
tive of clinical diagnosis and pharmacological treatment 
(including whether sex differences in such predictors exist), 
as it can lead to improved identification of females with the 
disorder. Furthermore, it may point towards certain biases 
in the diagnostic and treatment process which has implica-
tions for clinical practice and can inform our understanding 
of the way that clinicians recognise ADHD symptoms, and 
potentially apply the diagnostic criteria.
Methods
Sample
Participants were from The Child and Adolescent Twin 
Study in Sweden (CATSS) [16], an ongoing prospective lon-
gitudinal cohort twin study that targets all twins in Sweden 
born since 1992. A telephone interview is conducted with 
parents of all twins, no more than 1 month before or after 
their 9th or 12th birthdays (CATSS-9/12; baseline). For the 
present study, data from 19,804 CATSS children assessed at 
age 9 years were available for analyses (50.64% males). The 
CATSS-9/12 study has ethical approval from the Karolinska 
Institute Ethical Review Board and participants are protected 
by the informed consent process.
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Measures
ADHD symptoms and co-occurring behavioural traits 
The Autism-Tics, AD/HD and other Comorbidities Inven-
tory (A-TAC) was administered to parents of twins over 
the telephone, and questions were asked from a lifetime 
perspective. The A-TAC is a broad screening instrument 
that encompasses multiple neurodevelopmental disorders. 
Two modules of the A-TAC are used to assess ADHD (one 
assessing inattention [9 items] and one assessing hyperac-
tivity/impulsivity [10 items]), consisting of a total of 19 
items that correspond closely to DSM-5 diagnostic crite-
ria for ADHD [17]. Questions are answered on a 3-point 
scale: ‘no’ (scored as 0), ‘yes, to some extent’ (scored as 
0.5), and ‘yes’ (scored as 1). Thus, the maximum score 
that can be obtained is 19. These questions were identified 
to achieve the optimal sensitivity, specificity, and predic-
tive value for clinical ADHD diagnoses in validation stud-
ies, with high internal consistency [18–21].
Using the A-TAC ADHD items, it is possible to cat-
egorise individuals based on DSM-5 symptom criteria for 
the three ADHD presentations: the predominately inat-
tentive presentation, based on the presence of six or more 
symptoms of inattention; the predominantly hyperactive/
impulsive presentation, based on the presence of six or 
more symptoms of hyperactivity/impulsivity (using nine 
of the ten A-TAC items); and the combined presentation, 
based on six or more symptoms of both inattention and 
hyperactivity/impulsivity. From the three-point scale 
described above, we dichotomised responses for each item 
into ‘symptom present’ (‘yes’ and ‘yes to some extent’ 
were collapsed into one category) and ‘symptom absent’ to 
enable categorisation of participants into one of the three 
ADHD presentations.
The A-TAC also includes questions that target other 
well-described clinical features of psychiatric disorders, 
such as conduct problems (five items relating to lying, 
cheating, stealing, being cruel, or starting fights) and 
learning difficulties (three items relating to reading and 
maths skills and slow learning), also scored on a three-
point scale as above. Thus, whilst looking specifically at 
one disorder, co-occurring problems can also be exam-
ined. Of note, although the A-TAC also includes questions 
on anxiety and mood, we were unable to examine these 
variables due to a reduced number of CATSS participants 
completing these questions.
Socio-Economic Status (SES) Maternal education from 
the Swedish Register of Education was used as an indica-
tor of socio-economic status. A categorical variable was 
created (low = primary and secondary education, ≤ 9 years; 
medium = upper secondary education, 10–12  years; 
high = post-secondary education, > 12 years).
Population‑based registers
Unique personal identifier numbers enable data from par-
ticipants in the CATSS sample to be accurately linked with 
information from National population-based registers up 
until December 2013. Thus, it was possible to determine 
whether participants in CATSS had been referred to a spe-
cialist clinic and diagnosed with ADHD, and if they were 
prescribed ADHD medication. Registry data were also used 
to identify 273 participants in CATSS who had emigrated 
(obtained from The Migration Register) or died (obtained 
from The Cause of Death Register) after their participation 
in the study; these individuals were excluded from analyses.
The National Patient Register (NPR) The NPR contains 
information about all psychiatric inpatient (from 1987) 
and outpatient (from 2001) care in Sweden, from both pri-
vate and public caregivers (primary care is not currently 
included). Clinical ADHD diagnoses are based on the Inter-
national Classification of Diseases (ICD), code F90 [22], 
but most clinicians base their clinical assessment on DSM 
criteria for ADHD and recode to ICD. Participants were 
identified as having a diagnosis of ADHD from the NPR if 
they had at least one record of inpatient or outpatient care 
for ADHD from 2001 to 2013.
Prescribed Drug Register (PDR) The PDR contains data 
for all dispensed drug prescriptions to the entire Swedish 
population since July 2005. Information on the indication for 
the prescription is not recorded; however, ADHD is a group 
that can be identified as treatment is characterised by a few 
drugs exclusively used for this disorder (methylphenidate 
hydrochloride, atomoxetine, amphetamine sulfate, or dex-
troamphetamine sulfate). Participants treated with ADHD 
medication were identified if they had at least one prescrip-
tion from 2005 to 2013.
Statistical analysis
Descriptive statistics are presented to describe the sever-
ity and presentation of ADHD symptoms and co-occurring 
behaviours in males and females with and without clinically 
diagnosed ADHD. Sex differences in parent-rated ADHD 
symptom scores (inattention and hyperactivity/impulsivity) 
and co-occurring conduct and learning problems scores were 
tested using linear regression models (hypotheses 1), and 
sex differences in ADHD medication status was tested using 
logistic regression.
To assess whether the predictive associations of inat-
tention, hyperactivity/impulsivity, conduct problems, and 
learning problems with clinical diagnoses differed in males 
and females, we used a series of logistic regression models 
(hypotheses 2). The models were conducted separately for 
each symptom domain (inattention, hyperactivity/impul-
sivity, conduct problems, and learning problems) using 
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the continuous score, and stratified by sex. We also applied 
logistic regression models with males and females included 
in one model to investigate sex-by-symptom interactions on 
diagnostic status (again, separate models were run for each 
symptom domain using the continuous score).
Next, we used a series of logistic regression models to 
examine sex differences in the associations between these 
symptom domains and ADHD medication status in children 
with clinically diagnosed ADHD (hypotheses 3). The mod-
els were conducted separately for each symptom domain 
using the continuous score and stratified by sex. We also 
investigated sex-by-symptom interactions on treatment 
status.
All regression models were adjusted for the effects of 
year of birth and family SES. Furthermore, as the data were 
used as population data and not analysed in a twin analysis 
model, we controlled for the clustered data structure (to cor-
rect for the inclusion of two study children in each family) 
using a cluster-robust sandwich estimator (the cluster(vce) 
command in Stata [23]).
Results
Prevalence
In the CATSS sample, 3.28% (n = 650) of the children had a 
clinical diagnosis of ADHD recorded in the National Patient 
Register (NPR). Clinically diagnosed ADHD was more 
common in males (4.65%, n = 466) than in females (1.88%, 
n = 184), which corresponds to a prevalence ratio of ~ 2.5:1.
Based on DSM-5 ADHD symptom criteria using the par-
ent-reported A-TAC questionnaire, 2556 individuals (12.9%) 
from the CATSS sample met criteria for ADHD. More 
males (16.3%, n = 1635) than females (9.43%, n = 921) met 
the symptom criteria, corresponding to a prevalence ratio 
of ~ 1.8:1. Among these children, 303 (18.5%) of the males 
with elevated symptoms, and 111 (12.1%) of the females 
with elevated symptoms had an ADHD diagnosis recorded 
in the NPR.
Symptom severity
Table 1 shows mean symptom scores for children with and 
without a clinical diagnosis of ADHD in the NPR. Among 
non-diagnosed children, females had significantly lower 
scores compared to males for total ADHD, inattention, 
hyperactivity/impulsivity, conduct problems, and learn-
ing problems (p values < 0.001). In contrast, among chil-
dren with clinically diagnosed ADHD, males and females 
showed similar severity across the symptom domains, except 
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d = 0.21). Females and males with a clinical diagnosis were 
equally likely to be prescribed ADHD medication.
ADHD presentations
Among all children from the CATSS sample meeting 
DSM-5 symptom criteria for ADHD as identified with the 
parent-reported A-TAC questionnaire, the inattentive presen-
tation was most common (53.7%), followed by the combined 
(26.8%) and hyperactive/impulsive (19.5%) presentations 
(Table 2). A significantly greater percentage of females met 
symptom criteria for the inattentive presentation category 
compared to males (χ2(1) = 11.27, p = 0.002, d = 0.11), and 
a significantly greater percentage of males met symptom 
criteria for the combined presentation category compared to 
females (χ2(1) = 17.39, p < 0.001, d = 0.15). There was a sim-
ilar percentage of males and females meeting symptom crite-
ria for the hyperactive/impulsive presentation (χ2(1) = 0.19, 
p = 1.0, d = 0.08).
Looking exclusively among the children clinically diag-
nosed with ADHD in the NPR, the combined presentation 
was most common (55.3%), followed by the inattentive 
(36.7%) and hyperactive/impulsive (8.0%) presentations 
(Table 2). Among these cases, there were no statistically 
significant differences between males and females in the 
ADHD presentations (Table 2).
Does the predictive value of ADHD symptoms, 
conduct problems, and learning problems on ADHD 
diagnosis and treatment differ by sex?
Using the A-TAC continuous scores, in both males and 
females, symptom severity with respect to inattention and 
hyperactivity/impulsivity increased the likelihood of receiv-
ing a clinical ADHD diagnosis (Table 3) (for example, for 
males, with each unit increase on the inattention scale the 
odds of having a clinical diagnosis of ADHD increased by 
1.67, whereas in females the odds increased by 1.73). Co-
occurring conduct and learning problems were also associ-
ated with an increased likelihood of ADHD diagnosis in 
both males and females. Odds ratios were higher across all 
predictors in females than males, although these differences 
were small and non-significant for inattention and learning 
problems. Interaction analyses revealed sex-by-symptom 
interactions for hyperactivity/impulsivity (OR 1.08, 95% CI 
1.01, 1.15, p = 0.03) and conduct problems (OR 1.43, 95% 
CI 1.09, 1.87, p = 0.01), suggesting that externalising symp-
toms of hyperactivity/impulsivity and conduct problems are 
more strongly associated with the prediction of clinically 
diagnosed ADHD in females than in males.
Symptom severity with respect to hyperactivity/impul-
sivity increased the likelihood of being prescribed ADHD 
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problems were associated with an increased likelihood of 
being prescribed medication in females, but not in males. 
Interaction analyses revealed sex-by-symptom interactions 
for hyperactivity/impulsivity (OR 1.24, 95% CI 1.02, 1.50, 
p = 0.03) and conduct problems (OR 2.20, 95% CI 1.05, 
4.63, p = 0.04), suggesting that externalising symptoms of 
hyperactivity/impulsivity and conduct problems influence 
being prescribed pharmacological treatment for ADHD to 
a greater extent in females than males. Learning problems 
did not predict medication treatment in the sample overall, 
or for either males or females (Table 4).
Discussion
This large population-based study investigated the role of 
sex differences in ADHD symptoms and co-occurring con-
duct and learning problems on clinical diagnosis and phar-
macological treatment of ADHD. The main finding was 
that the predictive association of hyperactive/impulsive and 
conduct symptoms on ADHD diagnosis and treatment sta-
tus was stronger in females than in males. We also found, 
consistent with previous findings, greater ADHD symptoms 
and co-occurring conduct and learning problems in males 
than females at the population level [2, 14], more males 
than females received a clinical diagnosis of ADHD, and 
that clinically diagnosed males and females showed similar 
symptom severity [5, 15, 24, 25], except for higher inat-
tention scores in males (which is not in line with the most 
recent meta-analysis showing greater inattention in females, 
but the effect size was modest: d = 0.21).
Severity of all the symptom domains assessed increased 
the likelihood of having a clinical diagnosis of ADHD in 
both males and females. Across all domains, odds ratios 
were slightly higher for females, suggesting greater devia-
tion from their typical behaviour, and may indicate a greater 
symptom threshold requirement for referral and diagnosis 
in females. Significant sex differences were found for the 
predictive value of hyperactivity/impulsivity and conduct 
problems, with these externalising behaviours being stronger 
predictors of diagnosis in females than males. This finding 
is consistent with a previous study showing that girls with 
externalising symptoms were referred at a younger age than 
boys with similar behavioural problems [24]. One explana-
tion for this finding is that externalising symptoms are in 
greater contrast to what is perceived as normative behaviour 
Table 3  Predictive value of 
core ADHD symptoms and 
co-occurring problems on 
clinical ADHD diagnosis 
(based on the National Patient 
Register) in males and females
Bold data signify statistical significance of the tests
All models were adjusted for familial clustering, year of birth, and SES
OR Odds Ratio (95% confidence interval)
a Data were missing on some variables; all available data were used in analysis
Characteristica Males Females Interaction (sex-by-
symptom)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Inattention 1.67 (1.61, 1.74) <.001 1.73 (1.63, 1.84) <.001 1.02 (0.96, 1.10) .43
Hyperactivity/impulsivity 1.55 (1.49, 1.61) <.001 1.68 (1.58, 1.77) <.001 1.08 (1.01, 1.15) .03
Conduct problems 2.79 (2.41, 3.25) <.001 4.09 (3.20, 5.23) <.001 1.43 (1.09, 1.87) .01
Learning problems 2.53 (2.28, 2.81) <.001 2.87 (2.45, 3.35) <.001 1.11 (0.93, 1.33) .25
Table 4  Influence of core 
ADHD symptoms and 
co-occurring problems 
on prescription of ADHD 
medication (in the Prescribed 
Drug Register) in males and 
females with a clinical diagnosis 
of ADHD (in the National 
Patient Register)
Bold data signify statistical significance of the tests
All models were adjusted for familial clustering, year of birth, and SES
OR Odds Ratio (95% confidence interval)
a Data were missing on some variables; all available data were used in analysis
For mean scores of clinically diagnosed males and females stratified by medication prescription, see Sup-
plementary Table 2
Characteristica Males Females Interaction (sex-by-
symptom)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Inattention 1.08 (.98, 1.20) .12 1.22 (1.05, 1.42) .01 1.13 (0.95, 1.34) .16
Hyperactivity/impulsivity 1.12 (1.02, 1.23) .01 1.37 (1.15, 1.64) .001 1.24 (1.02, 1.50) .03
Conduct problems 1.04 (.78, 1.36) .76 2.29 (1.09, 4.82) .03 2.20 (1.05, 4.63) .04
Learning problems 1.05 (.79, 1.39) .75 0.83 (.56, 1.23) .36 0.84 (0.53, 1.31) .44
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in females [7, 24, 26]. Indeed, we found lower levels of 
hyperactivity/impulsivity and conduct problems in females 
versus males without a diagnosis of ADHD (i.e., lower base-
line levels). These results may also suggest that externalis-
ing behaviours drive referral for ADHD [7], speaking to the 
view that externalising behaviours are more likely to get 
females clinical recognition for their symptoms. Finally, our 
finding that externalising behaviours are stronger predictors 
of diagnosis in females than males suggests that females 
with ADHD may be more easily missed in the ADHD diag-
nostic process unless they have prominent externalising 
problems. This may suggest that the current diagnostic cri-
teria and/or clinical practice are somewhat biased towards 
the male presentation of ADHD, and has implications for 
clinical training related to sex role socialisation.
Both hyperactivity/impulsivity and conduct problems 
were also stronger predictors of ADHD medication status 
in females compared to males, despite clinically diagnosed 
males and females being equally as likely to be prescribed 
ADHD medication. This suggests that if females display less 
prominent externalising behavioural problems they are less 
likely to be prescribed medication, whereas males may be 
prescribed medication based on ADHD diagnostic status 
alone.
We found no difference in learning problem scores by 
sex in those with ADHD, which is in contrast to previous 
research showing more pronounced learning and school-
related problems in males with ADHD than in females [14, 
15]. Furthermore, the predictive association between learn-
ing problems and ADHD diagnosis was similar in males 
and females. However, learning problems were not asso-
ciated with being prescribed medication, suggesting that 
learning problems may not be pertinent to pharmacological 
treatment decisions for children with ADHD, and in cases 
where learning problems are particularly prominent in the 
presentation, alternative interventions may be adopted. The 
relevance of learning problems to referral, diagnosis, and 
treatment of ADHD may also differ across countries, where 
differing importance may be placed on these difficulties in 
the diagnostic process. It would be interesting to see if find-
ings regarding the impact of learning problems on diagnosis 
and treatment are replicated in other countries.
Our study found that the combined presentation was 
the most common ADHD presentation in children with a 
clinical diagnosis. In contrast, among the children meeting 
ADHD criteria based on parent-rated symptoms, the inatten-
tive presentation was the most common, which is consistent 
with some previous research [3, 7, 14, 27, 28], but not all 
studies [1, 29]. This suggests that some children with pri-
marily inattentive symptoms may not get diagnosed with 
ADHD. It is possible that: (1) children with predominantly 
inattentive symptoms are referred but may receive alterna-
tive diagnoses in the absence of externalising behaviours [7, 
11]; (2) children with the inattentive presentation may be 
perceived as less impaired and their behaviour as less prob-
lematic in comparison to disruptive behavioural problems 
[30, 31]. These possibilities may be of particular relevance 
to females, since we found a greater percentage of females 
than the percentage of males presented with predominately 
inattentive symptoms at the population level. This could par-
tially explain the greater number of males than females in 
clinical samples of children with ADHD compared to non-
referred samples [14].
This study represents one of the largest samples used to 
investigate sex differences in ADHD. In addition, previous 
studies have investigated sex differences in either clinical 
or population samples; here, we uniquely bring the two 
together. This enabled investigation of a population-based 
and clinical sample for which there is not an ascertainment 
bias, overcoming limitations of studies using one type of 
sample alone. Prevalence rates in this cohort are in line with 
expectations and suggest an overall reasonable detection of 
ADHD in Sweden. The administrative prevalence of ADHD 
was 3.28%, and the symptomatic prevalence based on the 
A-TAC was substantially higher at 12.9% as impairment 
criteria and symptom pervasiveness across settings were 
not applied, consistent with previous estimates of ADHD 
classification based on symptom counts alone [3]. However, 
this rate is similar to estimates from other community studies 
that apply impairment criteria [2]. Of note, another potential 
explanation for the prevalence difference between clinically 
diagnosed ADHD and symptomatic ADHD is that males and 
females who have less pronounced levels of externalising 
behaviours and a predominantly inattentive presentation are 
less often clinically diagnosed. Among children clinically 
diagnosed with ADHD, the ratio of males to females was 
2.5:1, which is somewhat lower than previously reported 
[5, 9]. Of the entire CATSS sample, the ratio of males to 
females meeting symptomatic threshold was 1.8:1, which is 
consistent with previous findings [3]. Thus, the difference 
in ratios of males to females in the clinical and population 
sample was small, and findings of this study may not gen-
eralise to countries with lower (or higher) administrative 
prevalence rates.
Our findings should be considered in the context of some 
limitations. Our findings are telling us about diagnosis pat-
terns and do not provide information about referral pat-
terns. It is possible that a number of children are referred 
but receive alternative diagnoses or are not considered 
sufficiently impaired by symptoms to obtain a diagnosis. 
Future studies should investigate such hypotheses. We were 
also unable to confirm whether additional children from 
CATSS should have a clinical diagnosis of ADHD (i.e., 
children who are potentially ‘missed’ in the community); as 
an epidemiologic cohort, our study did not have objective 
clinician or research interviews. Furthermore, we relied on 
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parent-ratings of ADHD symptoms and co-occurring prob-
lems, which may be influenced by sex-specific biases and 
expectations [26, 32]. For example, there is some evidence 
that parents may underrate females’ ADHD symptoms 
compared to males [32]. A further limitation is that, unfor-
tunately, our main analyses did not examine co-occurring 
internalising problems due to a reduced number of CATSS 
participants completing these measures. Sex differences in 
internalising problems have been reported [9] and further 
research is needed to explore the predictive associations with 
diagnosis and treatment of ADHD. We were also unable to 
explore potential sex differences in referral to non-pharma-
cological interventions for ADHD. Finally, the study was 
carried out in a twin sample and findings may not generalise 
to singletons; for example, twins are more likely to have 
lower birth weight compared to singletons which is a risk 
factor for ADHD [33, 34]. Findings require replication in a 
non-twin sample.
These limitations notwithstanding, overall the current 
findings highlight the importance of the clinical presenta-
tion of ADHD as it can influence diagnosis and treatment 
decisions differentially in males and females, and the promi-
nence of different symptoms clearly matters. Externalising 
behavioural problems were more predictive of diagnosis and 
pharmacological treatment in females than males, perhaps 
because they contrast more with perceptions of normative 
behaviour in females. One interpretation of these findings 
is that females with ADHD may be under-identified in the 
absence of prominent externalising problems.
We hope that our findings encourage more research in this 
area to foster greater understanding of sex-specific diagnos-
tic patterns and more effective recognition, diagnosis, and 
treatment of ADHD in females in clinical, educational, and 
other settings.
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The diagnosis of ADHD is based mainly on descriptions of 
behaviors that reflect inattention, hyperactivity, and impul-
sivity. Yet older children, adolescents, and adults frequently 
report phenomenological descriptions of internal subjective 
experiences that may underlie the behavioral changes seen in 
ADHD. Characteristic descriptions of the mental state in 
ADHD include reports of ceaseless mental activity, thoughts 
that are constantly on the go, or a mind constantly full of 
thoughts. Thoughts are experienced as uncontrolled, with 
multiple occurring at the same time. Another common 
description is of short-lived thoughts that flit from one thing 
to another, jumping between different ideas (Asherson, 2005; 
Downey, Stelson, Pomerleau, & Giordani, 1997; Weyandt 
et al., 2003). Here, we propose that such excessive mind wan-
dering (MW) may reflect a core difficulty in ADHD that 
underlies some of the experienced impairments.
MW is conceptualized as periods in time when attention 
and the contents of thoughts shift away from external 
sources and/or ongoing tasks to unrelated internal thoughts 
or feelings (Smallwood & Schooler, 2015). It is a universal 
human experience; individuals in the general population are 
estimated to spend between 24% and 50% of their waking 
hours engaging in self-generated thoughts unrelated to their 
external environment (Kane et al., 2007; Killingsworth & 
Gilbert, 2010; Smallwood & Schooler, 2015; Song & Wang, 
2012). Two main types of MW have been identified; first, 
self-generated internal thoughts that occur intentionally/
deliberately, such as planning the menu for a party while 
driving to work. Second, unintentional/spontaneous MW 
when the mind drifts off, for example, during a lecture or 
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Objective: This study investigates excessive mind wandering (MW) in adult ADHD using a new scale: the Mind Excessively 
Wandering Scale (MEWS). Method: Data from two studies of adult ADHD was used in assessing the psychometric 
properties of the MEWS. Case-control differences in MW, the association with ADHD symptoms, and the contribution 
to functional impairment were investigated. Results: The MEWS functioned well as a brief measure of excessive MW 
in adult ADHD, showing good internal consistency (α > .9), and high sensitivity (.9) and specificity (.9) for the ADHD 
diagnosis, comparable with that of existing ADHD symptom rating scales. Elevated levels of MW were found in adults 
with ADHD, which contributed to impairment independently of core ADHD symptom dimensions. Conclusion: Findings 
suggest excessive MW is a common co-occurring feature of adult ADHD that has specific implications for the functional 
impairments experienced. The MEWS has potential utility as a screening tool in clinical practice to assist diagnostic 
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conversation. Despite its ubiquitous nature, individuals dif-
fer in the frequency and intentionality of their MW.
Excessive spontaneous MW has been associated with 
functional impairment and implicated in psychopatholo-
gies such as ADHD (Franklin et al., 2014). Mental rest-
lessness, a descriptive term encompassing excessive MW, 
has been reported as more common in ADHD than non-
ADHD individuals (Downey et al., 1997; Weyandt et al., 
2003). Previous work suggests that ADHD is associated 
with spontaneous MW, rather than deliberate MW, and 
detrimental episodes of MW (Franklin et al., 2014; Seli, 
Smallwood, Cheyne, & Smilek, 2015; Shaw & Giambra, 
1993). Detrimental MW has been defined as instances 
when task-unrelated thoughts (TUTs) interfere with task 
performance. In contrast, strategic MW occurs at times 
when TUTs are less likely to interfere with performance 
(whether intentional or not) or when the benefits out-
weigh the costs, and can be an economic use of neuronal 
resources (Franklin et al., 2014; Smallwood & Schooler, 
2015).
Using an experience sampling technique to measure on- 
and off-task thoughts during an attention task, Shaw and 
Giambra (1993) found the frequency of spontaneous (but 
not deliberate) TUTs was increased in college students with 
a childhood history of ADHD compared with controls. 
Furthermore, a sub-clinical group with high levels of ADHD 
symptoms demonstrated more TUTs compared with those 
with low ADHD scores. This finding was subsequently rep-
licated using a rating scale measure of deliberate and sponta-
neous MW in both clinical and non-clinical ADHD samples 
(Seli et al., 2015). In addition, regression analyses revealed 
spontaneous MW to be independently related to ADHD 
symptomatology, whereas deliberate MW was unrelated, 
further suggesting that spontaneous MW is a feature of 
ADHD.
ADHD symptomatology has also been shown to posi-
tively correlate with both the frequency of MW and the lack 
of awareness of engaging in MW (Franklin et al., 2014). A 
sub-clinical group with high ADHD symptom scores had 
disruptive MW episodes even when they were detrimental 
and interfered with function in daily life. In this study, lack-
ing awareness of MW was shown to mediate between 
ADHD symptoms and impairment, suggesting that increas-
ing awareness of MW in ADHD might lead to functional 
improvements.
Collectively, these findings suggest that adults with 
ADHD are highly susceptible to excessive spontaneous MW 
and may have a core difficulty controlling spontaneous 
thoughts unrelated to the current context. Excessive MW 
could therefore underlie many of the symptoms and impair-
ments that characterize the disorder. To explore the role that 
MW may play in the pathogenesis of ADHD, as well as its 
potential role in diagnosis, our research group developed the 
Mind Excessively Wandering Scale (MEWS; see Figure 1). 
The MEWS is a 15-item self-report measure designed to 
reflect MW in ADHD, derived from patient reports of subjec-
tive experiences of their thought processes. The scale cap-
tures the main characteristics of the mental state described by 
adults with ADHD: thoughts on the go all the time, thoughts 
that jump or flit from one topic to another, and multiple lines 
of thoughts at the same time (Asherson, 2005). The MEWS 
therefore reflects the form as opposed to the content of the 
experienced thought processes in ADHD. Uniquely, the 
MEWS assesses a mental phenomenon as opposed to the 
behavioral symptoms conventionally assessed with ADHD 
rating scales.
The aim of the present study was to validate the MEWS 
as an instrument to assess MW in adult ADHD using two 
study samples. In Study 1, we conducted a preliminary 
evaluation of the psychometric properties of the MEWS in 
a small sample of adult males with ADHD selected for the 
absence of comorbid psychiatric conditions. In Study 2, 
we cross-validated the MEWS in a larger independent sam-
ple including males and females, less highly selected 
against comorbidity. We further investigated the relation-
ship of MEWS scores to other measures of ADHD 
Figure 1. Items from the Mind Excessively Wandering Scale 
(MEWS).
Note. Items are scored on a 4-point Likert-type scale (0 = not at all or 
rarely, 1 = some of the time, 2 = most of the time, 3 = nearly all of the time 
or constantly). The MEWS scale is copyrighted and available without 
charge from the corresponding author, and we welcome use of this scale 
in research.
aItems we recommend excluding from the scale in future research, based 
on analysis conducted here.
Item:
1. I have difficulty controlling my thoughts
2. I find it hard to switch my thoughts off
3. I have two or more different thoughts going on at the same time
4. My thoughts are disorganised and ‘all over the place’
5. My thoughts are ‘on the go’ all the time
6. a Because my mind is ‘on the go’ at bedtime, I have difficulty
falling off to sleep
7. I experience ceaseless mental activity
8. I find it difficult to think about one thing without another
thought entering my mind
9. I find my thoughts are distracting and prevent me from
focusing on what I am doing
10. a I try to distract myself from my thoughts by doing something
else or listening to music
11. I have difficulty slowing my thoughts down and focusing on 
one thing at a time
12. I find it difficult to think clearly, as if my mind is in a fog
13. I find myself flitting back and forth between different thoughts
14. a I use alcohol or other drugs to slow down my thoughts and 
stop constant ‘mental chatter’
15 I can only focus my thoughts on one thing at a time with 
considerable effort
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symptomatology, and investigated the relationship between 
MW and functional impairment.
Method
Study 1 Sample
Participants were a small subset of adults from the MIRIAD 
(Mood Instability Research in ADHD) project, a longitudi-
nal case-control study of emotional lability (EL) and neuro-
psychological functioning in adult men with ADHD with no 
co-occurring comorbidities (Skirrow & Asherson, 2013). 
Forty-one adults with ADHD and 47 controls aged between 
18 and 65 years (ADHD: M = 28.54 years, SD = 9.52 years; 
control: M = 29.00 years, SD = 10.46 years) participated in 
the MIRIAD project. There were no significant differences 
between groups for age or IQ (see Table 1). ADHD partici-
pants were recruited from the waiting list of the National 
Adult ADHD Clinic at the South London and Maudsley 
Hospital (SLaM) and were medication free at the time of 
the research assessment. Further detail on the recruitment 
process is provided elsewhere (Skirrow & Asherson, 2013).
As the MEWS was developed after the MIRIAD project 
began, only a subset of the ADHD cases and controls pro-
vided MEWS data. At study entry (baseline), 25 cases and 
24 controls completed the MEWS. Follow-up assessments 
completed approximately 9 months after baseline provided 
data on 18 cases and 18 controls at both time points. In 
addition, six cases and 18 controls provided MEWS data at 
follow-up assessment alone. Of the 18 ADHD cases with 
data at both time points, 16 were treated with methylpheni-
date and one with atomoxetine at follow-up, initiated by 
local services and not following a specific protocol. Ethical 
approval for this study was obtained from the Joint Research 
Ethics Committee of the Institute of Psychiatry and SLaM.
Study 2 Sample
Participants were from the OCEAN (Oils and Cognitive 
Effects in Adult ADHD Neurodevelopment) project, a study 
investigating the relationship of omega-3 dietary supple-
mentation (not analyzed in this study) to cognitive and elec-
trophysiological measures in adults with ADHD. Participants 
were aged between 18 and 65 years. The sample consisted of 
81 adults with ADHD (37 female, 44 male; M age = 33.52 
years, SD = 10.26 years) and 30 healthy controls (14 female, 
16 male; M age = 29.51 years, SD = 8.8 years). Groups did 
not significantly differ on age, sex, or IQ (see Table 1). 
ADHD participants were recruited through SLaM Adult 
ADHD Service, advertisements on ADHD support websites, 
and previous study databases. See online supplementary 
material for further information on recruitment.
At baseline (Time 1), 79 cases and 29 controls provided 
MEWS data. Two separate follow-up assessments of the 
ADHD cases took place, 3 months (Time 2) and 6 months 
(Time 3) after baseline. At Time 2 and Time 3, 79 and 55 
ADHD cases provided MEWS data, respectively. Ethical 
approval for the study was granted by the National Research 
Ethics Service (NRES) Committee London.
Measures
ADHD symptoms. ADHD symptoms were assessed using 
the self-rated Barkley Adult ADHD Rating Scale (BRS; 
Barkley, 1998) in Study 1, and the Conners’ Adult ADHD 
Rating Scales (CAARS; Conners, Erhardt, & Sparrow, 
1999) in Study 2. Both scales cover the same list of 18 
DSM-IV/DSM-5 items for inattention and hyperactivity 
(Diagnostic and Statistical Manual of Mental Disorders 
(4th ed. and 5th ed.; American Psychiatric Association 
[APA], 1994 and 2013).
Table 1. Case-Control Differences for Age, Sex, IQ, MEWS, INN, HI, EL, and IMP.




pN M SD N M SD N M SD N M SD
Age 41 28.54 9.52 47 29.00 10.46 .83 81 33.52 10.26 30 29.51 8.80 .06
Male 41 47 — 44 16 .93
Female 0 0 37 14
IQ 41 108.95 15.08 47 113.15 13.36 .17 80 109.38 13.68 23 111.59 11.62 .44
Time 1
 MEWS 25 25.00 10.11 24 4.79 6.98 <.0001 79 27.72 9.31 29 7.21 6.26 <.0001
 INN 41 19.34 5.03 47 3.87 3.44 <.0001 81 27.16 6.13 30 6.23 3.99 <.0001
 HI 40 16.20 6.59 47 3.28 3.30 <.0001 81 20.09 5.80 30 5.33 4.08 <.0001
 EL 40 45.93 11.76 46 25.24 9.17 <.0001 80 24.31 12.09 30 4.17 4.86 <.0001
 IMP 41 1.23 0.41 47 0.30 0.28 <.0001 80 1.22 0.49 30 0.20 0.20 <.0001
Note. See Online Supplementary Table 1 for Time 2 and Time 3. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/
impulsivity; EL = emotional lability; IMP = impairment.
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Emotional dysregulation. Emotional Lability (EL) was mea-
sured using the Affective Lability Scale–Short Form (ALS-
SF; Oliver & Simons, 2004), which measures rapid changes 
in emotional states.
Impairment. Functional impairment across major life 
domains (family, work, school, life-skills, self-concept, 
social, and risk) was measured using the Weiss Functional 
Impairment Rating Scale–Self-Report (WFIRS-S; Sadek, 
2014).
Mind wandering. MW was measured using the newly cre-
ated MEWS (see Figure 1). This publication is the first 
report of this scale. The MEWS is a 15-item self-report 
measure reflecting MW in ADHD. Items were based on 
patient descriptions of MW in ADHD as previously 
described by Asherson (2005). P.A., C.S., and P.R. drew up 
the list of questions based heavily on their combined experi-
ence of patient’s reports of MW, and questions were refined 
during several consensus meetings. The final item checklist 
was agreed by all three authors and implemented initially in 
the MIRIAD study before further testing in the OCEAN 
study (reported here). The MEWS scale is copyrighted and 
available without charge from the corresponding author.
Statistical Analyses
Mean values for each rating scale and subscale were used as 
summary measures. The raw data and square-root transfor-
mations were used in analysis, and parametric and non-
parametric tests were used as appropriate.
Principal components analysis (PCA) with varimax rota-
tion was conducted to examine the factor structure of the 
MEWS. Cronbach’s alpha was used as a measure of reli-
ability to assess internal consistency and Pearson’s correla-
tion coefficient was used to analyze test–retest reliability of 
the scale. Construct validity was assessed with independent 
t tests and Mann–Whitney U tests to investigate case- 
control differences. Receiver operating characteristic 
(ROC) analysis was used to examine diagnostic accuracy 
and the optimal cut-off point of the measure.
Convergent validity of the MEWS in relation to ADHD 
symptom scales was assessed using polyserial correlations 
to provide unbiased estimates of cross-variable correlations 
in case-control samples (Olsson, 1979). For these analyses, 
we fixed the z value threshold for affection status corre-
sponding to 3.4% prevalence of ADHD in adults (Fayyad 
et al., 2007). In Study 1, polyserial correlations were also 
conducted on change scores (Time 1-Time 2). For change 
scores in Study 2, we used partial correlations to control for 
potential influences of the study intervention (placebo or 
essential fatty acid). Hierarchical multiple regression was 
used to investigate whether MEWS scores were independent 
predictors of impairment; inattention and hyperactivity/




Psychometric evaluation. The scree plot and eigenvalues 
indicated a unidimensional structure to the MEWS with one 
factor accounting for 69.16% of the variance (eigenvalue = 
10.37; see online supplementary material). Factor loadings 
were greater than .7, with the exception of Item 14 (.51). 
Table 2 shows Cronbach’s alpha coefficients for the full 
15-item MEWS in comparison with the other rating scales.
At baseline, internal consistency was high for all scales for
both cases and controls (α > .78). Examination of item total
correlations showed each item to correlate well with the full
15-item scale (correlations > .75, with the exception of
Items 6 [.66], 10 [.70], and 14 [.47]), suggesting items are
measuring the same underlying construct. Inter-item corre-
lations ranged from .27 to .88, with an average inter-item
correlation of .66, reflecting the internal consistency of the
scale items.
There was a mean interval of 9.7 months (SD = 3.3 
months) for cases and 9.5 months (SD = 4.0 months) for 
controls between baseline and follow-up. Test–retest reli-
ability was significant for the whole sample (r = .84, 95% 
confidence interval [CI] = [.74, .92], p < .001), and for both 
cases (r = .63, 95% CI = [.06, .88], p = .005) and controls 
(r = .82, 95% CI = [.40, .93], p < .001).
Construct validity. Case-control comparisons at baseline 
revealed significantly elevated ratings of MW in individu-
als with ADHD, t(47) = −7.83, p < .0001, comparable with 
that found for the other rating scales of ADHD symptom 
domains: inattention, t(73.07) = −14.58, p < .0001; hyper-
activity/impulsivity, t(85) = −11.40, p < .0001; emotional 
lability, U = 168.5, z = −6.53, p < .0001 (Table 1). Partici-
pants with ADHD also demonstrated significantly greater 
overall impairment on the WFIRS-S, t(86) = −13.08, p < 
.0001, as well as for each domain of impairment, t range = 
−5.78-11.40, p < .0001, for impairment in family life, work,
school, life-skills, self-concept, social problems, and risk
taking. Similar results were found at follow-up (see online
supplementary material).
ROC analysis was used to examine the capacity of the 
scale to discriminate between cases and controls. Area 
under the curve (AUC) was .92 (95% CI = [.85, 1.00], p < 
.0001) which, being close to 1, indicates excellent discrimi-
nant capacity of the MEWS. This was comparable with the 
AUC value of existing rating scales of ADHD symptom 
domains (inattention: AUC = .99, 95% CI = [.97, 1.00]; 
hyperactivity/impulsivity: AUC = .95, 95% CI = [.91, .99]; 
emotional lability: AUC = .91, 95% CI = [.84, .97]). A score 
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of 15 or above provides the optimal balance of sensitivity 
(.88) and specificity (.88), suggesting a cut-off for disorder 
threshold (see online supplementary material).
Convergent validity. Polyserial correlations in the combined 
case-control data set showed strong positive correlations 
between MW and the other rating scales of ADHD and 
impairment: inattention (r = .81, 95% CI = [.72, .87]), 
hyperactivity/impulsivity (r = .77, 95% CI = [.66, .84]), 
emotional lability (r = .81, 95% CI = [.72, .88]), and impair-
ment (r = .82, 95% CI = [.71, .89]), as well as ADHD 
affection status (r = .70, 95% CI = [.57, .79]). The strongest 
correlation was between MW and impairment (Table 3). In 
addition, moderate to large positive correlations were seen 
between MW and ADHD symptom dimensions and impair-
ment in both cases and controls analyzed separately (see 
online supplementary material), indicating severity of 
symptoms and impairment in both cases and controls.
For the sub-sample with both baseline and follow-up 
data, the correlation of baseline to follow-up change scores 
for MW with change scores for the rating scale measures of 
ADHD symptoms and impairments revealed temporal 
Table 3. Polyserial Correlations (95% Confidence Intervals), Corrected for Selection (Affection Threshold = 3.4%), Between the 
MEWS, INN, HI, EL, and IMP Rating Scales, and AFF.
Time 1 MEWS INN HI EL IMP
Study 1
 MEWS — — — — —
 INN .81 [.72, .87] — — — —
 HI .77 [.66, .84] .85 [.79, .89] — — —
 EL .81 [.72, .88] .74 [.65, .81] .75 [.64, .81] — —
 IMP .82 [.71, .89] .83 [.76, .88] .82 [.75, .87] .77 [.68, .83] —
 AFF .70 [.57, .79] .83 [.75, .89] .71 [.60, .79] .65 [.51, .75] .75 [.64, .83]
Study 2
 MEWS — — — — —
 INN .77 [.69, .83] — — — —
 HI .69 [.58, .76] .76 [.68, .82] — — —
 EL .74 [.66, .81] .62 [.50, .71] .53 [.40, .65] — —
 IMP .81 [.74, .086] .74 [.65, .80] .65 [.54, .73] .78 [.70, .83] —
 AFF .67 [.55, .77] .83 [.76, .88] .74 [.64, .81] .59 [.46, .70] .68 [.57, .78]
Note. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = impairment; 
AFF = affection status.
Table 2. Reliability Coefficients (α) for the MEWS as Compared With the INN, HI, EL, and IMP Rating Scales.
Study 1
Time 1 Time 2
Whole sample Cases Controls Whole sample Cases Controls
MEWS .97 .93 .95 .96 .94 .93
INN .96 .83 .80 .96 .92 .82
HI .95 .88 .78 .92 .88 .76
EL .96 .91 .95 .96 .91 .96
IMP .98 .96 .96 .97 .88 .98
Study 2
Time 1 Time 2 Time 3
Whole sample Cases Controls Cases Cases
MEWS .96 .91 .90 .94 .95
INN .96 .85 .82 .91 .98
HI .93 .83 .75 .87 .99
EL .95 .92 .87 .91 .93
IMP .98 .98 .86 .98 .97
Note. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = impairment.
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covariance between the measures: positive correlations 
were found between change in MW and change in inatten-
tion (r = .72, 95% CI = [.54, .83]), hyperactivity/impulsivity 
(r = .55, 95% CI = [.33, .70]), emotional lability (r = .70, 
95% CI = [.44, .84]), and impairment (r = .51, 95% CI = 
[.23, .72]; see Table 4). In the 16 cases treated with methyl-
phenidate at follow-up, there was a significant reduction in 
MEWS scores, t(15) = 2.28, p = .04, between the baseline 
medication-free period (M = 23.38, SD = 10.93) and follow-
up (M = 17.25, SD = 10.58).
Impairment. Data from 49 participants were used in regres-
sion analyses with the WFIRS-S total impairment score. 
Inattention and hyperactivity/impulsivity accounted for 
82.4% of the variability in functional impairment (R2 = 
.824). The addition of MW as a predictor led to a significant 
increase in predictive power of the model (R2Δ = .024), with 
the variability accounted for by the model increasing to 
84.9%, FΔ(1, 45) = 7.17, p = .01. This indicates that MW is 
having a small but significant effect beyond that accounted 
for by inattention and hyperactivity/impulsivity. Inattention 
carried the most importance in the model (β = .45), fol-
lowed by MW (β = .31) and hyperactivity/impulsivity (β = 
.21). Only inattention and MW significantly contributed to 
the model (p = .001 and .01, respectively).
Within the ADHD group, MW had an independent effect 
on impairment in the domains of self-concept, R2Δ = .145, 
FΔ(1, 21) = 6.57, p < .02, and social problems, R2Δ = .137, 
FΔ(1, 21) = 4.50, p < .05. For the social problems domain, 
MW carried more importance in the model (β = .44) than 
inattention (β = −.42), but not hyperactivity/impulsivity (β = 
.50). Only MW and hyperactivity/impulsivity significantly 
contributed to the model (p = .05 and .03, respectively). 
Interpretation of work and life-skills dimensions was not 
possible due to heteroskedasticity in the data.
Study 2
Psychometric evaluation. The scree plot and eigenvalues sug-
gested a one-factor solution with an eigenvalue of 9.44, 
accounting for 62.92% of the variance (see online supple-
mentary material). All items loaded highly onto this factor 
(>.76, with the exception of Items 6 [.60], 10 [.68], and 14 
[.40]). Internal consistency was high for all scales for both 
cases and controls (α > .78; see Table 2). Examination of item 
total correlations showed each item to correlate well with the 
full 15-item scale (correlations > .72, with the exception of 
Items 6 [.56], 10 [.63], and 14 [.37]). Inter-item correlations 
ranged from .24 to .82, with an average inter-item correlation 
of .59, reflecting the internal consistency of the scale items.
The mean interval between Time 1 and Time 3 was 6.4 
months (SD = 0.58 months), and MEWS scores showed sat-
isfactory retest reliability across this time period (r = .63, 
95% CI = [.42, .80], p < .0001).
Construct validity. Case-control comparisons revealed sig-
nificantly elevated ratings of MW in individuals with 
ADHD (U = 87.00, z = −7.34, p < .0001). This difference 
was comparable with that found for the other rating scales 
of ADHD symptom domains (inattention: U = 20.00, z = 
−7.94, p < .0001; hyperactivity/impulsivity: U = 64.50, z =
−7.65, p < .0001; emotional lability: U = 140.50, z = −7.12,
p < .0001; see Table 1). ADHD cases also demonstrated sig-
nificantly greater overall impairment on the WFIRS-S (U =
53.50, z = −7.70, p < .0001), as well as for each domain of
impairment (z range = −4.87 to −7.57, p < .0001 for impair-
ment in family life, work, school, self-concept, social prob-
lems, life-skills, and risk taking; see online supplementary
material).
ROC curve analysis indicated that the MEWS success-
fully discriminated between cases and controls (AUC = .96, 
Table 4. Correlations (95% Confidence Intervals) Between Change Scores for the MEWS, INN, HI, EL, and IMP Rating Scales.
Change scores MEWS INN HI EL
Study 1
 MEWS — — — —
 INN .72 [.54, .83] — — —
 HI .55 [.33, .70] .73 [.59, .82] — —
 EL .70 [.44, .84] .55 [.35, .70] .58 [.39, .72] —
 IMP .51 [.23, .72] .62 [.45, .74] .62 [.45, .74] .55 [.35, .70]
Study 2
 MEWS — — — —
 INN .53 [.25, .71]**** — — —
 HI .31 [.01, .52]* .74 [.53, .86]**** — —
 EL .43 [.19, .62]*** .48 [.16, .71]**** .31 [−.03, .59]* —
 IMP .62 [.37, .78]**** .50 [.31, .66]**** .41 [.18, .59]** .44 [.18, .65]***
Note. Polyserial correlations corrected for selection (affection threshold = 3.4%) were used in Study 1, and partial correlations to correct for study 
intervention in Study 2 (with significance levels). MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity;  
EL = emotional lability; IMP = impairment.
*p < .03. **p < .01. ***p = .001. ****p < .0001.
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95% CI = [.93, .99], p < .0001). This was comparable with 
the AUC value of existing rating scales of ADHD symptom 
domains (inattention: AUC = .99, 95% CI = [.98, 1.00]; 
hyperactivity/impulsivity: AUC = .97, 95% CI = [.95, 1.00]; 
emotional lability: AUC = .94, 95% CI= [.90, .98]). A score 
of 15 on the MEWS provides the optimal balance of sensi-
tivity (.90) and specificity (.90; see online supplementary 
material).
Convergent validity. Using polyserial correlations in the 
combined case-control data set, we found a positive correla-
tion between MW and the other rating scales of ADHD and 
impairment: inattention (r = .77, 95% CI = [.69, .83]), 
hyperactivity/impulsivity (r = .69, 95% CI = [.58, .76]), 
emotional lability (r = .74, 95% CI = [.66, .81]), impairment 
(r = .81, 95% CI = [.74, .86]), and ADHD affection status 
(r = .67, 95% CI = [.55, .77]). The strongest correlation was 
between MW and impairment (see Table 3). Moderate to 
large positive correlations were also seen between MW and 
ADHD symptom dimensions and impairment in both cases 
and controls analyzed separately (see online supplementary 
material).
Investigation of change scores also revealed a temporal 
relationship. Analyses indicated significant covariation of 
change in MW with change in inattention (r = .53, 95% CI 
= [.25, .71], p < .0001), hyperactivity/impulsivity (r = .31, 
95% CI = [.01, .52], p = .02), emotional lability (r = .43, 
95% CI = [.19, .62], p = .001), and impairment 
(r = .62, 95% CI = [.37, .78], p < .0001). MW and impair-
ment showed the strongest relationship (see Table 4).
Impairment. Data from 108 participants were used in regres-
sion analysis with the WFIRS-S total impairment score. 
Inattention and hyperactivity/impulsivity accounted for 
71.3% of the variability in functional impairment (R2 = 
.713). The addition of MW as a predictor led to a significant 
increase in predictive power of the model (R2Δ = .076), with 
the variability accounted for by the model increasing to 
78.9%, FΔ(1, 104) = 37.17, p < .0001. MW carried the most 
importance in the model (β = .49), followed by inattention 
(β = .29) and hyperactivity/impulsivity (β = .17). Only MW 
(p < .0001) and inattention (p = .002) significantly contrib-
uted to the model.
Within the ADHD group, MW had an independent effect 
on impairment in life-skills, R2Δ = .18, FΔ(1, 75) = 24.79, 
p < .0001; self-concept, R2Δ = .10, FΔ(1, 75) = 9.72, p = 
.003; social problems, R2Δ = .10, FΔ(1, 75) = 9.92, p = .002; 
and risk taking, R2Δ = .09, FΔ(1, 75) = 9.37, p = .003. MW 
carried the most importance in the model for life-skills (β = 
.52), self-concept (β = .39), and social problems (β = .39), 
and was the only significant contributor to the model for the 
self-concept (p = .003) and social problems (p = .002) 
domains. Interpretation of the family and work domains 
was not possible due to heteroskedasticity in the data.
Discussion
We report the psychometric properties and initial validation 
findings for a new self-report scale of excessive MW in 
adults with ADHD. Using two independent samples, we 
found that MEWS scores functioned extremely well as a 
measure of the mental phenomenon of MW in ADHD, with 
good reliability and high sensitivity and specificity for 
ADHD case-control differences. We found that elevated 
levels of MW (as indexed by the MEWS) in participants 
with ADHD were related to self-report measures of func-
tional impairment. Furthermore, the contribution of MW to 
impairment was independent of the core ADHD symptoms 
of inattention and hyperactivity/impulsivity. These findings 
suggest that excessive MW is a characteristic feature of 
adult ADHD that has specific effects on impairment.
Principal components analysis indicated a unidimen-
sional structure to the scale and other psychometric proper-
ties of the MEWS were comparable with existing rating 
scales of ADHD core symptoms, including good internal 
consistency and test–retest reliability. The MEWS was able 
to differentiate between those with and without ADHD with 
high sensitivity and specificity of the scale, using a thresh-
old score of 15. This is remarkable given that patients were 
selected for high ADHD symptoms and not specifically for 
subjective reports of internal thought processes as measured 
by the MEWS.
In both studies, item total correlations with the full 
15-item scale and factor loadings were high apart from
Items 6 (Because my mind is “on the go” at bedtime, I have
difficulty falling off to sleep), 10 (I try to distract myself
from my thoughts by doing something else or listening to
music), and 14 (I use alcohol or other drugs to slow down
my thoughts and stop constant “mental chatter”). This is
likely explained by the nature of these items, which refer to
how individuals cope with MW or how it directly affects
their functioning, as opposed to a description of the mental
phenomenon. To investigate whether the scale could be
shortened by dropping Items 6, 10, and 14 without reducing
its sensitivity and specificity, we repeated the ROC analy-
sis, finding the shorter 12-item scale had a sensitivity of .89
and specificity of .90 (see online supplementary material).
Further analyses in larger data sets could be used to further
refine the scale, but based on these data we recommend that
future studies use the reduced 12-item scale.
Our findings are in line with previous studies which 
report elevated levels of MW in ADHD compared with con-
trols, whether measured using clinical rating scales 
(Franklin et al., 2014; Seli et al., 2015; Weyandt et al., 2003) 
or experience sampling of TUTs during a sustained atten-
tion task (Shaw & Giambra, 1993). Furthermore, the 
strength of case-control differences for MEWS scores was 
comparable with that seen for rating scale measures of core 
ADHD symptoms, for which clinical cases of ADHD are 
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selected on. MEWS scores were also found to be highly 
correlated with ADHD symptoms and impairment in the 
total sample, as well as in cases and controls analyzed sepa-
rately, replicating previous studies of the association 
between spontaneous MW and ADHD (Franklin et al., 
2014; Seli et al., 2015). These results indicate that the 
MEWS is a marker of symptom severity in both cases and 
controls, in line with previous data indicating that ADHD 
symptoms lie along a continuum in the general population 
(Chen et al., 2008; Salum et al., 2014).
Change scores for MW also covaried with ADHD symp-
toms and impairments over time, indicating a close tempo-
ral relationship consistent with a potential causal role of 
MW in ADHD. The finding of significant pre–post treat-
ment effects of methylphenidate in a subset of Study 1 par-
ticipants raises the possibility that treatment effects on 
ADHD might be mediated by reductions in MW. However, 
we were unable to test specifically for treatment effects of 
methylphenidate because we did not randomize to treat-
ment or include a placebo control arm.
The link between MW and impairment was particularly 
strong, indicating the clinical importance of MW in adults 
with ADHD. Of specific interest was the finding that MW 
showed a main effect on impairment beyond the influence 
of inattention and hyperactivity/impulsivity and was overall 
the strongest predictor of impairment in Study 2. 
Investigating specific domains of impairment, MW was 
found to be an independent predictor of self-concept and 
social problems in both studies, and additionally life-skills 
and risk taking in Study 2. The reasons the MEWS is a par-
ticularly good predictor of impairment in ADHD are not 
well understood, but could be explained by both clinical 
and theoretical considerations. One possible explanation is 
that the scale items are rooted in qualitative accounts from 
adult ADHD patients of experiences of their mental state. 
When asked to describe the subjective experience of the 
flow of their thoughts, adults with ADHD repeatedly give 
descriptions of ceaseless, short-lived, and unfocused 
thoughts that flit from one topic to another (Asherson, 
2005). Such a distractible and poorly regulated mental state 
could be impairing for several reasons.
First, excessive MW may have a specific effect on func-
tional outcomes due to the failure to deal with distraction 
and deficient mental processing of “task”relevant events. In 
social situations, an individual with excessive MW may 
miss verbal and non-verbal information and effectively not 
listen or lack awareness of social cues. MW may make it 
difficult to follow a single line of thought and interrupting 
others during conversations could be a strategy to avoid los-
ing their train of thought. Behaviors such as these are likely 
to have negative effects on an individual’s social 
interactions.
Second, lack of attention paid to events due to one’s 
mind constantly being “on the go” in a non-focused way 
can also create difficulties with thinking through and plan-
ning activities, linked to forgetfulness and disorganization 
and leading to impairments in basic life-skills. Impaired 
self-concept may then arise as a bi-product of the effect of 
excessive MW on other domains of functioning, but could 
also be due to distress from the constant effort to focus or 
the experience of having a mind constantly full of unfo-
cused distractible thoughts. Many patients report a sense of 
calm and relief when the flow of their thoughts becomes 
more focused and regulated following stimulants or other 
treatments for ADHD.
Third, the connection between MW and risk-taking 
behavior is less obvious, but could be due to the impact of 
highly salient activities, which engage the attention of indi-
viduals, leading to a reduction of spontaneous MW and a 
sense of relief. For the same reasons, some patients with 
even severe levels of ADHD may excel at activities such as 
exciting/stimulating sports. Although there is as yet no 
direct evidence for this hypothesis, studies investigating 
default mode deactivation (Liddle et al., 2011) and reaction 
time variability (RTV; Andreou et al., 2007) during tasks 
requiring sustained attention have shown reduced or absent 
case-control differences when conducted under highly 
salient conditions. Reductions in default mode activity 
under rewarding conditions have been hypothesized to 
reflect reductions in excessive MW (Liddle et al., 2011). 
Thus, risky behavior may reflect individuals seeking out 
activities with salient content, which decreases MW and 
helps individuals with ADHD to focus their attention.
These accounts of MW leading to impairment in ADHD 
remain speculative because of the lack of research on MW 
in ADHD. However, an increase in understanding of MW 
states in control participants provides a strong theoretical 
basis for the hypothesis that excessive MW may underlie 
many of the behavioral symptoms and impairments seen in 
ADHD. In healthy control samples, MW is associated with 
performance deficits that overlap with impairments seen in 
ADHD, including educational performance, driving acci-
dents, and performance on cognitive tasks including errors 
of commission and RTV during sustained attention and 
inhibition tasks (Smallwood & Schooler, 2015). 
Understanding of the neural processes involved in the regu-
lation of internal thought, involving default mode network 
(DMN) and executive control networks, has advanced in 
recent years, and overlaps with neural mechanisms impli-
cated in ADHD. TUTs are strongly associated with defi-
cient task-induced deactivation of the DMN (correlation 
about .9; McKiernan, D’Angelo, Kaufman, & Binder, 
2006), and deficient DMN deactivation during task condi-
tions is strongly associated with ADHD (Christakou et al., 
2013). Spontaneous MW that is detrimental to performance 
has, therefore, been proposed as a mechanism that explains 
many of the symptoms and functional impairments of 
ADHD (Seli et al., 2015; Weyandt et al., 2003), reflecting 
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aberrant inter-relationships between default and task posi-
tive networks (Fox, Spreng, Ellamil, Andrews-Hanna, & 
Christoff, 2015; Sripada, Kessler, & Angstadt, 2014).
Interestingly, in one study, meta-awareness of MW (being 
aware that your mind has wandered) was found to mediate 
the relationship between ADHD symptoms and detrimental 
forms of MW, suggesting that psychological treatments 
aimed at enhancing meta-awareness of MW, such as mind-
fulness-based interventions (MBIs), might ameliorate the 
negative consequences of MW in ADHD (Franklin et al., 
2014). Recent studies support the beneficial effects of MBIs 
on ADHD, with the largest study to date showing an effect of 
d = .85 on ADHD symptoms compared with a treatment as 
usual group (Hepark et al., 2015). Future large-scale con-
trolled experimental designs are therefore indicated to inves-
tigate the potential role of MW as a treatment target for the 
control of ADHD symptoms and impairments using both 
pharmacological and non-pharmacological interventions.
Current screening tools for adult ADHD consist of rating 
scales for inattention and hyperactivity/impulsivity. Our 
findings suggest potential utility of the MEWS as an addi-
tional screening tool for adult ADHD in clinical practice, 
particularly as the MEWS is a strong predictor of impair-
ment. Furthermore, as discussed above MW may also be 
measured more objectively using experience sampling 
methods in daily life or during experimental paradigms. 
Measures of MW may therefore assist in the accurate diag-
nosis of individuals based on their mental state rather than 
descriptions of behavior, which may be more subject to bias 
or influenced by an individual’s ability to develop compen-
satory behavioral strategies.
However, currently we do not know the role that exces-
sive MW, as measured by the MEWS, plays in other clinical 
disorders. For example, in depression depressive rumina-
tion represents another form of MW. Thus, the specificity of 
the MEWS across common mental health disorders needs 
to be explored. Therefore, we do not currently recommend 
the routine use of the MEWS to identify patients with 
ADHD until the scale has been comprehensively evaluated 
in other psychiatric disorders with overlapping clinical fea-
tures, although high MEWS scores could be used to support 
the diagnosis. Investigation of the role of excessive MW in 
childhood and early adolescent ADHD is also recom-
mended, including use of the scale in this population. 
Whether children and young adolescents would be able to 
conceptualize MW and reliably report on their mental state 
requires investigation.
Limitations and Future Research
Some participants in Study 2 presented with co-occurring 
anxiety and depression, raising the possibility that MW 
might be linked to comorbid conditions. However, in Study 
1 participants were free from co-occurring disorders 
(Skirrow & Asherson, 2013), yet similar results were found. 
Nevertheless, TUTs are a common feature of most mental 
health disorders and future research will need to investigate 
the distinction of excessive MW in ADHD from depressive 
ruminations, anxious worrying, and other sources of MW.
In relation to ADHD, a key question is whether MW dif-
fers conceptually from the inattentive symptoms currently 
used to define the disorder or whether the mental phenom-
enon of MW underlies the behavioral expression of inatten-
tion. As discussed above, it is feasible that measures of MW 
in ADHD are a more direct reflection of the neurobiology, 
leading to the inattentive symptoms of ADHD. Further 
work is required to evaluate the plausible hypothesis that 
aberrant regulation of DMN activity linked to excessive 
MW leads to ADHD symptoms and impairments. The study 
of MW has several potential advantages over behavioral 
inattention for research, because it may be measured using 
rating scales, as reported here, as well as experience sam-
pling during daily life (Killingsworth & Gilbert, 2010), or 
during sustained attention tasks (Shaw & Giambra, 1993) 
and neuroimaging studies (Baird, Smallwood, Lutz, & 
Schooler, 2014; Christoff, Gordon, Smallwood, Smith, & 
Schooler, 2009).
A fruitful next step in this research will be to take the 
MEWS into experimental paradigms. For example, an 
experimental trial of methylphenidate could be used to for-
mally evaluate whether improvements in MW mediate 
improvements in ADHD symptoms and impairments, and 
to investigate the underlying neural mechanisms. Yet, cur-
rently, there are very little data that link rating scale mea-
sures of MW to experimentally derived measures in ADHD. 
Validation of MW in ADHD is therefore required across the 
various levels of measurement (rating scale, experience 
sampling, and experimental paradigms including neuroim-
aging studies). We hypothesize that MW is a phenomenon 
that can be reliably measured, and it will be highly informa-
tive to see to what extent MEWS scores reflect TUTs mea-
sured during cognitive task performance in ADHD. It will 
also be advantageous to see how it relates to various cogni-
tive measures such as omission and commission errors 
(Losier, McGrath, & Klein, 1996), and RTV (Kofler et al., 
2013), which may reveal further information about the 
underlying neurobiology of ADHD.
Conclusion
This research provides further insight into the mental phe-
nomenon of MW in ADHD. We investigate a questionnaire-
based measure of excessive MW recently developed in our 
research group. The MEWS was found to be a valid and 
reliable measure, with comparable sensitivity and specific-
ity for case-control differences as existing rating scale mea-
sures of core ADHD symptoms currently used in clinical 
practice. The MEWS functioned extremely well for a brief 
94
10 Journal of Attention Disorders 
15-item measure and is potentially a useful measure to
incorporate in future clinical and etiological research.
MEWS scores were found to be a particularly good predic-
tor of impairment, highlighting the clinical utility of the tool
for diagnosis and treatment. Based on these findings, there
is strong premise to view MW as a common co-occurring
feature of adult ADHD with a specific effect on impair-
ment, potentially explaining a variety of deficits not easily
accounted for by the core symptom dimensions.
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Chapter 5. Evaluating a scale of excessive mind wandering among males 
and females with and without attention-deficit/hyperactivity disorder from 
a population sample 
This chapter is adapted from a manuscript currently under review. 
Mowlem, F.D., Agnew-Blais, J., Pingault, JB., & Asherson, P. (under review). Evaluating a scale of 
excessive mind wandering among males and females with and without attention-
deficit/hyperactivity disorder from a population sample 
Supplementary materials for this chapter, as detailed in the text, are attached in Appendix D. 
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5.1 Abstract 
Recent studies highlight the role of excessive mind wandering in attention-deficit/hyperactivity 
disorder (ADHD) and its association with impairment. We believe assessing mind wandering could 
be especially relevant to individuals, including many females, who present with less externalising 
manifestations of ADHD. Using a new measure based on ADHD patient reports, the Mind 
Excessively Wandering Scale (MEWS), we previously found adults with ADHD had elevated levels 
of mind wandering that contributed to impairment independently of core ADHD symptoms. Using 
data from an online general population survey, the current study assessed the factor-structure, 
reliability, validity and measurement invariance of the MEWS. We also investigated sex differences 
in mind wandering, as well as ADHD symptoms, impairment and wellbeing in those with and 
without ADHD. The MEWS had a unidimensional structure, was invariant across sex, age and 
ADHD status, and accounted for unique variance in impairment and wellbeing beyond core ADHD 
symptoms. Among those with ADHD, we found no evidence for sex differences in mind wandering 
and among those without ADHD males had higher scores. We also found similar levels of 
hyperactivity/impulsivity, emotional lability, and impairment in males and females with ADHD, but 
males reported greater inattention and lower wellbeing. Results suggest the MEWS is a reliable 
and valid instrument measuring the same construct across sex, age and ADHD status, which could 
aid diagnosis and monitoring of outcomes. The pattern of sex differences for the behavioural 
ADHD symptoms in adults also appears to be reflected in the internalised/subjective experience of 






Given the extensive evidence that ADHD is not confined to childhood and also occurs in adulthood, 
identifying measures to aid diagnostic assessment and monitoring of treatment outcomes in this 
age group is of considerable interest to research and clinical practice (Asherson et al., 2016). 
Although ADHD diagnosis is made based on the presence of core symptoms of inattention and 
hyperactivity/impulsivity (American Psychiatric Association, 2013), other characteristic features, 
such as subjective reports of excessive mind wandering could aid the diagnostic process and/or 
monitoring of treatment outcomes (Mowlem et al., 2016). Mind wandering is conceptualised as 
periods in time when attention and the contents of thoughts shift away from external sources 
and/or ongoing tasks, to unrelated internal thoughts or feelings (Smallwood & Schooler, 2015). 
Excessive mind wandering has been linked to impairment in ADHD (Biederman et al., 2017; 
Franklin et al., 2014; Jonkman et al., 2017; Mowlem et al., 2016; Seli et al., 2015; Shaw & Giambra, 
1993) and could reflect a core underlying symptom (Bozhilova et al., 2018). 
In contrast to the core ADHD symptoms, mind wandering reflects internal thought processes, as 
opposed to directly observable behaviours. Excessive mind wandering may be particularly relevant 
to the assessment of ADHD in adolescence and adulthood when self-report plays a larger role in 
the diagnostic process. It may also be more difficult for individuals to reflect upon the behavioural 
symptoms that are currently used in the diagnostic criteria, while they may be better able to 
report on internal thought processes. Furthermore, the traditional symptoms of ADHD may not be 
obvious in people who have developed good adaptive skills that mask the behavioural symptoms 
of ADHD. Assessing mind wandering in ADHD could be especially relevant to individuals, including 
many females, who present with less externalising manifestations of ADHD. Thus, investigation of 
sex differences in mind wandering is especially pertinent as it does not depend on behavioural 
adaption to the same degree as traditional ADHD measures. 
We recently developed and validated a new rating scale reflecting excessive mind wandering in 
ADHD: the Mind Excessively Wandering Scale (MEWS) (Mowlem et al., 2016). The scale 
demonstrated a unidimensional structure with good internal consistency, and high sensitivity and 





existing ratings scales of ADHD symptoms used in clinical practice. Adult ADHD cases showed 
elevated levels of mind wandering that contributed to impairment independently of the core 
ADHD symptom domains. Thus, excessive, uncontrolled mind wandering appears to be a common 
co-occurring feature of adult ADHD with specific implications for impairment in daily-life (Mowlem 
et al., 2016). 
The current study sought to further validate the MEWS in a large adult population sample, 
including those who report a diagnosis of ADHD, and assess measurement invariance of the scale 
across sex, ADHD diagnostic status, and age.  Measurement invariance examines whether a scale 
captures fundamentally the same processes and construct across groups. Comparisons of group 
means for any scale is based on the assumption that the scale is measurement invariant across 
groups being compared, and a lack of invariance can render between-group comparisons 
meaningless and lead to incorrect interpretation of differences (Marsh, Nagengast, & Mori, 2013; 
Orri et al., 2016). Between-group differences (e.g., ADHD cases vs controls) should not be analysed 
unless measurement invariance is held across the groups, yet this is rarely tested in empirical 
studies of psychiatric disorders (Orri et al., 2016).  
Given the well documented sex differences in ADHD (Gershon, 2002; Williamson & Johnston, 
2015), and persistence of ADHD across the lifespan, it is important that the scale is also 
measurement invariant across sex and age. Further, as previous studies show mixed results with 
regard to whether males and females are affected differently by ADHD in adulthood (Biederman et 
al., 2004; Fedele et al., 2012; Fredriksen et al., 2014; Nussbaum, 2012; Rasmussen & Levander, 
2009; Wilens et al., 2009), we examined sex differences within those with and without self-
reported ADHD with regard to mind wandering, as well as inattention, hyperactivity/impulsivity, 
emotional lability, impairment and wellbeing. Given that sex differences in adult ADHD have 
received much less attention in the literature compared to childhood (Corbisiero et al., 2017; 
Fedele et al., 2012; Williamson & Johnston, 2015), there is a clear need for additional research. 
Furthermore, given that mind wandering may account for unique variance in functional 
impairment beyond core ADHD symptoms, and impairment is the most frequent reason for 





5.3 Materials and methods 
5.3.1 Sample 
This study uses data from a large online survey of individuals from the general population, 
implemented using Qualitrics. The survey was advertised through King’s College London research 
recruitment page, ADHD user-group and information websites, and social media. The only 
exclusion criterion was participants could not be below 16 years of age. Data from 1484 
participants (425 males, 1059 females) who fully completed the MEWS were used for analysis in 
the current study. 
Participants were aged between 16–83 years (M = 34.80, SD = 13.55) and were categorised into 
age groups as follows: 1) 16-23 years (n = 382), 2) 24-30 years (n = 360), 3) 31-45 years (n = 365), 
and 4) 46+ years (n = 372). Those with and without full MEWS data did not differ significantly for 
sex (χ2(1) = 1.05, p = .31) or age group (χ2(3) = 5.74, p =.13). Participants who endorsed a childhood 
or adulthood diagnosis of ADHD based on self-report were included in the ADHD group (n = 198: 
76 males, 122 females) and those reporting no diagnosis or ‘not sure’ (n = 59) were included in the 
non-diagnosed ADHD group (n = 1181: 319 males, 862 females). 
5.3.2 Ethical Approval 
Ethical approval was granted by the East of England–Cambridgeshire and Hertfordshire REC 
(ref:16/EE/0226). The study was carried out in compliance with the Helsinki Declaration of 1975, 
as revised in 2008. Participants provided informed consent online prior to completing the survey. 
5.3.3 Measures 
 
Excessive mind wandering was measured using The Mind Excessively Wandering Scale (MEWS) 





psychometric evaluation and validation found 3 items had low factor loadings and that shortening 
the scale to 12-items did not reduce its sensitivity or specificity, so we use the 12-item measure. 
To assess validity of the MEWS, unintentional (spontaneous) and intentional (deliberate) mind 
wandering were also assessed with the Mind Wandering Spontaneous (MW-S) and Mind 
Wandering Deliberate (MW-D) self-report scales (Carriere, Seli, & Smilek, 2013). Previously it has 
been shown that spontaneous, but not deliberate mind wandering is associated with ADHD (Seli et 
al., 2015). 
 
ADHD symptoms were assessed using the self-rated Barkley Adult ADHD Rating Scale which 
consists of 18 items that closely parallel the DSM-5 symptom criteria for ADHD; 9 items pertain to 
inattention and 9 to hyperactivity/impulsivity (Barkley & Murphy, 2006). The Barkley Current 
Behaviour Scale Self-report was used to measure the degree to which a participant’s inattention 
and hyperactivity/impulsivity symptoms cause problems for them in major life domains (e.g., 
family, work, education, social, life-skills, relationships, money, driving, recreation, and daily 
responsibilities) (Barkley & Murphy, 2006). Emotional lability was assessed with the Affective 
Reactivity Index self-report measure of irritability (Stringaris et al., 2012), and the Mental Health 
Continuum-Short Form assessed wellbeing (emotional, psychological, and social) (Keyes, 2009). 
Further detail on the measures, including Cronbach’s alphas, are provided in the Supplementary 
Content (Supplementary Table S1, Appendix D). 
5.3.4 Statistical Analysis 







First, we performed item factor analysis to identify the dimensionality of the MEWS, using 
exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). We used a random 
number algorithm to split the sample into two halves, which did not significantly differ for sex 
(χ2(1) = .95, p = .33) or age group (χ2(3) = 2.64, p = .45); EFA was carried out on the first half (n = 
742) and CFA on the second half (n = 742). EFA (oblimin rotation) and CFA were carried out using a 
structural equation modelling framework and the Robust Weighted Least Squares (WLSMV) 
estimator, since this does not make distributional assumptions and is more appropriate for use 
with categorical variables (Yu, 2002). Goodness of fit was assessed based on the following 
(Hooper, Coughlan, & Mullen, 2008): standardised mean square residual (SMSR), root mean 
square error of approximation (RMSEA), Taylor-Lewis Index (TLI), and the comparative fit index 
(CFI). In line with recommendations, the following values were used as indicators of good-fit: 
SMSR < .08 (Hooper et al., 2008; Hu & Bentler, 1999; Schmitt, 2011; Yu, 2002), RMSEA < .06 
(Hooper et al., 2008; Hu & Bentler, 1999; Schmitt, 2011), TLI values > .9, and CFI close to 1 (Hooper 
et al., 2008; Hu & Bentler, 1999; Yu, 2002). Of note, although chi-square is the traditional fit index 
used to evaluate model fit, it is very sensitive to sample size and can be inflated in large samples 
(Blunch, 2008; Hooper et al., 2008; Schmitt, 2011) and so this was not used as a goodness of fit 
index for the CFA model.  
 
The total sample was used to test measurement invariance across sex, age, and ADHD status using 
multi-group CFA (MGCFA) for categorical variables (sex and ADHD status) and multiple indicators 
multiple causes (MIMIC) models for continuous variables (age). MGCFA is tested in a 
sequential/hierarchical manner where constraints are consecutively added to the model. The first 
step involves running an unconstrained model for all groups combined to test for configural 
invariance (whether the same factor structure is observed between-groups). This is followed by a 
series of constrained models where parameters (factor-loadings and thresholds) are constrained 
to be equal across groups. Metric invariance refers to when factor-loadings are equivalent across 
groups, and scalar invariance refers to when the factor-loadings and item-thresholds are 





Supplementary Table S2, Appendix D, for more detail). If the difference in fit indices between the 
model and the preceding, less constrained model, is ≤ -.01 for ΔCFI and ≤ .015 for ΔRMSEA, then 
we considered the corresponding level of measurement invariance was held (Chen, 2007; Cheung 
& Rensvold, 2002; Lúcio et al., 2017). If non-invariance was identified, modification indices were 
used to identify noninvariant items and remove the corresponding equality constraint (i.e., the 
parameter was freely estimated in each group). Then, if the fit indices were in line with the 
accepted cut-offs, partial invariance was held and the parameter remained unconstrained in the 
subsequent models. Of note, the nested chi-square  difference test between two models 
(DIFFTEST) was not used  due to its sensitivity to sample size (it has been noted that if sample size 
is greater than 200, any differences between groups indicated by the DIFFTEST are likely to be 
trivial and subsequent analyses can proceed (Meade, Johnson, & Braddy, 2008)). 
MIMIC models allow covariates in the CFA model (Yu, 2002) and as they do not split the sample by 
group can accommodate continuous covariates. If the covariate shows a significant direct effect on 
any of the individual scale items, this provides evidence of measurement non-invariance and the 
identified items are assumed to be affected by differential item functioning (DIF). However, if the 
magnitude of any direct effects is very small, then it is likely to have a trivial impact on the model 
(Brailean, Guerra, Chua, Prince, & Prina, 2015). In the baseline model, associations between the 
covariate and items are fixed to 0 and then modification indices are consulted, with modification 
indices >4 of the covariate on an item presenting DIF (Lúcio et al., 2017). If the covariate shows an 
association with the latent structure (i.e., the factor), this provides evidence of population 
heterogeneity. 
 
To assess the reliability of the scale we estimated internal consistency using Cronbach’s alpha and 
examined item-total correlations. Convergent validity was assessed to provide an indication of the 
degree of relationship between the scale of interest (the MEWS) and other scales measuring 
similar entities, by calculating Pearson’s correlation coefficients between the MEWS and MW-S, 
ADHD symptom scales, emotional lability, and impairment. To examine discriminant validity, 
providing an indication of whether two measures that should not be correlated are actually not 





wellbeing. We then examined ADHD case-control differences and conducted receiver operating 
characteristic (ROC) analysis to examine the capacity of the scale to discriminate between those 
with and without ADHD. 
We also carried out regression analysis in the ADHD group to assess whether mind wandering 
accounts for unique variance in impairment and wellbeing beyond that accounted for by the core 
ADHD symptoms, which would further emphasise the potential value of the scale. Specifically, a 
hierarchical regression was conducted with impairment/wellbeing summary scores as the 
dependent variable and inattention and hyperactivity/impulsivity summary scores entered in 
Step1, and MEWS summary scores entered in Step2.   
 
Sex differences across ADHD diagnostic status in mind wandering, as well as ADHD symptoms, 
emotional lability, impairment, and wellbeing, were tested using linear regression models adjusted 
for age. Cohen’s d was used as an indication of effect size where: d ≥ 0.20 is a small effect, d ≥ 0.50 
a medium effect, and d ≥ 0.80 a large effect. 
5.4 Results 
5.4.1 Factor Analysis 
All 12-items in the scale were included in the EFA model. The sample correlation matrix produced 
1 eigenvalue >1 (8.55), in line with the scree plot (Supplementary Fig S1, Appendix D). The next 
largest eigenvalue was 0.89. Goodness of fit indices for the 1-factor model were: SMSR = .06, 
RMSEA = .13 [0.12, 0.14], TLI = .97, CFI = .97. Next, we entered the 12-items into a CFA model 
specifying a 1-factor solution. Each of the 12-items demonstrated a high loading on to the single 
hypothesised factor (> 0.75) (Table 5.1). Three out of four fit indices (SMSR = .06, RMSEA = .15 
[0.14, 0.16], TLI = .96, CFI = .96) were indicative of good/acceptable model fit; only the RMSEA was 





5.4.2 Measurement Invariance 
Table 5.1 shows standardised factor loadings for the MEWS items across sex and ADHD status. 
Table 5.2 summarises the change in goodness of fit indices for measurement invariance (assessed 
with MGCFA) across sex and ADHD status. 
 
The configural model showed acceptable model fit according to TLI and CFI (TLI = .96, CFI = .97), 
although RMSEA was higher than the recommended cut-off (RMSEA = .14[0.14, 0.15]). Thus, 
model fit indices were similar to those for the CFA carried out above, with two out of three fit 
indices reaching acceptable levels, implying the factor structure is equivalent between males and 
females. Metric and scalar invariance both held in relation to the ΔCFI and ΔRMSEA.  
 
The configural model showed acceptable model fit according to TLI and CFI (TLI = .95, CFI = .96), 
although RMSEA was higher than the recommended cut-off (RMSEA = .14 [0.13, 0.14]). Thus, 
model fit indices were similar to the CFA results, with two out of three fit indices reaching 
acceptable levels, implying the factor structure is equivalent between those with and without a 
self-reported ADHD diagnosis. Both metric and scalar invariance held as assessed by ΔCFI and 
ΔRMSEA. 
Thus, the MEWS showed full measurement invariance across sex and ADHD status at the scalar 
level, and we are satisfied that there is no substantial measurement bias.  
 
MIMIC analysis testing the direct effect of age on individual items suggested DIF for Item 12 (“I can 
only focus my thoughts on one thing at a time with considerable effort”) as a function of age. 
Assuming equivalent levels of mind wandering, increasing age was associated with increased 





small. Further, consideration should be given to the fact that Item 12 appeared last in the scale 
and the effect could be an artefact of this. Results therefore indicate that age is not a concern 
regarding measurement non-invariance. Regarding population heterogeneity, the MIMIC model 
suggested that mind wandering increased with age. 





















Table 5.1 Standardised factor loadings for the 12-items for EFA (with oblimin rotation) and CFA 
and across sex and ADHD status, and Cronbach’s alpha for the scale 
Item 














I have difficulty controlling my 
thoughts 
.83 .80 .83 .81 .75 .80 
2. I find it hard to switch my thoughts off .82 .80 .82 .81 .80 .79 
3. 
I have two or more different thoughts 
going on at the same time 
.74 .76 .69 .78 .73 .72 
4. 
My thoughts are disorganised and ‘all 
over the place’ 
.85 .88 .85 .87 .80 .84 
5. 
My thoughts are ‘on the go’ all the 
time 
.84 .84 .88 .83 .89 .82 
6. I experience ceaseless mental activity .86 .82 .85 .84 .82 .82 
7. 
I find it difficult to think about one 
thing without another thought 
entering my mind 
.88 .84 .87 .86 .83 .85 
8. 
I find my thoughts are distracting and 
prevent me from focusing on what I 
am doing 
.87 .88 .89 .87 .80 .86 
9. 
I have difficulty slowing my thoughts 
down and focusing on one thing at a 
time 
.91 .91 .90 .91 .82 .90 
10 
I find it difficult to think clearly, as if 
my mind is in a fog 
.78 .79 .78 .78 .65 .77 
11. 
I find myself flitting back and forth 
between different thoughts 
.88 .83 .83 .86 .76 .84 
12. 
I can only focus my thoughts on one 
thing at a time with considerable 
effort 
.79 .79 .80 .79 .54 .78 
Internal 
consistency 





Table 5.2 Multi-group CFA models for measurement invariance across sex and ADHD diagnostic 
status for the MEWS 
 
Measurement invariance model a 
(constraints) 
CFI ΔCFI RMSEA ΔRMSEA 
Sex Configural  
(no equality constraints) 
0.968 - 0.141 (0.135, 0.147) - 
Metric  
(factor loadings) 
0.969 -.001 0.132 (0.127, 0.138) .009 
Scalar  
(factor loadings and thresholds) 
0.970 -.001 0.120 (0.115, 0.125) .012 
ADHD Configural 0.960 - 0.138 (0.132, 0.144) - 
Metric 0.964 -.004 0.125 (0.120, 0.131) .013 
Scalar 0.964 .000 0.113 (0.108, 0.119) .012 
a See Supplementary Table S2 (Appendix D) for further detail on the constraints applied to each model.  
5.4.3 Reliability and validity 
Internal consistency for the 12-item scale was high for the complete sample (α = .95), with no 
improvement in the reliability index gained by omitting items. Item-total correlations were all 
above .69. Similar results were found across sex and ADHD status. For males and females α was 
.95, with no improvement in the reliability index gained by omitting items, and item-total 
correlations all >.64. Alpha was also high in those with ADHD (α = .91) and those without (α = .94), 
with no improvement in the reliability index gained by omitting items, and item-total correlations 
>.48 in those with ADHD and >.66 in those without ADHD. 
Demonstrating convergent validity, the MEWS correlated moderately-to-strongly with 
spontaneous mind wandering (MW-S r = 0.76, p <.001), ADHD symptoms (inattention r = 0.76, p 
<.001; hyperactivity/impulsivity r = 0.71, p <.001), emotional lability (r = 0.44, p <.001), and 
impairment (r = 0.74, p <.001) (Table 5.3). It also demonstrated discriminant validity, with a weak, 
non-significant correlation with deliberate mind wandering (MW-D r = 0.05, p = .06) and a negative 





We found elevated levels of mind wandering as measured by the MEWS in those with a self-
reported diagnosis of ADHD compared to those without ADHD (p <.001, d = -1.17), with the same 
pattern of findings for measures of spontaneous mind wandering (MW-S) (p <.001, d = -.98), 
inattention (p <.001, d = -1.54), hyperactivity/impulsivity (p <.001, d = -1.42), emotional lability (p 
<.001, d = -.45), and impairment (p <.001, d = -1.47). We also found higher scores for wellbeing in 
those without ADHD compared to ADHD cases (p <.001, d = .35) (see Supplementary Table S3, 
Appendix D, for mean scores across subscales). ROC analysis examined the capacity of the MEWS 
to discriminate between those with and without ADHD. Area under the curve (AUC) was .81 (95% 
CI: .78, .84, p<.001); the closer the value to 1, the better the discriminant capacity of the measure, 
and so this indicates that in the current sample including individuals with self-reported ADHD the 
MEWS has good discriminant capacity. This was comparable to the inattention (AUC = .86, 95% CI: 
.84, .89) and hyperactivity/impulsivity rating scales in the sample (AUC = .83, 95% CI: .80, .86). 
Regression analysis in the ADHD group examining if mind wandering (measured by the MEWS) 
accounts for unique variance in impairment beyond core ADHD symptoms found that inattention 
and hyperactivity/impulsivity accounted for 53.4% of the variability in impairment (R2 = .53). The 
addition of mind wandering in the model led to a significant increase in the variability accounted 
for by the model (R2Δ = .02), with an increase to 55.3%, FΔ(1,194) = 8.34, p = .004. This indicates 
that mind wandering is having a small but significant effect beyond that of inattention and 
hyperactivity/impulsivity. Inattention was the most strongly associated (β = .56), followed by mind 
wandering (β = .19) and hyperactivity/impulsivity (β = .08). Only inattention and mind wandering 
were significantly associated with impairment in the model (p <.001 and p = .004, respectively).  
Similar findings were found for the measure of wellbeing. Within those with self-reported ADHD, 
mind wandering accounted for unique variance in total wellbeing beyond core ADHD symptoms. 
Inattention and hyperactivity/impulsivity accounted for 10% of the variance in wellbeing (R2 = .10). 
The addition of mind wandering as a predictor led to a significant increase in the variability 
accounted for by the model (R2Δ = .04), with an increase to 15%, FΔ(1,194) = 9.29, p = .003. Mind 
wandering was the most strongly associated (β = -.28, p = .003), followed by inattention (β = -.25, 
p = .009) and hyperactivity/impulsivity (β = .24, p = .005). This implies that excessive mind 
wandering in ADHD is having a small but significant independent negative effect on wellbeing 





Table 5.3 Correlations between excessive mind wandering scores and rating-scale measures of 
spontaneous and deliberate mind wandering, inattention hyperactivity/impulsivity, emotional 
lability, impairment, and wellbeing  
 MEWS MW-D MW-S INN HI EL IMP 
MEWS - - - - - - - 
MW-D .05 - . - - - - 
MW-S .76 .19 - - - - - 
INN .76 .03 .67 - - - - 
HI .71 .03 .58 .72 - - - 
EL .44 -.04 .35 .41 .43 - - 
IMP .74 .006 .63 .84 .68 .46 - 
WB -.41 .10 -.30 -.40 -.21 -.37 -.46 
Note. MEWS = Mind Excessively Wandering Scale; MW-S = Mind Wandering Spontaneous; MW-D = Mind 
Wandering Deliberate; INN = inattention; HI = hyperactivity/impulsivity; EL= emotional lability; IMP = 
impairment; WB = wellbeing. 
Statistically significant correlations are presented in bold: significant at p<.001 
 
Table 5.4 Mean scores (SD) for the study subscales comparing males and females with and without 
ADHD*  














Cohen’s d  
(95% CI) 
MEWS 26.34 (6.57) 25.38 (7.75) .44 .13 (-.16, .42) 16.90 (9.98) 15.36 (8.53) .01 .18 (.05, 0.31) 
MW-S 23.41 (3.44) 23.47 (4.60) .78 -.01 (-.30, .27) 18.99 (5.39) 17.96 (5.50) .006 .19 (.06, .32) 
MW-D 17.39 (7.07) 17.16 (6.35) .78 .04 (-.25, .32) 18.16 (5.58) 17.47 (5.72) .008 .12 (-.01, .25) 
INN 19.92 (4.27) 18.30 (5.48) .045 .32 (.03, .61) 11.34 (6.67) 8.80 (6.02) <.001 .41 (.28, .54) 
HI 15.70 (5.10) 15.31 (6.43) .75 .06 (-.22, .35) 8.86 (5.46) 7.74 (4.92) .003 .22 (.09, .35) 
EL 3.63 (2.91) 4.29 (3.17) .13 -.21 (-.50, .07) 3.02 (3.11) 2.65 (2.69) .04 .13 (.002, .26) 
IMP 2.02 (0.55) 1.90 (0.63) .23 .20 (-.09, .49) 1.08 (0.72) 0.86 (0.70) <.001 .31 (.18, .44) 
WB 42.42 (13.77) 47.26 (12.92) .01 -.37 (-.65, -.08) 48.24 (13.89) 51.09 (14.45) .008 -.20 (-.33,-.07) 
Note. MEWS = Mind Excessively Wandering Scale; MW-S = Mind Wandering Spontaneous; MW-D = Mind 
Wandering Deliberate; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = 
impairment; WB = wellbeing. 
Statistical analysis adjusted for age. 
Statistically significant findings are presented in bold. 





5.4.4 Sex differences in those with and without self-reported ADHD 
Overall, males had significantly higher scores across all scales (p range <.001 to .004, d range .12 to 
.44), except greater wellbeing reported by females (p <.001, d = -.25) and no significant difference 
in emotional lability (p = .17) (Supplementary Table S3, Appendix D). In those with self-reported 
ADHD, males and females showed similar symptom scores, except males with ADHD reported 
significantly greater levels of inattention (p = .045, d = .32) and lower wellbeing than females (p = 
.01, d = -.37) (Table 5.4). Among those without ADHD, males reported significantly greater 
symptom levels across all variables (p range <.001 to .04, d range .12 to .41) and lower wellbeing 
than females (p = .008, d = -.20). 
5.5 Discussion  
We validated the Mind Excessively Wandering Scale (MEWS) using a large population sample. The 
scale showed measurement invariance across sex, age and ADHD diagnostic status, suggesting the 
MEWS is a reliable and valid instrument measuring the same construct across the studied groups. 
Among those with ADHD, we found no evidence for sex differences in mind wandering, nor were 
there sex differences in levels of hyperactivity/impulsivity, emotional lability, or impairment. 
However, males with ADHD reported higher levels of inattention and lower wellbeing than 
females with ADHD. Among individuals without ADHD, males had higher scores across all ADHD 
related scale and reported significantly lower wellbeing than females. 
In the current study, analysis involved a series of factor analysis models. EFA suggested that a 1-
factor structure is appropriate for the MEWS. Model fit indices for the CFA model were 
acceptable, with three out of four fit indices suggesting acceptable fit for the unidimensional 
structure. The RMSEA exceeded the recommended cut-off, however this does not mean that one 
should automatically disregard the model (Lai & Green, 2016). It can be difficult to achieve good fit 
in large samples (Maccallum, Browne, & Sugawara, 1996; Schmitt, 2011) and fit indices should be 
interpreted with this in mind. Further, there is also debate regarding model fit indices and the 
‘rules of thumb’, with a general consensus that strictly adhering to recommended cut-offs can lead 
to incorrectly rejecting an acceptable model (i.e., a Type I error) (Hooper et al., 2008) and that 





structural equation modelling (Hooper et al., 2008; Schmitt, 2011). Thus, we believe the results 
support the MEWS as measuring one unified construct of excessive mind wandering. 
This study is the first to test measurement invariance of the MEWS, which is important to establish 
for any new measure, and extends our previous findings. The MEWS had full scalar invariance 
across sex and ADHD diagnostic status. No sex differences were observed at the level of factor 
loadings or thresholds, indicating scalar invariance across sex in the total sample. This attests that 
the same latent construct of mind wandering is related to the items and their thresholds similarly 
for males and females. Measurement invariance also held in those with and without a self-
reported diagnosis of ADHD (i.e., scalar invariance held). Thus, comparisons of mean scores across 
these groups is appropriate and meaningful, and any between group differences observed can be 
reliably interpreted as true differences in the latent construct of mind wandering. We also found 
scale items functioned similarly across age, but that increasing age may be associated with higher 
levels of mind wandering, so age should be considered as an important covariate in analyses of 
mind wandering. 
Reliability and validity analysis showed the 12-item scale had high internal consistency in the total 
sample, as well as in males and females and those with and without self-reported ADHD. The 
MEWS demonstrated convergent validity, with moderate to strong correlations found between 
the MEWS and measures of core ADHD symptoms, impairment, and wellbeing (negative 
correlation). The MEWS showed strong correlation with another existing measure of spontaneous 
mind wandering but not with deliberate mind wandering, supporting the MEWS as specifically 
reflecting spontaneous mind wandering. Of note, the correlation between the MEWS and 
emotional lability was lower than demonstrated in our previous study, which may be due to 
different measures of emotional lability being employed in the studies. Regarding discriminant 
validity, both ROC analysis and examination of mean differences showed the MEWS distinguished 
between those with and without self-reported ADHD. Importantly, in the current sample the ROC 
analysis using the MEWS produced results comparable to those of the core ADHD symptom 
dimensions. 
The National Collaborating Centre for Mental Health (NCCMH, 2009) emphasise the importance of 





benefit from treatment rather than somewhat arbitrary symptom counts. Replicating our previous 
findings, among adults with ADHD, mind wandering accounted for unique variance in impairment 
above that of core ADHD symptoms of inattention and hyperactivity/impulsivity. The ability for the 
MEWS to account for unique variance beyond core ADHD symptoms demonstrates the value of 
the measure and its potential clinical utility. Similar findings were also found for wellbeing, further 
emphasising the value of the scale. Thus, findings indicate the mind wandering is associated with 
both increased impairment and reduced wellbeing even after accounting for levels of inattention 
and hyperactivity/impulsivity. 
Examination of sex differences showed that among those without ADHD males reported greater 
levels of mind wandering compared to females, but among those with ADHD, males and females 
reported similar levels. A similar pattern was found for inattention and hyperactivity/impulsivity, 
with the exception that among those with ADHD males reported more inattention than females. 
This is in line with recent findings amongst youth (Mowlem et al., 2018) showing higher ADHD 
symptoms in males than females in the general population, but similar symptom severity amongst 
those with a diagnosis, except for higher inattention in males. To our knowledge this is the first 
investigation of sex differences in those with and without ADHD in a population-based sample of 
adults, and we found that the pattern of sex differences for the behavioural ADHD symptoms in 
adults with and without ADHD is also reflected in the more internalised/subjective experience of 
excessive mind wandering. 
Regarding impairment, males without ADHD reported greater impairment than females, but 
similar levels were reported among those with a self-reported ADHD diagnosis. Additionally, 
despite similar symptom levels and impairment in males and females with ADHD, females with 
ADHD reported significantly greater wellbeing, potentially indicating differing perceptions of 
behaviour in males and females with ADHD. In youth, studies show parents may under-rate ADHD 
symptoms and impairment in girls with ADHD compared to boys, suggesting sex-specific biases in 
perceptions of behaviour (Abikoff et al., 2004; Meyer et al., 2017). It is possible that differing 
perceptions of behaviours and impairment in males and females also occurs in adulthood. This 





A strength of the current study is the large sample size including a large age range and 
representation of females, both of which are often a limitation of studies in the ADHD literature. 
However, some limitations should be considered. First, despite the online survey being a general 
population sample, it is not necessarily representative of the general population, but of those who 
chose to participate in an online survey. Our sample included significantly more females than 
males suggesting that females may be more willing to participate in such studies. Further studies 
should examine if results are replicated across other populations. Second, our definition of ADHD 
was based on self-report and not clinical diagnosis data. However, this approach has previously 
been employed in a survey design (Hesson & Fowler, 2018), and was adopted in the most recent 
large-scale genome-wide association study of ADHD using 23andme (Demontis et al., 2017). In 
addition, our findings replicate those of our previous study that included a clinical sample of adults 
with ADHD (Mowlem et al., 2016). 
Enhancing our understanding of the broader range of symptoms or problems associated with 
ADHD and the phenomenology that underlies ADHD symptomatology has the potential to aid 
diagnosis and inform targets for interventions. Valid and reliable assessment of disorders is a 
prerequisite for clinical treatment and intervention. The MEWS has been shown to be a reliable 
and valid measure of mind wandering in ADHD that discriminates between those with and without 
ADHD, with satisfactory sensitivity and specificity, and specific association with functional 
impairment. Finding measures to assess adult ADHD, a disorder primarily defined in behavioural 
terms, is of value, and mind wandering could be more useful when self-report is possible as it is 
the experience of the internal mental states rather than observed behaviours. The MEWS shows 
promise as a brief screening tool in the general population and could be a potential target for 
monitoring of treatment effects.  
The replicated finding that mind wandering had an independent effect on impairment beyond that 
of core ADHD symptoms of inattention and hyperactivity/impulsivity, indicates that symptoms of 
mind wandering are strongly linked to impairment and so may be an important target for 
therapeutic interventions. Further studies are needed to establish such interventions, but 






Chapter 6. Discussion and conclusions 
This thesis sought to further our understanding of sex differences in ADHD across youth and 
adulthood. The main aims were to examine whether: 1) different factors are associated with 
meeting diagnostic criteria in females versus males, 2) sex-dependent biases in parental 
perceptions of ADHD symptoms exist, 3) the predictive associations of symptoms on being 
diagnosed and treated for ADHD differs in males and females, and 4) investigate whether a new 
measure based on the internal subjective experience of ADHD - excessive mind wandering - could 
have clinical utility in ADHD diagnosis and add to our understanding of sex differences in the 
manifestation of ADHD. The specific findings, limitations, and implications of each individual 
empirical study have been discussed in detail within their respective chapters and will not be 
repeated here. Rather, this chapter summaries the key findings and draws them together to 
consider the wider research and clinical implications of the work presented in relation to 
individuals with ADHD. I then provide an overview of the general strengths and limitations of this 
body of work, including methodological considerations, and suggest future directions for research.  
6.1 Summary of key findings and implications 
The first empirical chapter (Chapter 2) in this thesis used a population-based sample to examine if, 
amongst a group of children with comparably elevated ADHD symptoms, different factors 
influence whether females and males meet diagnostic criteria. ADHD diagnosis was derived from 
an investigator-rated semi-structured interview; thus the children meeting diagnostic criteria were 
not ascertained from clinical settings, removing potential bias related to factors influencing 
referral to clinics. The findings showed that females meeting diagnostic criteria for ADHD had 
higher rated emotional, conduct, and peer problems, total problem scores, and complaints about 
hyperactivity at school compared to females with high symptoms that did not meet diagnostic 
threshold. Although similar differences were observed in males (except for emotional problems), 
effect sizes were greater in females. These results suggest that factors which distinguish females 
who meet full ADHD diagnostic criteria from high-symptom peers who do not may be somewhat 
sex-specific, and additional behavioural and emotional problems may play a larger role in 





Potentially females’ ADHD symptoms may need to be made more prominent by additional 
behavioural problems for them to display clinically recognisable ADHD behavioural symptoms. 
Furthermore, the prominence of emotional problems for females meeting diagnostic criteria, 
which is in line with previous findings (Novik et al., 2006), suggests this characteristic is more 
specific to the female phenotype of ADHD and females may express their difficulties differently to 
males with ADHD. 
Additionally, sex differences in parental perceptions of ADHD behaviours and impairment were 
demonstrated. Despite the objective investigator-rated interview measure of impairment 
distinguishing between the diagnosed and high-symptom groups of females, parent ratings of 
impairment did not. That is, parents rated females meeting diagnostic criteria for ADHD as having 
similar levels of impairment as females who did not meet diagnostic threshold for ADHD. 
However, both measures distinguished the two groups of males. In addition, amongst children 
meeting diagnostic criteria for ADHD, parents were found to under-rate females’ 
hyperactive/impulsive symptoms compared to the more objective accounts from the diagnostic 
interview, with the opposite pattern observed in males. These results are in line with those of a 
previous study comparing parent-ratings of ADHD to an objective classroom observational 
measure which found that, despite comparable levels of ADHD symptoms in males and females 
based on objective assessment, parent-ratings reflected observed ADHD status less well in females 
(Meyer et al., 2017). These findings suggest the existence of sex-dependent biases among parental 
perceptions of ADHD symptoms and that parents may be less sensitive to impairment in females, 
perhaps due to it being expressed differently to in males.  
Following on from Chapter 2, the second empirical study (Chapter 3) also investigated sex 
differences related to childhood ADHD diagnosis in a population-based sample, but uniquely this 
sample could be linked to clinical diagnoses data obtained from national population registries. 
Thus, a clinical sample was available, but participants had not been ascertained via clinics and so 
are representative of all those receiving a clinical diagnosis of ADHD, overcoming a key methodical 
issue in this research area. Specifically, Chapter 3 investigated whether the predictors of ADHD 
clinical diagnosis and pharmacological treatment differ in males and females. At the population 
level, compared to females, males were found to have higher scores for all measured symptom 





females received a clinical diagnosis of ADHD, and clinically diagnosed males and females showed 
similar symptom severity. Symptom severity for all domains increased the likelihood of having a 
clinical diagnosis of ADHD in both males and females. Additionally, significant sex-by-symptom 
interactions on diagnostic and treatment status were found for hyperactivity/impulsivity and 
conduct problems, such that these behaviours were stronger predictors of clinical diagnosis and 
prescription of pharmacological treatment in females. These findings, using one of the largest 
datasets to date to investigate sex differences in ADHD, suggest that females with ADHD may be 
more easily missed in the ADHD diagnostic process and less likely to be prescribed medication in 
the absence of prominent externalising problems. 
The sex differences observed in ADHD led me to think more about the expression of ADHD and 
how investigating additional symptoms and ways to measure them could increase our 
understanding of whether males and females manifest their ADHD differently. Thus, the third and 
fourth empirical studies in this thesis (Chapters 4 and 5) investigated the ‘symptom’ of excessive 
mind wandering in ADHD. 
Chapter 4 evaluated the psychometric properties of a newly developed measure of mind 
wandering - The Mind Excessively Wandering Scale (MEWS) – created based on patients’ reports 
of their internal, subjective experience of ADHD. This is the first study published using this scale, 
and I evaluated the MEWS in two independent case-control samples. The findings from both 
samples indicated a unidimensional structure to the MEWS which accounted for between 62 – 
70% of the variance, and that the scale has high internal consistency and good test-retest 
reliability. 
Consistent with previous findings (Franklin et al., 2014; Seli et al., 2015; Shaw & Giambra, 1993; 
Weyandt et al., 2003), investigation of case-control differences revealed significantly elevated 
levels of mind wandering in individuals with ADHD compared to controls. Furthermore, the MEWS 
successfully discriminated between cases and controls with high sensitivity (~.9) and specificity 
(~.9), as shown by ROC analysis. Importantly, these differences were comparable to those of 
existing scales used in assessment of ADHD, which demonstrates potential clinical utility of the 
scale. However, the finding that adds weight to the potential value of the MEWS was that mind 





inattention and hyperactivity/impulsivity. Further, in the second sample, mind wandering had the 
most impact on impairment in the model. In the subset of individuals with ADHD who were 
treated with methylphenidate at follow-up, a significant reduction in mind wandering scores was 
found compared to the baseline medication-free period. These findings suggest that excessive 
mind wandering is a common co-occurring feature of adult ADHD that has specific effects on 
impairment, and that the MEWS could have clinical utility as an additional screening tool in adult 
ADHD assessment and could also be used for treatment monitoring. 
Following on from Chapter 4, the final empirical study (Chapter 5) further validated the MEWS in a 
large general population sample and examined sex differences in the manifestation of adult ADHD. 
As in Chapter 4, findings revealed a unidimensional structure to the MEWS, with confirmatory 
factor analysis indicating good model fit. Additionally, I assessed measurement invariance to 
examine whether the scale is capturing fundamentally the same construct across sex, ADHD 
status, and age. Measurement invariance is rarely tested in empirical studies of psychiatric 
disorders (Orri et al., 2016), yet a lack of invariance can render group comparisons (e.g., cases vs 
controls) meaningless and lead to incorrect interpretations of differences (Marsh et al., 2013; Orri 
et al., 2016). This study is the first to examine measurement invariance of the MEWS. Across sex, 
ADHD status and age, I found the MEWS to be measurement invariant, giving confidence that any 
subsequent between-group comparisons would be meaningful. Reliability and validity analyses 
indicated strong internal consistency for the whole sample and across sex and ADHD status. 
Further replicating the previous findings (Chapter 4; Mowlem et al., 2016), mind wandering was 
elevated in individuals with ADHD compared to those without, and the MEWS showed good case-
control discriminatory capacity and accounted for unique variance in impairment beyond the core 
ADHD symptoms. Strengthening the latter finding, I also found mind wandering to contribute 
independently to wellbeing.  
Sex differences in mind wandering in those with and without ADHD were also examined, along 
with the symptom dimensions of inattention, hyperactivity/impulsivity, emotional lability, 
impairment, and wellbeing. Among those without ADHD, males reported significantly greater 
symptom levels across all variables and lower wellbeing compared to females. Conversely, in 
individuals with self-reported ADHD, males and females demonstrated similar scores, except for 





children) and lower wellbeing compared to females. To my knowledge, this is the first 
investigation of sex differences in adult ADHD in a population-based sample including those with 
and without an ADHD diagnosis, and adds to the limited literature in this field. The findings further 
support mind wandering as a common co-occurring feature of ADHD, and the MEWS as an 
instrument that could aid the screening and diagnostic process. Moreover, the findings show that 
the pattern of sex differences observed for the behavioural symptoms of ADHD and impairment 
are also reflected in the internalised and subjective experience of excessive mind wandering.   
6.2 Wider themes and their implications  
The literature is clear in identifying that females with ADHD may be underdiagnosed compared to 
males. However, it is unclear whether this is truly because females are less likely to be affected or 
whether there are biases in the referral and diagnostic process leading to under-referral and 
under-identification of females with ADHD, especially in youth. The sex ratio balances out in 
adulthood, but the diagnosis in adulthood is still relatively rare in comparison to youth and is 
based on criteria developed for diagnosis in children and adolescents. Taken together, the findings 
from this thesis have highlighted some emerging themes regarding these issues, discussed below. 
6.2.1 Referral and diagnosis of females with ADHD symptoms 
 
The findings from Chapters 2 and 3 identify a potential link to the under-recognition and/or under-
diagnosis of ADHD in females compared to males. In Chapter 3, more males than females had a 
clinical diagnosis of ADHD (2.5:1), yet among those from the population the ratio based on 
symptomatic criteria was slightly lower (1.8:1). Among children in the population with elevated 
symptoms, a higher percentage of the males had a clinical diagnosis compared to the percentage 
of the females. In Chapter 2, the ratio of diagnosed to high-symptom females was 0.65:1 
compared to 1.5:1 for males, suggesting that males with high symptoms are more likely to meet 
diagnostic criteria than females. Furthermore, Chapter 3 found that externalising problems were 
stronger predictors of ADHD diagnosis in females compared to males, yet in Chapter 2 parents 





them in males. These findings are in line with studies showing that parents perceive the ADHD 
criteria as being descriptive of males (Ohan & Johnston, 2005), and that externalising behaviours 
drive referral (Biederman et al., 1999). Additionally, parents’ ratings of their child’s impairment 
demonstrated a sex-specific bias, with lower rated impairment in females meeting diagnostic 
criteria compared to males meeting diagnostic criteria, and no differences in impairment ratings 
shown between high symptom and diagnosed females, neither of which were in line with findings 
based on the objective interview measure. 
As discussed, behavioural diagnoses can bring issues of symptom interpretation and perception 
from individuals key to the diagnostic process, and the tendency to view ADHD as a predominantly 
male disorder can affect how behaviour in males and females is perceived by individuals key to the 
diagnostic process (such as parents and teachers). If a male stereotype of ADHD is the norm, then 
it is possible that parents and teachers may not as readily recognise manifestations of ADHD in 
females compared to males. Thus, potentially only the most severe females or those whose 
symptoms manifest as disruptive behaviours will be identified. In line with this, and based on the 
findings from this thesis, the high sex ratio in diagnostic rates of ADHD could therefore partly 
reflect: 1) sex-specific stereotypes operating in the referral process due to parents not judging 
females to be as impaired or to demonstrate as many externalising symptoms, and 2) bias in the 
current diagnostic criteria or the way they are applied to males and females in clinical settings, as 
if the diagnostic criteria are biased or poorly defined for females compared to males (Williamson & 
Johnston, 2015) then females will be more likely to have a diagnosis if they have externalising 
symptoms. Further, clinicians use parental report in clinical assessment, and if parents are less 
sensitive to ADHD-type behaviours in females and more attuned to notice and endorse symptoms 
in males, even if the rates of ADHD behaviours are similar in males and females, females may be 
missed in the referral and diagnostic process. Overall these results are consistent with 
explanations of a sex bias in the recognition of symptoms of ADHD that have been argued to 
contribute to the under-referral and under-diagnosis of females (Biederman et al., 2005; Ohan & 
Johnston, 2005). Furthermore, this has implications for females with ADHD receiving appropriate 
treatments, and it was also the case that externalising behaviours were stronger predictors of 
receiving pharmacological treatment in females. It is also entirely possible that ADHD occurs more 





Given the need for early identification to optimise treatment outcomes, the negative long-term 
outcomes associated with ADHD that are likely to be increased in individuals whose symptoms are 
untreated, and that those with undiagnosed or subthreshold ADHD (failure to meet full diagnosis) 
are unlikely to access services from which they would benefit, the current findings identify a need 
for improving awareness that females are also affected by ADHD. It is important that parents and 
clinicians are sensitive to the fact that females with ADHD may not present in the same ways as 
males. By increasing our knowledge of sex differences in ADHD, and working towards improved 
recognition of females, the negative societal impact of ADHD can potentially be reduced. 
Another message to draw from the work in this thesis is the importance of reliable measures for 
screening and diagnosing ADHD in both childhood (specifically to ensure that females are not 
missed) and adulthood (to ensure that adults with ADHD are effectively screened), in both 
research and clinical practice. As shown in Chapter 2, some diagnostic tools, such as parent rating-
scale measures, may lead to underestimating females’ symptoms and impairments and contribute 
to their under-diagnosis. Further, it can mean that females are less likely to be included in 
research studies of ADHD or to be given ADHD case status in a study, as many population-based 
studies derive diagnosis based on parent-rating scales. The use of structured diagnostic interviews 
for subject identification when exploring sex differences in research on ADHD has been highlighted 
as a necessity (Gaub & Carlson, 1997). 
 
As previously detailed in this thesis, it has also been proposed that the observed sex differences in 
referral and diagnosis in youth results from females being more likely to present with an 
internalising presentation of ADHD, comprising predominantly inattentive symptoms, compared to 
an externalising set of symptoms in males (Arnold, 1996; Quinn, 2008). This thesis found that 
across youth (Chapter 3) and adulthood (Chapter 5), it was not the case that females had more 
severe inattention than males. In fact, in those with a diagnosis of ADHD males had higher 
inattention scores than females. However, in Chapter 3, at the population level females were 
found to be more likely to have the inattentive presentation compared to males. This suggests 
that females do not have more inattention than males, but that they are less likely to have as 





inattentive symptoms tend not to be rated as being as impairing as the externalising symptoms 
(Coles et al., 2012; Willcutt, 2012), individuals with a primarily inattentive presentation of ADHD 
may be less frequently referred for services (Nussbaum, 2012). The findings from Chapter 3 appear 
to suggest that this is the case, as despite at the population level more females than males had the 
inattentive presentation, at the clinical level the combined presentation was most common in 
both sexes, again speaking to the view that externalising behaviours drive referral. Of note, this 
could also affect males with an inattentive presentation. 
Currently, each of the symptoms listed in the DSM criterion A (which details the two symptom 
dimensions each comprising nine symptoms; see Table 1.1) carries the same weight. Recent work 
has suggested that inattention drives hyperactivity/impulsivity, but not the converse (Sokolova et 
al., 2016), and it could be argued that the inattentive items should be more heavily weighted than 
the hyperactivity/impulsivity items. More research is needed to replicate this finding and 
investigate it further, but if this were to be the case then potentially more females with ADHD 
would receive a diagnosis, but it should not miss those with externalising presentations if 
inattention drives hyperactivity/impulsivity. 
 
Studies in clinical samples tend to show that males and females have similar severity (Gaub & 
Carlson, 1997), but in population-based sample males tend to have higher ratings (Larsson et al., 
2012; Levy et al., 2005; Martin et al., 2014). This suggests that females will need a greater severity 
of symptoms to reach and pass the diagnostic threshold compared to the norm for females, 
whereas males generally have a higher level of symptoms and will not require the same increase in 
symptoms from their norm to reach diagnostic threshold. In Chapters 3 and 5, at the population 
level males scored higher than females across all symptoms domains – showing greater symptom 
severity – whereas similar symptom severity was demonstrated at the clinical level (except for 
greater inattention in males, as mentioned). In Chapter 2, regarding traits relevant to the 
pathology of ADHD, the magnitude of difference in scores between females meeting diagnostic 
threshold and females with comparably high ADHD symptoms not meeting threshold was greater 
than in the equivalent groups of males. Taken together, these findings are indicative of normative 





symptoms and correlates, may have to deviate further from their group norm to reach diagnostic 
threshold. I also extended previous findings by showing that the pattern of sex differences for the 
behavioural ADHD symptoms in those with and without ADHD seems to be reflected in the more 
internalised experience of excessive mind wandering, at least in adulthood. 
Due to the replicated finding that females generally have a lower intensity of symptoms, it could 
be argued that sex-specific modification in the severity of symptoms required for diagnosis should 
be implemented (Staller & Faraone, 2006). Further research would be beneficial to establish the 
most appropriate thresholds for the diagnosis of ADHD and if it should differ for females. 
However, whether it is imperative to establish if a categorical decision for the presence of a 
disorder should be based on normative comparisons (i.e., if the child is more severe than children 
of the same sex and age) is debateable if more emphasis were to be placed on impairment (Frick & 
Nigg, 2012). Despite impairment measures forming a key component of the referral and diagnostic 
process, current criteria still focus on the number of symptoms rather than a more precise 
definition of functional impairment (Cortese & Coghill, 2018). This is an important line of inquiry 
given it is anticipated that there are a substantial number of youth in the community who do not 
meet full symptom criteria for ADHD but experience significant functional impairment and would 
benefit from treatment (Polanczyk et al., 2015). This clearly indicates the importance of managing 
diagnostic thresholds effectively as failure to meet full diagnosis limits access to a range of 
services, such as school accommodations, despite the association of subthreshold symptoms with 
real world impairment (Angold et al., 1999; Balazs & Kereszteny, 2014; Bussing et al., 2010; 
Faraone, Biederman, Spencer, et al., 2006; Hong et al., 2014; Noren Selinus et al., 2016). 
6.2.2 Additional symptoms could aid screening for ADHD in adults 
Currently, there are no biomarkers to determine ADHD and the diagnosis is made when a set of 
defined behavioural symptoms and criteria for onset, course and impact have been met which are 
very much based on childhood research. However, ADHD is now recognised to occur in adulthood 
(Asherson et al., 2016; Biederman et al., 2010; Faraone, Biederman, & Mick, 2006). In this age 
group diagnosis is usually made based on self-report, compared with the parent report that is a 
key source of information for childhood ADHD diagnosis. Evidence shows that informant report 





(Asherson et al., 2016; Du Rietz et al., 2017; Merwood et al., 2013). A potential reason for this 
discrepancy is that it is more difficult for an individual to reflect upon the behavioural symptoms 
that currently characterise ADHD diagnosis, such as if others think that you “do not listen to when 
spoken to directly”, compared to a parent reporting on such symptoms. Reporting on an internal, 
subjective mental state could be a more accurate way to capture self-report of ADHD, yet current 
screening tools for adult ADHD comprise rating scales largely of behaviours. 
In conjunction with existing findings in the literature (Franklin et al., 2014; Seli et al., 2015; Shaw & 
Giambra, 1993; Weyandt et al., 2003), the results from Chapters 4 and 5 of this thesis suggest that 
adults with ADHD frequently experience excessive and uncontrolled mind wandering, which 
appears to be a strong predictor of the daily functional difficulties they experience. This 
demonstrates that individuals with ADHD also present with subjective psychopathology that goes 
beyond behavioural descriptions, which may form part of the core symptomatology of ADHD. 
Additional measures to aid assessment and monitoring of adult ADHD and provide new insights 
into the disorder in this age group is of considerable relevance to research and clinical practice 
(Asherson et al., 2016). The current findings show the significance of mental phenomena in the 
disorder, its specific association with impairment, and the validation of a measure pertaining to 
this. Thus, it is believed that the MEWS could have utility as a screening tool to incorporate into 
clinical practice and research studies of ADHD to assist with accurate diagnosis in adulthood. The 
National Institute for Health and Care Excellence (NICE) clearly states the importance of linking 
symptoms to impairment, and if, as implied here, the MEWS is potentially explaining a variety of 
deficits not easily accounted for by the core symptom dimensions, this further strengthens its 
potential utility. Moreover, it could be argued that some of the current symptoms used to define 
ADHD are conflated with impairment. For example, losing things, being forgetful, and being 
disorganised are ‘symptoms’ of ADHD, yet could easily be considered impairments. Thus, the 
criteria are not exclusively describing a symptom but behaviours that could be prone to 
adaptation. The current symptoms may not be sensitive to the underlying disorder, in that if 
individuals have developed adaptive skills to manage the symptoms, then the symptoms may not 
be as apparent. Self-reflection on an internal mental state which is independent of adaptive skills 





thinking, it can be argued that mind wandering is entirely different from measures of impairment 
as it is only reflecting a subjective experience of the flow of thoughts. 
As it was shown that the MEWS correlates highly with the existing core behavioural symptoms 
specified in the ADHD diagnostic criteria, by-and-large the MEWS may be picking up the same 
symptoms (it is possible that it could underlie, and thus lead to the ADHD symptoms, or it could be 
another reflection of inattention/distractibility). However, as MEWS scores also distinguished 
between cases and controls with high sensitivity and specificity, potentially it could pick up 
individuals who may otherwise be missed or receive a delayed diagnosis, for example those with 
less overt behavioural presentations of ADHD or those who lack confirmation of behavioural 
symptoms from additional informants. Furthermore, adults may find it easier to accurately report 
mind wandering than the traditional DSM symptoms of inattention and hyperactivity/impulsivity, 
and so the MEWS may enable more accurate self-report of ADHD. If self-report is the main source 
of information for diagnosis (as is often the case in adulthood), then questionnaires based more 
on internal experiences that the individual can better reflect on themselves may be more 
appropriate. However, it is important to reiterate that currently we do not recommend the routine 
use of the MEWS to identify patients with ADHD until the scale has been comprehensively 
evaluated in other psychiatric disorders with overlapping clinical features (see section 6.4.3.1). The 
possibility that mind wandering could especially aid in the diagnosis of females with ADHD was 
discussed in Chapter 5, however, the findings were not clear that this was the case, since levels of 
mind wandering were found to be similar in males and females with ADHD.   
The finding that mind wandering contributes to functional impairment beyond the core symptoms 
of ADHD also has implications for treatment. First, given that mind wandering scores reduced 
when individuals with ADHD took pharmacological treatment (Chapter 4), the MEWS could be 
effectively used to monitor treatment outcomes. Second, mind wandering itself could be a 
treatment target, and interventions such as mindfulness that are likely to reduce levels of mind 
wandering (Bachmann, Lam, & Philipsen, 2016), could also reduce impairment. For example, it has 
recently been shown that mindfulness increased nonreactivity to inner experience in those with 





The findings could also have implications for the DSM. As previously mentioned, the DSM-5 
defines ADHD almost entirely by reports of behaviours, and mind wandering is only briefly 
mentioned as one example of distractibility (American Psychiatric Association, 2013). Further, the 
DSM has only recently been adapted to facilitate diagnosis in adulthood, which included simply 
adding descriptions of how the existing defined symptoms could affect adults (i.e., instead of 
leaving seat at school, also including leaving seat in the workplace) as opposed to a set of criteria 
specifically based on adulthood symptoms. With future work, potentially two sets of criteria could 
come to exist, one for diagnosis in children and adolescents and one for adults. For example, in 
adulthood greater emphasis could be placed on internal mental states as opposed to observable 
behaviours, given it may help them report their symptoms. This is not implying that they are two 
different disorders, but that diagnosing a disorder in childhood and adulthood is quite a different 
process. Further, even though the underlying psychopathophysiology is likely to be largely the 
same and that largely the same ‘symptoms’ will be specified, the criteria could be more tailored to 
the way the symptoms present in each age group and based on more robust research on the 
manifestation of the disorder in adulthood. However, it could be challenging to decide the point at 
which childhood/adolescence turns into adulthood (Blakemore & Choudhury, 2006; Johnson, 
Blum, & Giedd, 2010). 
6.3 Methodological considerations: strengths and limitations  
Each of the empirical chapters within this thesis includes a brief discussion of the main limitations 
and strengths relevant to that study. In the following section I describe in more detail the 
methodological considerations that apply to the research throughout this thesis. 
6.3.1 Sample sizes 
The research undertaken in this thesis capitalises on several strengths of the datasets used to 
advance knowledge on sex differences in ADHD. The large size of the samples used in Chapters 3, 4 
and 5 is a key strength of this body of work. The population-based sample of over 19,000 children 
used in Chapter 3 (The Child and Adolescent Twin Study in Sweden; CATSS) is one of, if not the, 
largest epidemiological studies used to investigate sex differences in ADHD which meant a more 





exclusively, made up of male participants meaning the findings may not generalise to females with 
ADHD or ADHD symptoms. Also, although the size of the case-control samples (MIRIAD and 
OCEAN) used in Chapter 4 who completed the MEWS were modest, they enabled initial validation 
of a new measure. Further, I replicated the findings in a much larger sample of 1484 individuals 
(Chapter 5).  
Recruiting participants and administering measures online (as I did in Chapter 5), where much 
larger and more representative samples are (in principle) readily available offers an attractive 
prospect (Gosling, Vazire, Srivastava, & John, 2004). However, despite these benefits, it is 
recognised that online surveys are not without their obstacles. For example, there exists a trade-
off between increased sample size and potentially decreased data quality (Germine et al., 2012). 
That said, such issues tend to be more of a concern for performance-based cognitive and 
perceptual measures (Germine et al., 2012), and there have been studies demonstrating the 
validity and reliability of web-based questionnaire measures (Chiorri & Vannucci, 2017; Gosling et 
al., 2004; Haworth et al., 2007). Additionally, studies comparing questionnaires completed in the 
lab versus online have found no significant or systematic differences in results (Casler, Bickel, & 
Hackett, 2013). The findings from Chapter 5 regarding the psychometric properties of the MEWS 
when administered online replicate the findings from Chapter 4 where the MEWS was 
administered face-to-face, providing confidence of psychometric equivalence and that online 
administration did not sacrifice data quality.  
In Chapter 2, even though the sample size for the female groups was modest (n=32 and 49), this 
was still sizeable for a study investigating sex differences in ADHD. Despite selection of 
participants from the wider TEDS sampling frame, there was a mismatch in the number of males 
(n=121 and 81) to females. The reason for the smaller number of females was not arbitrary; rather 
it was due to less females being identified as having high ADHD symptoms or meeting the 
diagnostic criteria. Furthermore, this study involved secondary analysis of existing data and the 
study was not originally designed for the purposes of sex difference analysis. Larger-scale 





6.3.2 Age range 
The studies in this thesis investigate ADHD in both youth and adulthood, acknowledging the 
presence of the disorder across the life trajectory. As a limit of the current sex differences 
literature in ADHD is that most studies focus on children and adolescents (Davies, 2014), the study 
of ADHD in adulthood in Chapters 4 and 5, and specifically investigation of sex differences in 
Chapter 5, offers a novel aspect to this research. Further, the participants from the online survey 
presented a wide age range (16 – 83 years), which is a benefit given that most studies of adult 
ADHD focus on early and middle adulthood. However, it is acknowledged that the broad age-range 
sampled may contribute to greater age-related variability in measures of interest, potentially 
masking some meaningful results, especially as analyses were run controlling for age to account 
for any of these effects. That said, the MEWS was found to be measurement invariant across age 
(Chapter 5), but future studies may wish to investigate more homogeneous groups. It is 
acknowledged that the samples in Chapters 2 and 3 were restricted to childhood, and the samples 
in Chapters 4 and 5 were restricted to adulthood and so each set of results may not generalise to 
other age groups than those studied in the specific chapters. Notably however, the sex differences 
analyses in adulthood (Chapter 5), replicated the findings from childhood (Chapter 3).  
6.3.3 Diagnostic classification 
Most population-based studies rely solely on parent or teacher rating scales to classify participants 
with and without ADHD. Such rating-scale measures of child behaviour reflect the perspective of 
untrained raters, which may be prone to sex-specific biases and perceptions of behaviours (Meyer 
et al., 2017). The PHAD study was unique in extending existing methodology used in population-
based samples by incorporating a detailed, ‘gold-standard’, objective diagnostic measure of ADHD. 
In the CATSS study, participants were linked to National Registry Data on whether they had a 
clinical ADHD diagnosis. Linking a population-based sample to clinical data for which there is not 
an ascertainment bias in this way overcomes limitations of using one source of information on 
ADHD alone (i.e., clinical data or parent-ratings). Additionally, the online survey study is a 
population-based sample with data from participants who self-reported a diagnosis of ADHD, but 





of information (as opposed to confirmation from clinical notes) previous studies have successfully 
taken this approach; for example the most recent large-scale genome-wide association study of 
ADHD found high genetic correlation (rg = 0.65) between self-reported cases of ADHD and those 
with an established clinical diagnosis (Demontis et al., 2017).  
Thus, the population-based studies used in this thesis uniquely reconcile trade-offs between 
epidemiological and clinical samples. They overcome some of the limitations of population-based 
samples that diagnose based on rating-scales alone, and of clinical samples where ascertainment 
bias exists, both of which could have implications specifically for studies of sex differences in 
ADHD. This is especially pertinent given that findings from Chapter 2 showed differences in 
parental ratings of males and females meeting diagnostic criteria for ADHD based on investigator-
rated interview. 
6.3.4 Dimensional and categorical definitions of ADHD 
Another strength of the studies in this thesis is that they employed both dimensional (symptoms 
and impairment ratings) and categorical (diagnostic cut-off) definitions of ADHD. For example, in 
Chapters 2, 3 and 5, categorical analyses compared males and females based on clinical cut-offs of 
ADHD and all chapters compared those with and without ADHD (obtained through diagnostic 
interview, national registry data, or self-report - as detailed in section 6.3.3). A strength of 
Chapters 4 and 5 was that they employed both approaches by looking at how the measures of 
mind wandering were associated with the continua of ADHD symptoms and impairment, as well as 
investigating case-control differences. In light of the converging evidence that the symptoms of 
ADHD are quantitative traits distributed continuously throughout the population (Frazier, 
Youngstrom, & Naugle, 2007; Haslam et al., 2006; Larsson et al., 2012; Levy et al., 1997; Lubke et 
al., 2007; Salum et al., 2014), and given the complexity of ADHD, adopting both approaches is 
valuable to obtaining a more complete understanding of ADHD. 
Studies employing a categorical approach better reflect clinical diagnostic discriminations between 
‘affected’ and ‘unaffected’ individuals that are likely to be implemented in the ‘real-world’. 
However, a fundamental conceptual issue relevant to the study of ADHD is that the diagnostic 





etiologically or biologically-based definitive delineation of disorder presence vs. absence. A 
dimensional approach enabled investigation of ADHD in population-based samples unselected for 
clinical extremes for epidemiological research, reducing the risk of ascertainment bias so often 
associated with clinical samples. It also allowed examination of ADHD symptoms and impairment 
separately (such as in Chapters 2, 4 and 5). This is valuable given the heterogeneity of ADHD and 
given: 1) the possibility that individuals who fall just below the threshold may have significantly 
impairing symptoms, 2) that individuals within a diagnostic category can vary greatly with regard 
to symptom severity and impairment, and 3) that individuals with high symptoms will not always 
experience significant impairment (Barry, Lyman, & Klinger, 2002; Frick & Nigg, 2012). The 
categorical approach to diagnosis can be seen to ignore these variations (Frick & Nigg, 2012). In 
Chapter 2 I aimed to address some of these factors in the study design. For example, the sample 
included a group of children who had comparably high levels of ADHD symptoms to those meeting 
diagnostic criteria, but it was not assumed that they would not experience impairment. It also 
acknowledged that children within a diagnostic category can differ with regard to impairment, 
specifically to address sex differences and understand if different factors characterise males and 
females within the ADHD diagnostic group. 
6.3.5 Rater effects 
In Chapters 2 and 3 of this thesis, ADHD symptom ratings were based on parent report; although it 
is important to note that the diagnosis of ADHD was not based on parent ratings alone. 
Measurement error is a contentious issue in psychopathology assessment. Whilst parent-rated 
reports of ADHD-symptoms have the highest and most consistent heritability estimates compared 
to self- and teacher- ratings (Nikolas & Burt, 2010; Sibley, Pelham Jr, Gnagy, et al., 2012) and 
previous studies show greater agreement with objective markers of ADHD outcomes, as well as 
superior predictive validity on long-term outcomes compared to self-reports (Barkley, Fischer, 
Smallish, & Fletcher, 2002; Du Rietz et al., 2016), this is not to say that sex-specific stereotypes are 
not influencing interpretations of behaviours by parents (Meyer et al., 2017). Indeed, in Chapter 2 
I found some evidence that parents may underrate females’ ADHD symptoms compared to more 
objective measures and over-rate males. This was only investigated for ADHD symptoms, but the 





Questionnaire (SDQ), cannot be excluded. It is also possible that parent-ratings may have shown 
rater bias in the other direction for behaviours that are deemed more stereotypically female, such 
as prosocial behaviour. It is important that in both clinical practice and research there is an 
awareness of the role of perceptions in informant ratings, and all informant report is subject to 
some degree of bias. 
The use of self-report for the mind wandering measure in Chapters 4 and 5 represents a strength 
of this work, as the use of parent-report or other external informant report may not provide an 
optimal assessment of internalising symptoms which can go unnoticed by external informants.  
6.3.6 Generalisability 
The studies in Chapters 2, 3 and 5 used population-based samples, and these types of studies are 
designed to provide results that can be generalised to individuals with the disorder in the general 
population, but it means that the findings may be less generalisable to clinical cohorts. This may 
be most obvious regarding sex differences in ADHD as the ratio of males to females with ADHD is 
much smaller in population-based samples compared to clinical samples. This suggests that more 
females are affected with ADHD than reflected in clinical samples, and so the findings from 
investigations in clinical samples may not be wholly representative of the population with ADHD. 
The scientific research literature on ADHD consistently illustrates the trade-off between clinical 
and epidemiological methodologies (Bauermeister et al., 2007), and as discussed, clinical samples 
can be unrepresentative of the general population with ADHD, especially if we are missing or mis-
diagnosing many females with ADHD. 
However, an important question is whether (and why) we are failing to diagnose ADHD in females. 
To address this, we need to clarify whether the current gender disparity is reflective of true 
etiological differences and/or a reflection of problems with a male-focused conceptualisation, 
recognition, and assessment process of ADHD. If we only study clinical samples, this will not 
provide information about non-referred individuals and females with ADHD may be missed, thus 
limiting our understanding of the disorder in general, and in females. The population-based 
datasets used in this thesis had a good female representation. Many studies in ADHD are primarily, 





symptoms. Thus, by using datasets that are both population-based and with strong female 
representation, the findings from the empirical studies in this thesis are more representative of all 
individuals with ADHD, including females. 
Finally, a concern when using twin samples is that it may limit generalisability to singletons. For 
example, relative to singletons, twins are more likely to have lower birth weight (Bhutta, Casey, 
Cradock, Anand, & Cleves, 2002; Pettersson et al., 2016) and be born preterm, both of which show 
association with later ADHD diagnosis (Aarnoudse-Moens, Weisglas-Kuperus, van Goudoever, & 
Oosterlaan, 2009; Bhutta et al., 2002; D’Onofrio et al., 2013; Johnson, Hollis, et al., 2010). Prior 
studies examining the generalisability of research using twin samples to singletons have reported 
mixed results regarding the effect of twin status on ADHD risk, with some studies showing 
differences between twins and non-twin sibling pairs regarding ADHD symptomatology and 
implicating a twin-specific effect (Ehringer, Rhee, Young, Corley, & Hewitt, 2006; Levy et al., 1997), 
and other studies not showing a difference (Moilanen et al., 1999). Importantly, the prevalence of 
ADHD observed in Chapter 3 (3.2%) using a twin sample was in the range reported in non-twin 
samples (Polanczyk et al., 2015), giving confidence in the generalisability of the findings. This also 
has implications statistically. Using twin samples means you have clustered data (i.e., the inclusion 
of two individuals per family), violating the assumption of independence of observations for the 
outcome. If unaccounted for in analysis this can lead to biased standard errors of the estimated 
regression coefficients. I addressed this by employing statistical techniques which produce robust 
standard errors in Stata. This is beneficial as it allows the use of all available data, rather than just 
one twin in each pair which can severely impact sample size. Nevertheless, it is important to 
replicate findings in non-twin samples.  
6.3.7 Effect sizes, significance thresholds, and multiple testing 
Following scientific convention, the analyses in this thesis used a p<0.05 significance threshold to 
judge statistical significance. Trend level associations are also acknowledged (i.e., p>0.05 and 
<0.10). The significance threshold is somewhat arbitrary (Hackshaw & Kirkwood, 2011) and there 
have been growing calls for researchers to focus on effect sizes and confidence intervals during 
the interpretation of findings. Thus, although the conventional threshold was used to judge the 





The data analyses in this thesis did not apply a correction for multiple testing. This is specifically 
relevant to Chapters 2 and 3. Although within each study several statistical tests were conducted, 
the choice was made not to employ a correction for multiple testing because this alters the 
statistical inference of a study from the testing of a number of specific hypotheses to a test of the 
universal null hypothesis (i.e., testing that the null hypotheses across all the variables are 
simultaneously true) (Biederman et al., 2005; Perneger, 1998; Rothman, 1990; Savitz & Olshan, 
1995). In the studies within this thesis, differences in specific variables among males and females 
could have important interpretive consequences and so testing the universal null hypothesis was 
not of interest. Furthermore, the main focus was sex differences as opposed to differences 
between the multiple variables. Other drawbacks also include an increase in the type II error rate 
(false negative findings) (Perneger, 1998; Rothman, 1990) and issues regarding how many tests 
should be included in the adjustment (Perneger, 1998). In addition, common multiple testing 
corrections such as Bonferroni assume that hypotheses are uncorrelated (or unrelated), which is 
not the case in studies such as these where all hypotheses relate to the overarching question of 
sex differences. However, due to the exploratory nature of these analyses, further replication of 
the results from this thesis is important to validate findings and before beginning to make strong 
assertions regarding implications for clinical practice. 
6.4 Future directions 
6.4.1 Replication 
To test reproducibility of the findings from this thesis, future observational studies should test for 
replication of the specific findings in large independent samples. My study of children with 
comparably high levels of ADHD who did and did not meet diagnostic criteria is, to my knowledge, 
the first empirical study of its kind. Specifically, the use of a detailed objective investigator-rated 
interview to obtain diagnostic information in a population-based sample complemented by 
parental-rating scales was a novel aspect. Although findings are interpreted conservatively given 
potential limitations, such as modest sample size, the initial evidence (namely larger effect sizes in 
diagnosed vs high-symptom females as compared to males) suggests that meaningful sex 





population-based sample for whom all participants receive a detailed diagnostic interview (as 
opposed to a selected high-risk sub-sample), and information would be gathered on individuals 
who were actually referred to clinical services. Such studies would add to our ability to uncover 
potential sex-specific biases in the ADHD referral and diagnostic process. Chapter 3 was carried 
out using data from the Swedish population, and findings regarding sex differences between males 
and females in the population but not in those with a clinical diagnosis replicate previous studies 
(Arcia & Conners, 1998; Biederman et al., 2002; Gaub & Carlson, 1997; Graetz et al., 2005; 
Ramtekkar et al., 2010; Sharp et al., 1999). Generalisability to countries with similar demographics 
and healthcare access is likely to be high. However, it is important to see if results from a country 
with universal healthcare coverage (as in Sweden) are replicated in other countries.  
As mentioned in section 6.3.1, Chapter 5 replicated the findings of Chapter 4 in a larger, 
population-based sample, which is a strength of this body of work. However, to my knowledge this 
was the first study of sex differences in those with and without ADHD in a population-based 
sample of adults, and so requires replication - although the results did replicate my findings in 
youth from Chapter 3. Further studies are also needed to extend the findings, for example though 
experimental paradigms or using experience sampling techniques. Potentially this could provide 
further information on differential manifestation of ADHD as a function of sex. 
6.4.2 ADHD sex differences research 
 
It is imperative to establish whether females with ADHD are being overlooked. The studies in 
Chapters 2 and 3 of this thesis looked at sex differences in ADHD in relation to associations with 
diagnosis. Whilst the study design and findings enabled speculation and inferences to be made 
regarding potential biases in the referral process, neither had explicit information on actual 
referral. A valuable next step in this line of research would be to interrogate the issue of sex 
differences in referral for ADHD behaviours. Following from this is the question of whether 
females with ADHD symptoms are being referred but receiving alternative diagnoses, which would 
imply potential biases in the diagnostic process. If it is the case that females with ADHD are being 





other conditions (e.g., anxiety, depression) and/or that diagnostic over-shadowing is occurring 
from genuine co-morbidities (e.g., anxiety, depression, anorexia, learning disability) (Quinn & 
Madhoo, 2014). Recently, it was shown that amongst children who had received a clinical 
diagnoses of anxiety or depression (based on administrative data), females had a higher burden of 
the genetic variants associated with increased risk for ADHD compared to males (Martin, Taylor, et 
al., 2018). Such findings indicate the possibility that females at genetic risk for ADHD may be 
underdiagnosed and receive alternative diagnoses such as anxiety or depression. 
The studies in this thesis were not able to examine the likelihood of children, and specifically 
females, being given alternative diagnoses. Leveraging registry data would offer a great 
opportunity to explore these questions in more detail. For example, one could examine whether 
females versus males with high ADHD symptoms are more likely to receive alternative diagnoses 
and whether certain presentations or manifestations of ADHD are associated with higher 
likelihood of alternative diagnoses in both sexes, and more so in females than males. This could 
potentially indirectly shed light on referral bias, as if most children who meet symptomatic criteria 
for ADHD from the population are observed in the national registry data for having a psychiatric 
diagnosis (not necessarily ADHD), then this would suggest that the children are being referred, but 
that not all are receiving an ADHD diagnosis. Such studies could also strengthen our understanding 
of whether the current diagnostic criteria for ADHD and/or clinical practice are somewhat biased 
towards a male presentation of ADHD. However, it is important to note that although national 
registry data is an incredibly valuable resource, there is a need for data on more than just the 
diagnostic code. For example, inclusion of phenotypic information to enable a greater 
understanding of why the diagnosis was made - especially with diagnoses that are so 
heterogeneous in nature. The proposed study findings could further inform our understanding of 
the way clinicians recognise ADHD symptoms and potentially apply the diagnostic criteria, and 
would benefit those working in this field in terms of improving understanding and recognition of 






To understand more about sex differences in ADHD and potential differences in referral, diagnosis, 
and treatment for males and females with ADHD, I believe it would be informative to carry out a 
qualitative study. This could provide rich data from a variety of informants, including clinicians, 
teachers, parents of children with ADHD or high ADHD symptoms, and individuals with ADHD, and 
potentially uncover issues not revealed in quantitative studies, such as the experiences and unmet 
social needs of females with ADHD or high ADHD traits, and potential masking and compensatory 
mechanisms amongst females (Quinn & Madhoo, 2014). If it is not known what these are, then 
they are unlikely to be measured in quantitative studies. In Chapter 2, the possibility that in the 
presence of positive social behaviour females’ symptoms may be ‘masked’ making them appear 
less impaired was discussed. Furthermore, studies have suggested that behaviour in the home 
versus school environment may be more different in females than males (Meyer et al., 2017). 
Qualitative studies hold promise for understanding more about these hypotheses and such 
findings could, for example, influence clinical aspects of ADHD assessment and help educators 
maximise students' compensatory skills. This improved information could lead to better 
recognition and theoretical understanding of the female presentation of ADHD. 
Qualitative studies could also increase understanding about treatment decisions. In Chapter 3, it 
was not possible to take into consideration the influence of parental preference for treatment. 
That is, prescribing medication (or not) for a child with ADHD could be influenced by whether a 
parent wishes their child to receive alternative forms of treatment first or if they deem the 
behaviour of the child to be problematic enough to warrant pharmacological treatment, rather 
than being exclusively decided by the clinician as a result of assessment. Such decisions could 
differ based on the child’s sex and I was not able to examine such underlying nuances in 







The studies included in this thesis are cross-sectional. It is important to examine how the 
symptoms of ADHD and associated traits differ from normal behaviour at different developmental 
periods and understand if the diagnostic criteria are effectively reflecting these differences, 
including as a function of sex. Findings from such studies may inform our understating of 
maturational effects, for example whether onset of ADHD is later in females (Agnew-Blais et al., 
2016) and if there are gendered maturation differences in the trajectory of ADHD symptoms and 
associated traits (Nussbaum, 2012) which would add to understanding of why ADHD would 
emerge later in adolescence for females. It could be that as life gets more complex, for example 
during adolescence and young adulthood when social demands may increase and/or there are 
changes in the environment and support system (e.g., leaving home and no longer living with 
parents), potential compensatory mechanisms employed by females with (undiagnosed) ADHD 
come undone. It could also be that there are different developmental processes that we do not 
yet fully understand. The findings from this thesis also indicate a need for increased understanding 
of the complex aetiological and developmental relationship between ADHD and internalising 
symptoms in males and females which could be addressed with longitudinal data. For example, 
examining whether these co-occurring symptoms develop as a consequence of untreated ADHD or 
are independent of ADHD.  
6.4.3 Mind wandering research 
 
Despite the research in this thesis strongly supporting the notion that adults with ADHD frequently 
experience excessive spontaneous mind wandering, the sensitivity and specificity of the MEWS for 
the ADHD diagnosis compared to other clinical diagnoses is not clear. Future studies are required 
to not only evaluate the psychometric properties of the MEWS in populations with other clinical 
disorders, but to determine the discriminant validity of the scale (and mind wandering) in those 
with ADHD compared to individuals with other psychiatric diagnoses. Given that mind wandering 
has been shown in other conditions, such as obsessive compulsive disorder (Seli et al., 2017), it 





diagnoses groups. For example, in ADHD it may just be a general tendency to mind wander and 
constantly have your thoughts on the go and flitting around, whereas in other disorders it may be 
driven by negative cognitions and rumination and only present itself in specific contexts.  
 
The research on mind wandering in this thesis explored the phenomenon in adults with ADHD. 
Given the link between mind wandering and impairment and wellbeing, it is of interest for future 
work to explore mind wandering in children. This is a complex undertaking and it is unclear if 
investigation of mind wandering in child ADHD populations is conceivable, although a recent study 
has begun to explore this (Van den Driessche et al., 2017). It is possible that children could 
describe the experience of a subjective mental state that reflects mind wandering but may not be 
able to conceptualise it, understand what it actually is, or reliably and validly report on it. 
Nevertheless, this is an important line of research to pursue given that parents may be better at 
recognising and reporting on externalising behaviours compared with internalising problems 
(Husky et al., 2017; Van Der Meer, Dixon, & Rose, 2008). Furthermore, children as young as 6 have 
been shown to be capable of providing valid reports of their mood and feelings (Ialongo, Edelsohn, 
& Kellam, 2001; Rebok et al., 2001; Ringoot et al., 2017). The necessity for mental health screening 
efforts in youth are highlighted by the fact children and adolescents rarely disclose 
(spontaneously) their emotional distress to an adult (Husky et al., 2017; Van Der Meer et al., 2008; 
Vander Stoep et al., 2005). Thus, additional ways of measuring internalising symptoms that are 
causing distress hold potential. However, measures such as the MEWS would clearly need to be 
adapted for use in children; for example, with computerised, cartoon-like self-report methods 
(Husky et al., 2017). 
Previous longitudinal research has revealed a greater developmental decline in hyperactive-
impulsive than inattentive symptoms (Biederman et al., 2000; Larsson et al., 2006). Given that 
mind wandering may underlie the inattentive behavioural symptoms of ADHD (Biederman et al., 
2017; Bozhilova et al., 2018; Jonkman et al., 2017), exploring longitudinally the relationship 
between mind wandering and ADHD and if its frequency differs across the developmental 





could help answer questions regarding whether excessive mind wandering in ADHD is an 
epiphenomenon of the processes that lead to ADHD symptoms or has a more direct causal role in 
generating the symptoms and impairments of ADHD. Additionally, such a study could incorporate 
investigation of potential sex differences in mind wandering across the developmental trajectory. 
Understanding of the maturational processes could potentially aid diagnosis and guide 
intervention. 
 
ADHD poses an evolutionary paradox, in that despite being strongly associated with negative long-
term outcomes and functional impairments, it persists in the population with a substantial 
worldwide prevalence rate. By definition, mental health disorders are maladaptive and impairing, 
and so a negative stance tends to be taken when investigating ADHD in terms of focusing on 
investigation of the associated impairments and adverse outcomes. However, for a ‘disorder’ to be 
so highly prevalent in a population suggests it is not exclusively maladaptive and certain 
advantages and adaptive characteristics of ADHD traits may exist.  For example, we know that 
some individuals with high levels of ADHD symptoms are able to excel in the workplace if they 
select jobs that take advantage of some of the characteristic features of ADHD, and adults with 
ADHD may choose specific types of jobs that best suit their symptoms (Wiklund, Patzelt, & Dimov, 
2016). 
Despite mind wandering often being associated with negative symptoms of ADHD, mind 
wandering is not always detrimental, and may confer functional benefits in some circumstances 
(Mooneyham & Schooler, 2013). Both ADHD and mind wandering demonstrate association with 
creativity (Baird et al., 2012; White & Shah, 2006, 2011), and those with ADHD are more likely to 
report interesting mind wandering episodes (Franklin et al., 2014). Mind wandering could 
therefore be accounting for the creativity often demonstrated in ADHD, and this is an interesting 
area for future research.  
There is very little research on the strengths and positive aspects of adult ADHD (Wiklund et al., 
2016; Wilmshurst, Peele, & Wilmshurst, 2010), and it is important to understand more about 





symptoms. Of note, this is not to downplay the impairing nature of ADHD and the many difficulties 
experienced by those living with ADHD, but instead recognising that there is value in showing that 
ADHD is not solely adverse, supporting the reduction of stigma of mental health disorders and the 
design of interventions and supportive environments that enhance wellbeing.  
6.5 Conclusion 
The research presented in this thesis contributes to our understanding of sex differences in ADHD 
and provides further insight into the nature of the disorder. In particular, it makes a significant 
contribution to our understanding of potential sex-specific biases in the referral and diagnostic 
process, and the literature on ADHD and mind wandering. The findings suggest females may be 
more easily missed in the referral and diagnostic process due to sex-specific biases in the 
interpretation of symptoms by parents, and in the absence of prominent externalising behaviours 
and additional co-occurring problems. Further, the findings show that mind wandering - as 
measured by a newly developed scale - is a common co-occurring symptom of ADHD with specific 
implications for the functional impairment experienced. Overall, the results of this thesis highlight 
the need for increasing awareness and knowledge of ADHD in females amongst parents, teachers, 
and clinicians, a careful approach in the assessment of females with symptoms of ADHD, and the 
clinical utility of a newly developed measure of mind wandering in the assessment of adults with 
ADHD. It is a public health concern if individuals with ADHD are being missed and not gaining 
access to serves and treatment that they could benefit from, and thus being at greater risk for the 
adverse outcomes associated with ADHD. I hope that information gained about sex differences in 
ADHD can improve understanding of ADHD in females and encourage and guide future research 
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Appendix A: Supplementary material for Chapter 2 
 
 
Online Supplementary Material 
Mowlem, F.D., Agnew-Blais, J., Taylor, E., & Asherson, P. Do different factors influence whether 
girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD 
symptoms. 
 
Additional sample information 
The Developmental Pathways to Hyperactivity and Attention Deficit Study (PHAD) 
PHAD is a spin-off study from the larger Twins Early Development Study (TEDS) [1]. The primary 
aim of PHAD was identifying early neuroimaging and cognitive markers underlying risk for ADHD. 
Twins from the TEDS sampling frame were screened for ADHD symptoms at age 7 years using 
combined parent and teaching ratings on the hyperactivity/inattention subscale of the Strengths 
and Difficulties Questionnaire (SDQ), plus three additional items addressing attention and 
hyperactivity and impulsivity problems (‘notices small details’, ‘has difficulty completing activities’, 
‘has difficulty waiting for things’). The SDQ is frequently used in both clinical and research 
assessments of ADHD and as a measure to detect children at high risk of mental health problems 
especially using multiple informants [2–4]. Twins at risk of ADHD were identified if at least one 
twin in each twin-pair scored in the top 15% of the TEDS population. Families were excluded if 
they had withdrawn from TEDS or were uncontactable, were involved in other TEDS spin-off 
studies, or if medical exclusions applied. Opposite sex-pairs were excluded as the original objective 
of the study was to compare within twin-pair cognitive and neuroimaging findings for ADHD, while 
removing the potential confounding effect of sex differences. This led to 861 families being 
selected from TEDS where at least one twin was at risk of ADHD. Of these, 690 families agreed to 
participate in a further screening telephone interview, based on which 200 families were excluded: 
67 due to reports of at least one twin having a learning disability, autistic spectrum disorder, or a 
neurological disability, and 133 who reported having no problems at home or school, or problems 





checklist based on DSM-IV criteria [5], based on which 138 families were excluded where neither 
twin met the required symptom threshold (score >22). This left a sample of 207 families with at 
least one twin with high levels of ADHD symptoms. 196 families with children identified as being at 
risk for ADHD (comprising 276 boys and 116 girls) completed the Parental Account of Childhood 
Symptoms (PACS) diagnostic interview. 
Additional information on study measures 
PACS diagnosis 
As in previous studies using the PACS [6, 7], an ADHD diagnostic algorithm combined data from the 
PACS and the Conners’ teacher-rating scale for DSM-IV ADHD symptoms to apply a research 
diagnosis of ADHD. Children were ‘diagnosed’ if sufficient items were identified to fulfil DSM-5 
criteria, and both impairment (based on severity of symptoms identified in the PACS) and 
pervasiveness (based on the presence of ADHD symptoms in more than one setting using 
information from the PACS and the Teacher Conners’) were present. Situational pervasiveness 
outside the home setting is also captured in the PACS interview. 
Impairment: SDQ Impact supplement 
Parents are first asked ‘Overall, do you think that your child has difficulties in one or more of the 
following areas: emotions, concentration, behaviour or being able to get on with other people?’. 
Subsequent items include: ‘Difficulties upset or distress child’, ‘Interfere with home life’, ‘Interfere 
with friendships’, ‘Interfere with classroom learning’, and ‘Interfere with leisure activities’. If ‘no’ is 
answered to the first question then the subsequent questions are not asked and the impact score 
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Mowlem, F.D., Rosenqvist, M.A., Martin, J., Lichtenstein, P., Asherson, P., & Larsson, H. (2018). Sex 
differences in predicting ADHD clinical diagnosis and pharmacological treatment. European Child & 
Adolescent Psychiatry.   
Supplementary Table 1. Characteristics of males and females in the entire sample (means and SD unless 
otherwise stated) 
Bold data signify statistical significance of the tests 
All models were adjusted for familial clustering, year of birth, and SES 
a Data were missing on some variables; all available data were used in analysis 
 
Supplementary Table 2. Characteristics of clinically diagnosed males and females stratified by medication 
prescription (based on the Prescribed Drug Register) (means and SD) 















Inattention 4.67 (2.82) 4.25 (2.72) 4.23 (2.97) 2.79 (2.67) 
Hyperactivity/Impulsivity  4.25 (3.20) 3.41 (2.88) 4.10 (3.23) 1.88 (2.03) 
Conduct problems 0.58 (0.99) 0.58 (0.90) 0.70 (1.08) 0.25 (0.48) 
Learning problems 0.98 (1.01) 0.96 (1.08) 1.07 (1.12) 1.30 (1.15) 








p  Cohen’s d 
Total ADHD  2.06 (3.13)  2.49 (3.46) 1.62 (2.68)  < .001 0.28 
Inattention  1.05 (1.75)  1.29 (1.92)  0.81 (1.52)  < .001 0.28 
Hyperactivity/ 
Impulsivity 
1.01 (1.71) 1.20 (1.88)  0.81 (1.48)  < .001 0.23 
Conduct 0.10 (0.37)  0.12 (0.41)  0.08 (0.32)  < .001 0.11 





Appendix C: Supplementary material for Chapter 4 
 
Mowlem, F.D., Skirrow, C., Reid, P., Maltezos, S., Nijjar, S.K., Merwood, A., Barker, E., Cooper, R., 
Kuntsi, J., & Asherson, P. (2016). Validation of the Mind Excessively Wandering Scale and the 
relationship of mind wandering to impairment in adult ADHD.  Journal of Attention Disorders. 
 
Recruitment process for the OCEAN study (Study 2)  
Controls  
Controls were recruited via recruitment circulars and advertisements in the local community.  
Cases  
Recruitment occurred through four sources:  
1. Recruitment through South London and Maudsley NHS Trust (SLaM): The medical records of 
patients (either follow-up patients or those on the waiting list) from the SLaM Adult ADHD Service 
were screened for eligibility, using the inclusion and exclusion criteria, by a member of the OCEAN 
research team who held honorary clinical contracts. In addition previous ADHD study databases 
were also screened for suitable participants. Those deemed eligible were sent study information 
sheets, invitations, a response slip and a stamped addressed envelope. Where no response slip 
was returned, participants were contacted by telephone to determine their interest in 
participating. Those who expressed an interest in participating in the study completed a telephone 
screening (detailed below). If deemed suitable following the telephone screening and if a Conners 
Adult ADHD Diagnostic Interview for DSM-IV (CAADID: a structured clinical interview for the 18 
ADHD symptoms in childhood and adulthood) (Epstein et al. 2001) had been completed as part of 
their diagnostic assessment at SLaM, then they were invited into the trial and their baseline 
assessment was booked. If a CAADID were not completed as part of their diagnostic assessment it 
was completed over the phone by a member of the research team. If the patient was on the 
waiting list then a research diagnostic assessment was carried out by P. Asherson and R. Copper 
(detailed below).  
2. Online questionnaire: In order to recruit undiagnosed patients an online screening 
questionnaire was set-up (http://neuroknowhow.com/adhdoraddquestionnairepage/) (although 
this link has now been disabled). This was established by a study participant who runs the website 
‘neuroknowhow’ (http://neuroknowhow.com/aboutus/) which provides services and online help 





screening questionnaire consisted of the six questions in Part A of the(ASRS) which have been 
found to be the most predictive of ADHD (Kessler et al. 2005). Those who screened above the 
threshold for ADHD were asked to complete the Barkley Childhood Behaviour Scale. If they scored 
positive for 6 or more symptoms of either or both domains of inattention or 
hyperactivity/impulsivity then a research assessment was conducted (see below).  
3. Online advertisements: Participants were also recruited from advertisements on the ADHD 
support websites AADD-UK (Adult ADHD-UK) (http://aadduk.org/about/) and ADDISS (The 
National Attention Deficit Disorder Information and Support Service) (http://www.addiss.co.uk/). 
We were also contacted from participants who saw the trial registered on clinical trials.gov 
(identifier: NCT01750307). If these participants had an existing diagnosis we asked them to send 
us a copy of their diagnostic assessment report. If inclusion/exclusion criteria were met then the 
CAADID (Epstein et al. 2001) was completed by a member of the research team. If the participants 
did not have an existing diagnosis and screened above threshold for ADHD on the ASRS (Kessler et 
al. 2005) and Barkley’s Childhood Behaviour Scales (Barkley 1998) then a research assessment was 
conducted (see below).  
4. Recruitment through other doctors: We attended the clinical team meetings at the Maudsley 
Adult ADHD Clinic to communicate the study to members of the healthcare team and ask if they 
had any suitable patients and if they could let their patients know about the study. The study was 
also circulated to clinicians on the email list of the UK Adult ADHD Network (UKAAN).  
Telephone screening  
Both ADHD and control participants underwent a structured telephone screening of exclusionary 
criteria, which consisted of detailed questions assessing any previous or current mental health 
problems including: presence, treatment for or diagnosis of anxious, depressive and 
manic/hypomanic symptoms, physical health problems, neurological problems, drinking and drug 
habits, use of omega-3 or 6 supplements, and any known allergies to fish.  
Research assessment  
Undiagnosed participants who met inclusion/exclusion criteria were asked to complete (over the 
telephone) the CAADID (Epstein et al. 2001). In line with DSM-5, symptom onset and chronicity 
was established before age 12 and in adulthood, the presence of a minimum of 5 symptoms of 
inattention and 3 symptoms of hyperactivity/impulsivity were established (American Psychiatric 
Associations 2013). The CAADID was also completed (over the telephone) with someone who 
knew the participant in childhood, most commonly a parent. The CAADID was then reviewed by P. 
Asherson, an experienced consultant psychiatrist specialising in adult ADHD, who approved the 
participants prior to inviting them into the study. In addition, P. Asherson met participants at their 
baseline assessment to review and confirm the diagnosis. Participants were then provided with a 
letter from P. Asherson detailing the outcome of the research assessment. Participants who had 





help gain a referral for a formal adult ADHD assessment, although they were asked to not begin 














Supplementary Figure 1. Scree plot produced during Factorial Analysis for Study 1 indicating a one-
factor solution.  
 
Supplementary Figure 2. Scree plot produced during Factorial Analysis for Study 2 showing a one-






Supplementary Tables  
Supplementary Table 1. Case-control differences for mind wandering (MEWS), inattention (INN), 
hyperactivity/impulsivity (HI), emotional lability (EL), and impairment (IMP) at Time 2 and 3 
 Study 1 Study 2 









 N M SD N M SD p N  M SD N M SD p 


































































- - - 




- - - 
IMP 30 0.87 0.41 38 0.26 0.29 <.0001 68 0.95 0.50 - - - - 
Time 3               
MEWS - - - - - - - 55 24.62 11.10 - - - - 
INN - - - - - - - 54 23.65 7.52 - - - - 
HI - - - - - - - 54 17.11 6.43 - - - - 
EL - - - - - - - 55 20.58 11.69 - - - - 









Supplementary Table 2. Case-control differences for each domain of impairment at each time 
point 
                  Study 1                               Study 2 









Time 1 N M SD N M SD p N M SD N M SD p 
Family Life 41 1.04 0.66 
 
47 0.25 0.34 <.0001 80 1.17 0.76 
 
30 0.23 0.30 <.0001 
Work 39 1.31 0.63 39 0.22 0.39 <.0001 68 1.27 0.74 26 0.11 0.19 <.0001 
School 31 1.90 0.61 38 0.37 0.46 <.0001 40 1.88 0.64 10 0.18 0.28 <.0001 











1.01 0.59 41 
 
0.20 0.28 <.0001 80 1.09 0.69 30 0.12 0.19 <.0001 
Risk Taking 
 
47 0.65 0.49 41 0.23 0.26 =.001 80 0.64 0.46 30 0.16 0.19 <.0001 
Time 2               
Family Life 30 0.59 0.44 38 
 
0.24 0.39 <.0001 67 0.85 0.70 - - - - 
Work 27 1.04 0.56 24 0.17 0.26 <.0001 54 
 
0.91 0.68 - - - - 
 









29 1.30 0.79 38 0.51 0.52 <.0001 68 1.49 0.98 - - - - 
Social  
 
29 0.71 0.48 38 0.18 0.25 <.0001 68 0.82 0.62 - - - - 
Risk Taking 29 0.40 0.38 38 0.18 0.21 =.001 68 0.49 0.43 - - - - 
Time 3               
Family Life - - - - - - - 54 0.81 0.70 - 
 
- - - 
Work - - - - - - - 42 0.89 0.73 - - - - 
School - - - - - - - 16 1.33 0.88 - - - - 
Life-Skills 
 
- - - - - - - 55 1.23 0.65 - - - - 
Self-
Concept 




- 55 1.33 0.92 - - - - 
Social 
 
- - - - - - 
 
- 55 0.80 0.68 - - - - 











Supplementary Table 3. ROC Analysis curve coordinates showing sensitivity and specificity of the 













Test result Sensitivity 1 - Specificity 
-1.00 1.000 1.000 
.50 1.000 .667 
1.50 1.000 .583 
2.50 .920 .542 
3.50 .880 .292 
5.00 .880 .250 
6.50 .880 .208 
10.50 .880 .167 
15.00 .880 .125 
16.50 .840 .125 
18.50 .800 .083 
22.00 .800 .042 
24.50 .680 .042 
25.50 .600 .000 
27.00 .440 .000 
28.50 .400 .000 
29.50 .360 .000 
30.50 .280 .000 
32.00 .240 .000 
33.50 .160 .000 
35.00 .120 .000 
37.50 .040 .000 





Supplementary Table 4. ROC Analysis curve coordinates showing sensitivity and specificity of the 
























Test result Sensitivity 1 - Specificity 
-1.00 1.000 1.000 
.50 1.000 .931 
1.50 1.000 .759 
2.50 1.000 .724 
3.50 1.000 .655 
4.50 1.000 .621 
5.50 .987 .552 
7.00 .987 .379 
8.50 .987 .345 
9.50 .987 .310 
10.50 .975 .241 
11.50 .949 .207 
13.00 .924 .207 
14.50 .911 .138 
15.50 .899 .103 
17.00 .848 .103 
18.50 .810 .069 
19.50 .785 .069 
20.50 .759 .069 
21.50 .759 .034 
22.50 .734 .000 
23.50 .684 .000 
24.50 .671 .000 
25.50 .633 .000 
26.50 .582 .000 
27.50 .557 .000 
28.50 .443 .000 
29.50 .418 .000 
30.50 .354 .000 
31.50 .329 .000 
32.50 .304 .000 
33.50 .278 .000 
34.50 .253 .000 
35.50 .215 .000 
37.00 .177 .000 
38.50 .152 .000 
39.50 .139 .000 
40.50 .127 .000 
41.50 .076 .000 
42.50 .063 .000 
43.50 .025 .000 





Supplementary Table 5. ROC Analysis curve coordinates showing sensitivity and specificity of the 























Test result Sensitivity 1 - Specificity 
-1.00 1.000 1.000 
.50 1.000 .897 
1.50 1.000 .759 
2.50 1.000 .724 
4.00 1.000 .483 
6.50 .987 .345 
8.50 .975 .276 
9.50 .937 .207 
10.50 .924 .172 
11.50 .911 .138 
12.50 .886 .103 
13.50 .873 .103 
14.50 .848 .103 
15.50 .835 .069 
16.50 .797 .069 
17.50 .785 .000 
18.50 .759 .000 
19.50 .722 .000 
20.50 .684 .000 
21.50 .646 .000 
23.00 .570 .000 
24.50 .494 .000 
25.50 .430 .000 
27.00 .342 .000 
28.50 .316 .000 
29.50 .266 .000 
30.50 .215 .000 
31.50 .177 .000 
32.50 .152 .000 
33.50 .127 .000 
34.50 .114 .000 
35.50 .063 .000 





Supplementary Table 6. Cross-scale correlations between the mind wandering (MEWS), 
inattention (INN), hyperactivity/impulsivity (HI), emotional lability (EL), and impairment (IMP) 
rating scales in cases and controls  
 
Study 1 
Time 1 INN HI EL IMP 
 Cases Controls Cases Controls Cases Controls Cases Controls 
MEWS 0.50* 0.87*** 0.38 0.81*** 0.63** 0.74*** 0.56** 0.75*** 
INN   0.62*** 0.77*** 0.48** 0.66*** 0.58*** 0.68*** 
HI     0.61*** 0.64*** 0.59*** 0.69*** 
EL       0.53*** 0.77*** 
Study 2 
Time 1 INN HI EL IMP 
 Cases Controls Cases Controls Cases Controls Cases Controls 
MEWS 0.50*** 0.38* 0.36** 0.23 0.58*** 0.65*** 0.67*** 0.56** 
INN   0.46*** 0.35 0.23** 0.52** 0.46*** 0.57** 
HI     0.13 0.35 0.23* 0.59** 
EL       0.62*** 0.56** 
* p < .05, ** p < .01, *** p <.001 
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Supplementary Table S1. Details of the study measures 







12 items 4-point likert scale 
 
Not at all or rarely [0], Some of the 
time [1], Most of the time [2], Nearly 






4 items 7-point likert scale 
 
Rarely [1] to A lot [7], or Almost never 






4 items 7-point likert scale 
 
Rarely [1] to A lot [7], or Not at all 
true [1] to Very true [7] 
28 .84 
Barkley Adult ADHD 
Rating Scale 3 
18 items 
(9 items for inattention, 
9 items for 
hyperactivity/impulsivity) 
4-point likert scale 
 
 Never or Rarely [0], Sometimes [1], 











10 items 4-point likert scale 
 
 Never or Rarely [0], Sometimes [1], 
Often [2], Very Often [3] 
 
A ‘Not Applicable’ option is available, 
which should be selected if the item 
refers to an area that is not part of 
their life (e.g., they do not drive), as 
opposed to not experiencing 






(6 symptom items, 1 
impairment item) 
3-point likert scale 
 
Not True [0], Somewhat True [1], 
Certainly True [2] 
12 .86 
The Mental Health 
Continuum-Short 
Form (MHC-SF) 5  
14 items 
(6 items for psychological 
wellbeing, 5 items for 
social wellbeing, 3 items 
for emotional wellbeing) 
6-point likert scale 
 
Never [0], Once or twice [1], About 
once a week [2], About 2 or 3 times a 









Supplementary Table S2. Details of the constraints applied to the 3 models used to test 
measurement invariance 
 Loadings Thresholds Item residual 
variances 
Factor variance Factor mean 
Configural Free to vary in both 
groups (one factor 
loading fixed at 1 for 
scaling purposes) 
Free to vary in both groups Fixed at 1 Free to vary in 
both groups 
Fixed at 0  
(for identification 
purposes) 
Metric Equal across groups Free  
(first threshold of each item 
is held equal across groups, 
and second threshold of the 
item used to set the metric 
of the factor is held equal 
across groups) 
 
Fixed at 1 in first 
group and free in 
the other 
Free to vary in 
both groups 
Fixed at 0 in first 
group and free in 
the other 
Scalar Equal across groups Equal across groups Fixed at 1 in first 
group and free in 
the other 
Free to vary in 
both groups 
Fixed at 0 in first 
group and free in 
the other 
 
Supplementary Table S3. Mean scores (SD) for the study subscales stratified by sex and self-reported ADHD 






Females      
(n=984-
1059) 
Males              
(n=395-425) 
Males vs Female 
ADHD       
(n=198) 
No ADHD              
(n=1180-
1181) 
No ADHD vs ADHD 
 M (SD) M (SD) M (SD) p 
Cohen’s d 
(95% CI) 
M (SD) M (SD) p 










































































































































Note. MEWS = Mind Excessively Wandering Scale; MW-S = Mind Wandering Spontaneous; MW-D = Mind Wandering 
Deliberate; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = impairment; WB = wellbeing. 
Statistical analysis adjusted for age.                                                                                                                                                
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